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MINIsTER’s FOREWORD
I am pleased to introduce this new policy framework covering all aspects of cardiovascular health, 
including stroke. It is now a decade since the first National Cardiovascular Health Strategy, Building 
Healthier Hearts (1999), was launched. It introduced a wide range of new services and initiatives, which 
have had a positive impact on reducing the burden of cardiovascular disease through prevention, 
better diagnosis and treatment. However, given the pace of change in scientific development and 
medical practices in this area during the last decade, an updated policy was required. Furthermore, 
any policy on cardiovascular care would be incomplete unless it includes a strategy on stroke.
This new policy, Changing Cardiovascular Health, covering the period 2010-2019, addresses the 
spectrum of cardiovascular disease and stroke, including prevention and management and how 
these are integrated to reduce the burden of these conditions. It covers the whole area of prevention, 
including measures that individuals can take as well as population interventions, and areas in which 
intersectoral action is necessary. It deals with the clinical management of cardiovascular disease 
and stroke, and covers all aspects of healthcare – from childhood through old age, from pre-hospital 
emergency care to rehabilitation and palliative care.
The policy is being launched in a challenging economic climate with little prospect of additional 
resources. However, the policy covers the period 2010-2019 and much can be done to advance it in 
tandem with other national strategies and the reorganisation of current resources. The Health Service 
Executive has been tasked with developing an implementation plan detailing how it intends to 
arrange services to support the delivery of care.
This policy represents a significant development coming after previous policies on cancer and diabetes, 
which together will account for the majority of healthcare in this country. The policy will operate 
alongside and complement existing policies on obesity, alcohol and chronic disease. The review is timely 
given the considerable changes in health services, the impact of unhealthy lifestyles, the future demand 
on health services and the scope for substantial improvements in cardiovascular mortality in the years to 
come. I am confident that this policy paves the way for enhanced prevention and care of cardiovascular 
disease and stroke in the next decade and will mark a new chapter for service delivery in this area.
I would like to take this opportunity to thank the members of the Cardiovascular Health Policy 
Group, who gave freely of their time and expertise in order to develop this framework, and especially 
Professor Hannah McGee, Professor of Health Psychology at the Royal College of Surgeons in Ireland, 
who worked tirelessly on this project.  
_______________________________________
Mary Harney, TD
Minister for Health and Children
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INTRODuCTION TO THE CARDIOvAsCuLAR HEALTH POLICY (CHAPTER 1)
The Cardiovascular Health Policy Group was established with the following terms of reference:
Having regard to the audit of the implementation of the cardiovascular health strategy, 
Building Healthier Hearts, and the audit of stroke services, Irish National Audit of Stroke Care, 
and consistent with developments in relation to the management of chronic diseases and 
the Primary Care Strategy, to develop a policy framework for the prevention, detection and 
treatment of cardiovascular disease, including stroke and peripheral arterial disease, which will 
ensure an integrated and quality-assured approach in their management.
This new cardiovascular policy, Changing Cardiovascular Health covering the period 2010-2019, comes 
a decade after the first national cardiovascular health strategy, entitled Building Healthier Hearts, was 
published by the Department of Health in 1999. The new policy is timely given the pace of scientific 
discovery and related changes in medical practice, changes in health service structures, and patterns 
and influences on population health behaviours in Ireland over the decade. Cardiovascular health and 
its maintenance is a microcosm of health more generally. A policy that can improve cardiovascular 
health and cardiovascular disease management will have beneficial effects for the whole healthcare 
system and population.
CARDIOvAsCuLAR DIsEAsE – TRENDs IN IRELAND (CHAPTER 2)
Cardiovascular disease remains the most common cause of death in Ireland, currently accounting 
for one-third of all deaths and one in five premature deaths. However, there has been substantial 
progress. Age-standardised death rates from cardiovascular disease have decreased by two-thirds over 
the past 30 years. Despite improvements, Ireland still ranks below the EU15 average for life expectancy 
for both men and women. As mortality rates have reduced, demand on health services has intensified.
Without changes in prevalence and practice, hospital bed use can be expected to increase 
substantially over the next decade as the number of people aged over 65 in Ireland is predicted to 
increase by 41%. In primary care, prescriptions for cardiovascular medication have increased two- to 
four-fold. At population level, the current lifestyle-related risk factor profile of the Irish population is 
a major concern: levels of smoking have not changed in the last 5 years, while levels of obesity and 
physical inactivity have increased (see Chapter 3). If these patterns continue, they threaten to reverse 
the declining trend in cardiovascular disease mortality of recent decades. There is thus considerable 
scope for improvement. This challenge is an intersectoral one – involving and being driven by those 
responsible for health and healthcare, but supported and enabled by sectors such as education, 
transport and agriculture.
Apart from the human cost, the cost of cardiovascular disease to the Irish economy – which includes 
the costs of healthcare, loss in productivity and informal care – is a significant burden. Spending on 
cardiovascular health, while substantial, accounts for only 6% of the Irish healthcare budget – lower 
than the EU27 average of 10%. A much greater level of analysis of the costs of cardiovascular disease 
is needed to inform discussions about service investments and value for investment over the 10-year 
timeframe of this new policy. 
3PREvENTION AND HEALTH PROMOTION (CHAPTER 3)
Cardiovascular disease must be addressed through a combination of population-based approaches, 
which target the entire population, and high-risk approaches, which focus on individuals in contact 
with health services. The burden of cardiovascular diseases and the lifestyle factors that contribute to 
them is borne disproportionately by those in lower socio-economic groups. Evidence suggests these 
differentials may be increasing. Given the documented inequity in cardiovascular health and risk factor 
profiles, measures to increase population health must permeate across all socio-economic groups, but 
with a specific focus on reducing inequity.
The individual determinants of cardiovascular health and disease are similar to those relating to overall 
disease burden – smoking, raised blood pressure, raised blood cholesterol, physical inactivity, obesity 
and diabetes mellitus. The current health behaviour profile of the Irish population, and resultant 
cardiovascular risk, means that a major effort is needed to change these patterns.
This policy proposes a series of 10-year targets for health behaviours influencing cardiovascular-
related population health (see Recommendation 3.1).
RECOMMENDATION 3.1
The Department of Health and Children should prioritise actions that promote the health 
behaviour profiles underpinning cardiovascular health, with specific targets to actively 
pursue and achieve within a 10-year period.
The prioritised areas are: 
• maintaining a healthy body weight;
• healthy eating and physical activity;
• reducing salt intake;
• refraining from or quitting smoking;
• consuming alcohol responsibly.
Actions will include fostering intersectoral support for initiation of activities promoting health and 
prohibition of activities that will maintain or foster unhealthy behaviours. Details on how to achieve 
these targets are contained in a range of recent Government policies. Reductions in inequalities in 
cardiovascular health across society must be an underlying principle in achieving improvements in 
health behaviour.
Lead organisation: Department of Health and Children
Executive Summary
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Health behaviour profiles in Ireland: Current status and 10-year targets
body weight: The prevalence of overweight and obesity is high and increasing in Ireland. Research 
shows that 38% of the adult population are overweight and 23% obese. By 7 years of age, 26% of girls 
and 18% of boys are overweight or obese.
HEALTHY bODY WEIGHT – TARGETs
Restore the BMI distribution of adults to levels as assessed 10 years ago (in 1999, 43% healthy 
weight; 39% overweight; 18% obese). This is to be achieved by:
• halting the current annual increase in the prevalence of overweight and obesity in the 
medium term (by 2014);
• achieving a modest reduction in prevalence of obesity within 10 years (by 2019).
Targets for adults over 10-year timeframe:
• Healthy weight: increase from 38% to 43%
• Overweight: maintain overall levels at 38%
• Obesity: decrease from 23% to 18%
Targets for children over 10-year timeframe:
• Healthy weight: increase from 78% to 84%
• Overweight: decrease from 11% to 7%
• Obesity: decrease from 11% to 9%
Nutrition/healthy eating: The national dietary profile is challenging. While there has been an increase 
in the recommended consumption of 5 portions of fruit and vegetables by adults daily (to 65%), 86% 
report that they consume more than the recommended daily servings of foods high in fats, sugar  
and salt.
HEALTHY EATING – TARGETs
• Increase by 20% the proportion of adults consuming the recommended 5 or more daily 
servings of fruit and vegetables (from 65% to 78%) by 2014.
• Ensure total fat provides less than 35% of dietary energy requirements. This is a ‘short-  
to medium-term’ goal, to be achieved by 2012. After 2012, the medium to  
long-term goal is less than 30% of dietary energy from fat by 10 years (2019).
• Reduce to less than 10% the dietary intake from saturated fats and trans-fatty acids.
• Reduce to less than 2% the dietary energy intake from trans-fatty acids.
• Reduce to less than 10% the dietary energy intake from foods with added sugars.
• Reduce to less than 3 daily servings those foods high in fats, salt and sugar from the  
‘top shelf’ of the Food Pyramid (e.g. oils, butter, cakes, soft drinks).
Note: Dietary energy does not include energy from alcohol.
5Physical activity: Levels of physical activity among the population are inadequate. Over one-fifth of 
Irish adults (22%) reported being completely physically inactive, with lack of interest or ‘no time’ given 
as the main reasons. For children, slightly less than half exercise at least 4 times a week, with striking 
gender differences – 41% of adolescent boys and 28% of girls exercise 4 or more times a week.
PHYsICAL ACTIvITY – TARGETs
• Increase by 20% the proportion of the population undertaking regular physical activity,  
i.e. increase proportion of physically active adults from 55% to 66% and children from 41% 
to 49% by 2019.
salt consumption: Average daily salt intake is significantly above the recommended amount, men 
currently consuming 10g/day of salt and women 9g/day. Most dietary salt comes from foods as 
purchased (e.g. take-aways, processed ‘ready-make’ meals) rather than from adding salt in cooking  
or at the table.
sALT CONsuMPTION – TARGETs
• Reduce salt consumption as set out in the EU Salt Reduction Initiative, i.e. reduction by 
16% in 4 years (2008-2012).
• Achieve reduction to a target of no greater than 6g/day salt for adults within the lifetime of 
this policy.
• Particular attention to be given to salt reduction in children, with target setting as 
appropriate.
smoking cessation: Smoking is the leading cause of preventable mortality, with Ireland ranking 2nd 
highest for smoking-related causes of death in the EU15. While the smoking ban in the workplace 
introduced in 2005 has significantly reduced exposure to secondary smoke, smoking rates for adults 
are still high – at 29% (31% of men and 27% of women).
sMOkING REDuCTION – TARGETs
• Reduce overall population prevalence of smoking by 1% per annum (from 29% to 19%  
by 2019).
• Reduce the smoking initiation rates by 1% per annum (from 31% to 21% by 2019).
Alcohol consumption: Alcohol consumption in Ireland – especially relevant to population blood 
pressure and overweight/obesity – is unacceptably high. Alcohol consumption is over 40% higher 
than the EU average, with substantial numbers reporting excessive or risky drinking, or both. Levels of 
drinking in adolescence are among the highest in Europe.
ALCOHOL CONsuMPTION – TARGETs
Reinforce the Strategic Task Force on Alcohol (2004) consumption targets by:
• reducing the total per capita consumption of alcohol to 9 litres per annum (the EU 
average);
• reducing the harmful individual consumption of alcohol, especially related to risky and 
excessive drinking.
Executive Summary
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blood pressure and cholesterol: In recent research, 60% of middle-aged and older Irish adults had high 
blood pressure and 82% had raised cholesterol. Most were either not on medication or had uncontrolled 
blood pressure and cholesterol on medication. Almost two-thirds had at least two of four key risk factors 
for cardiovascular disease – raised blood pressure, raised cholesterol, obesity and smoking. Management 
of blood pressure and cholesterol will in part be addressed by targeting the health behaviour profiles as 
outlined above and also by improving management in primary care (see Chapter 4).
Intersectoral work
There are broad social, economic, cultural and environmental determinants of health and well-being. 
The challenge for the health sector is the imperative to have action across multiple sectors of society (see 
Recommendation 3.2). Important partners include the education sector, the sports and leisure sector, urban 
planning and construction, transport, agriculture, the private sector, the food industry and the media.
RECOMMENDATION 3.2
Intersectoral work should be given the priority it needs to deliver health-related benefit.
To achieve real change, actions should be led by the Department of Health and Children, 
reporting to Government on a regular basis through the Cabinet Committee on Health.  
A key deliverable in evaluating the success of this work will be reductions in inequality in 
cardiovascular health targets.
Lead organisation: Department of Health and Children
PRIMARY CARE (CHAPTER 4)
Primary care has a vital role to play in raising awareness of cardiovascular disease, prevention, early 
detection, emergency response, risk assessment and management. The full potential of primary care 
to contribute to the containment of cardiovascular disease has yet to be realised. 
Promoting awareness
There is a need to promote awareness in the population of the need for regular monitoring of blood 
pressure and cholesterol levels, as well as the symptoms of diabetes (see Recommendation 4.1). In 
parallel, awareness of the early symptoms and appropriate emergency responses to cardiovascular 
signs is necessary in order to ensure effective interventions can be administered in a timely fashion.
RECOMMENDATION 4.1
Media and education campaigns should be undertaken to increase awareness by the general 
public of cardiovascular risk factors and levels of risk associated with them. This awareness 
should be reinforced in primary care settings, such as GP practices and pharmacies, by the 
HsE in partnership with voluntary agencies.
Such campaigns should include raising awareness of risk factors, symptoms and appropriate 
responses to heart attack, stroke, trans-ischemic attack, heart failure, peripheral arterial disease 
and other vascular conditions. Given the primacy of awareness to attitude and behaviour 
change, a series of campaigns needs to commence immediately and in a phased manner, with 
interim evaluations guiding the next educational phase.
Lead organisation: HSE, in partnership with voluntary agencies
7Clinical practice
Beyond prescribing cardiovascular medications in accordance with international guidelines, there is 
ample evidence that multidisciplinary input into preventive cardiovascular disease programmes in 
high-risk individuals can benefit lifestyle-related risk factor changes. As multidisciplinary primary care 
teams are established in Ireland, they must be empowered to support cardiovascular prevention.
An effective programme of chronic disease management is deliverable through a shared care 
model facilitated by multidisciplinary teams with designated care pathways. Shared care models 
need to be expanded and developed in order to achieve optimum chronic disease management for 
patients with cardiovascular disease. Strategies need to be developed and implemented to support a 
multidisciplinary team approach that promotes continuity of care. This includes the provision of self-
management education programmes. The role of general practices, pharmacies and other centres in 
supporting chronic disease management needs to be examined.
High-risk patients: The definition of ‘high risk’ needs to be extended to include all patients in the 
priority groups as identified by the current ESC Clinical Practice Guidelines – by the Fourth Joint Task 
Force of the European Society of Cardiology [ESC] and Other Societies on Cardiovascular Disease 
Prevention in Clinical Practice (Graham et al, 2007). This includes patients who have had an event 
and/or a revascularisation procedure, patients with established disease, close relatives of people with 
premature atherosclerotic disorders, as well as individuals with multiple risk factors. 
Recommendations 4.2-4.4 relate to the prevention of cardiovascular disease in clinical practice.
RECOMMENDATION 4.2
Professional standards: The 2007 ESC Clinical Practice Guidelines should be adopted and a 
care protocol for primary care based on these guidelines should be developed. Protocols on 
best practice in cardiovascular clinical care should be agreed.
This extends the group of individuals considered at high risk and includes patients with 
established disease, close relatives of people with premature atherosclerotic disorders and 
individuals with multiple risk factors.
Lead organisation: HSE, in partnership with Irish Heart Foundation, Irish Cardiac Society,  
Irish College of General Practitioners, Department of Health and Children, and HIQA
RECOMMENDATION 4.3
structured clinical care: Develop structured clinical care, which includes prevention of 
cardiovascular disease, in clinical practice.
This will provide targeted individualised assessment and management of cardiovascular 
disease in primary care, in accordance with the 2007 ESC Clinical Practice Guidelines,  
i.e. those at risk, those with established cardiovascular disease and selected family members. 
Structured clinical care is considered a key requirement to future general practitioner  
contract agreements.
Lead organisation: HSE, in conjunction with Irish College of General Practitioners
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A risk assessment programme – similar to the HeartWatch Programme, but incorporating the above 
definition of ‘high-risk’ individuals – should be piloted and implemented, taking into consideration 
the implications of this extended high-risk group (see Recommendation 4.4). It is proposed that a 
structured programme for cardiovascular risk ascertainment in primary care, with opportunistic 
recruitment of patients, be considered within the context of a rigorous scientific study to inform these 
developments. A health technology assessment, provided through the HIQA, will inform the scope of 
the clinical studies.
RECOMMENDATION 4.4
Population approach: Evaluation of a structured programme for cardiovascular risk 
ascertainment and management in the primary care setting is required to inform the 
development of a model for the delivery of care.
A health technology assessment and clinical study will determine the health and economic 
benefits of such systematic risk ascertainment for different population groups (compared to 
usual care). As clinical and cost-effectiveness benefits become clear, implications for service 
development must be agreed and interventions targeted at relevant population groups 
implemented. The evaluation should be completed and recommendations delivered in the first 
half of the lifetime of this policy (2010-2014).
Lead organisation: Department of Health and Children, in association with HSE, HIQA and  
Health Research Board
Diabetes mellitus
Those with Type 2 diabetes and those with Type 1 diabetes who have microalbuminuria are 
priority groups for the prevention, early detection and management of cardiovascular risk (see 
Recommendation 4.5). This policy supports the recent HSE integrated model for service delivery for 
these patients.
RECOMMENDATION 4.5
A protocol for the early detection and structured cardiovascular care of patients with 
diabetes should be agreed in order to manage this high-risk group.
Lead organisations: HSE and Irish Heart Foundation, in partnership with Irish Cardiac Society,  
Irish College of General Practitioners and Irish Endocrine Society
9Prevention of stroke in primary care
In addition to the 2007 ESC Clinical Practice Guidelines on the prevention of cardiovascular disease, 
which address common challenges for all cardiovascular patients, the detection and management of 
raised blood pressure (hypertension) and anti-thrombotic therapy for those with atrial fibrillation are 
of particular relevance in the prevention of stroke (see Recommendations 4.6 and 4.7). Elevated blood 
pressure has been considered the most important determinant of the risk of stroke due to cerebral 
infarction or haemorrhage and thus warrants particular attention.
Atrial fibrillation is a potent risk factor for stroke, increasing the risk five-fold. The risk of thrombotic 
complications, such as stroke, in patients diagnosed with atrial fibrillation can be dramatically reduced 
by treatment with anticoagulants. Despite the well-recognised benefits of anticoagulation therapy, 
many patients with atrial fibrillation remain undetected or untreated. Improved detection of atrial 
fibrillation and anticoagulation can be achieved by developing structured systems between primary 
care and the hospital setting.
RECOMMENDATION 4.6
Effective management of hypertension should be prioritised in primary care.
Guidelines are needed on standards of assessment, management and review of patients in 
primary care based on best practice and health technology. In addition, general practices need 
to be supported to establish rigorous systems for blood pressure assessment, management 
and review for their population of patients. This requirement should be considered in the 
context of future arrangements pertaining to the general practitioner contract.
Lead organisation: Department of Health and Children, in partnership with Irish College of 
General Practitioners
RECOMMENDATION 4.7
Anticoagulation service management should be formalised, including:
• Clinical leadership of integrated anticoagulation services: This must be established 
within service networks so that GPs and hospital staff (including stroke specialist 
consultants, consultant haematologists and nurse specialists) achieve and assure  
optimal care for all.
• structured anticoagulation services: These will have to be developed between and 
within primary care services and hospital anticoagulation clinics. This will necessitate 
appropriate resourcing being provided to participating practices (e.g. IT linkages to 
hospital/GP/pharmacy anticoagulation services, ‘near-patient’ anticoagulation testing, 
practice nurse appointments).
• A screening programme for atrial fibrillation: This should be established, with formal 
evaluation, to ensure an effective means of implementation for people aged 65 and over.
Lead organisation: HSE
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Heart failure
There is a potential epidemic of heart failure in Ireland over the next 10 years, arising from increasingly 
successful therapies to reduce early morbidity and mortality, and given the rise in the number of older 
people during this time. To address this scenario, heart failure management requires an integrated 
community-based approach, led by primary care teams, with the focus on keeping affected people 
out of the hospital setting (see Recommendation 4.8). This is paramount if the hospital system is to 
address acute care needs adequately.
RECOMMENDATION 4.8
A programme should be developed to increase and support the capacity of primary care to 
detect heart failure at an early stage and to provide proactive care, including:
• Education of the primary care team, particularly GPs and practice nurses, in accordance 
with agreed national guidelines across primary and secondary care providers.
• Agreement on and introduction of models of shared care, supporting the key role of the 
GP and primary care team (see Chapter 5, Hospital section).
• Deployment of specialist heart failure nurses within an integrated system to maximise 
the value of these nurses to work with GPs and primary care teams.
• Deployment of other staff to increase the capacity of primary care teams to support 
the community-based management of patients with heart failure, including specialist 
palliative care.
• staffing arrangements to provide 7-day access for heart failure patients with clinical 
deterioration.
• IT capacity to facilitate communication between primary and secondary care, including 
the establishment of heart failure registers and audits.
• Tele-monitoring to support patients in adopting and maintaining self-care. This will 
involve the adoption of agreed national guidelines across primary and secondary care 
providers.
• specialist palliative care for heart failure patients.
Lead organisation: HSE
Peripheral arterial disease
Patients with peripheral arterial disease (PAD) have a very substantial risk of other cardiovascular 
diseases. Many patients with symptoms fail to present because they may attribute symptoms to the 
normal effects of ageing or physical inactivity. Greater public awareness is needed about this disorder 
(see Recommendation 4.9).
RECOMMENDATION 4.9
A protocol for risk assessment and management of patients with suspected peripheral 
arterial disease (PAD) should be developed and evaluated in primary care.
Lead organisation: HSE, in partnership with Irish College of General Practitioners and  
Royal College of Physicians in Ireland
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HOsPITAL AND EMERGENCY CARE sERvICEs (CHAPTER 5)
Hospital and acute care services for cardiovascular conditions include emergency and acute cardiac 
and stroke care and related pre-hospital emergency services. They also include non-emergency care 
concerning surgery and management of heart failure, peripheral arterial disease (PAD) and grown-up 
congenital heart (GUCH) disease.
General clinical care pathways
While the focus here is on cardiac-specific and stroke-specific aspects of acute care pathways, 
clinical pathways also relate to how cardiovascular disease is prevented, its early detection, ongoing 
treatment and rehabilitation, and palliative care. Within the current resource framework, there is much 
that can be done to improve clinical care and outcomes, particularly for emergency patients, as well 
as to reduce costs while maintaining quality. There is much that can be put in place to improve clinical 
effectiveness and efficiency by way of organisational change, applying best practice procedures, 
developing new cardiovascular models of care and the introduction of clinical pathways that highlight 
improvement of clinical processes in cardiovascular care to enhance clinical effectiveness and 
efficiency. The introduction of these clinical pathways and cardiovascular models of care will provide 
an effective strategy to reduce clinical performance variations across the system.
Establishing care pathways means that those in hospital-based specialist services will need to adapt 
and provide more support to primary healthcare providers. These changes are already underway in 
some hospitals and regions throughout the country. In the current economic climate, it is envisaged 
that the development of new emergency models of care and new clinical networks will have to take 
place within current resources.
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ACuTE CARDIAC CARE
Acute cardiac care pathways
Survival followed by speedy reperfusion is the goal of emergency care for patients with myocardial 
infarction. Reperfusion through primary percutaneous intervention (PCI) has major advantages over 
thrombolytic therapy, but must be delivered in accordance with international safety standards. A 
system of delivering early PCI reperfusion will be provided by building up services that have well-
resourced and trained pre-hospital emergency facilities and staff. Where patients cannot reach PCI 
services within the time specified for safe and effective care, they will avail of emergency services 
developed to give timely access to centres providing thrombolysis. In each case, the aim will be to get 
the patient treated as rapidly and effectively as possible within the available reperfusion options. This 
service mix will provide the widest and most equitable coverage of acute cardiac services to the Irish 
public (see Recommendations 5.1-5.5).
RECOMMENDATION 5.1
Patients with sT elevation myocardial infarction should be treated with primary 
percutaneous intervention (PCI) as first-line therapy, in accordance with the 2007 ESC  
Clinical Practice Guidelines, if the time from first medical contact to primary PCI can be 
achieved within 120 minutes.
Optimal treatment under this development will require an emergency medical system to link a 
network of hospitals having cardiac facilities, with a clear designation of geographic coverage, 
shared risk stratification protocols for pre-hospital diagnosis and triage, and fast transport in 
appropriately equipped ambulances or helicopters. 
Lead organisation: HSE
RECOMMENDATION 5.2
If PCI cannot be provided within 120 minutes of first patient contact, the patient should be 
assessed for thrombolysis as soon as possible. Treatment options should include pre-hospital 
thrombolysis in addition to the in-hospital service, depending on patient presentation.
Protocol-driven emergency thrombolysis should be provided in either pre-hospital or hospital 
settings. The priority in service development will be to deliver the fastest service to the widest 
range of patients and this should be reflected in future service plans. Pre-hospital thrombolysis 
has been incorporated in the advanced paramedic scope of practice by the Pre-Hospital 
Emergency Care Council and a supporting clinical practice guideline has been published. 
A programme to train GPs for appropriate roles in pre-hospital emergency care, including 
thrombolysis in certain rural areas, is also underway.
Lead organisation: HSE
continued
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RECOMMENDATION 5.3
Emergency PCI services should be delivered on a 24-hour 7-day basis in a small number of 
centres, sited to maximise patient access and workforce expertise and coverage.
Some centres which do not provide emergency services may be able to provide PCI for 
patients presenting directly to them during restricted hours, provided that there is a sufficient 
throughput to maintain expertise.
Lead organisation: HSE
RECOMMENDATION 5.4
Patients assessed as having forms of acute myocardial ischemia other than sT elevation 
myocardial infarction should be taken to the nearest acute medical facility, triaged at the 
emergency department, treated and stabilised, moved to the nearest acute coronary care 
setting and then transferred within 24 hours to the nearest comprehensive cardiac centre.
Most of these patients will require diagnostic angiography and some will require early 
intervention. These recommendations refer to patients transferred to hospital by ambulance. 
The same diagnostic and treatment protocol applies for those patients (currently approximately 
50%-55%) who arrive at hospital independently of the emergency services.
Lead organisation: HSE
RECOMMENDATION 5.5
Designation of cardiac networks providing diagnostic and interventional services should 
include non-invasive diagnostic imaging facilities, in addition to echocardiography, 
catheterisation and angiography.
Pragmatically, a minimum of two investigative/angiographic laboratories are needed in each 
centre providing the service to deliver on a timely basis. Furthermore, the period of changeover 
from a largely thrombolysis-based reperfusion service to a primary PCI needs to be carefully 
monitored to ensure that standards of patient care are maintained in the transition period. 
Network development is a core first step in the implementation of this policy.
Lead organisation: HSE
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Intensive cardiac care
Reflecting changing practices and population profiles, the current Coronary Care Unit needs to evolve 
into an Intensive Cardiac Care Unit (ICCU), functioning in close liaison with the emergency department 
while remaining under the control of the cardiology service. Protocols must ensure that individualised 
patient treatment plans, including adequate patient education, are formulated and put in place before 
discharge. This is essentially Phase I of an integrated rehabilitation programme (see Recommendations 
5.6 and 5.7). 
RECOMMENDATION 5.6
The current Coronary Care unit should be substantially reconfigured, following needs 
assessment, to become an Intensive Cardiac Care unit (ICCu), meeting the changing clinical 
profile of the patients now encountered.
A review of the changing pattern of need and supply for acute cardiac care is required to 
underpin this reconfiguration.
Lead organisation: HSE
RECOMMENDATION 5.7
Protocols need to be developed to ensure provision of individualised patient treatment plans 
in Intensive Cardiac Care units, incorporating education of patients within a tailored, phased 
rehabilitation framework.
It is acknowledged that new procedures and increased efficiency, resulting in shorter stays in 
hospital, challenge the traditional model of patient education and early rehabilitation at this 
point. New ways to achieve the same effects are needed.
Lead organisation: HSE
Emergency care for chest pain
In the acute setting, the goal will be to triage the high-risk patient for urgent treatment of acute 
coronary syndrome; in the sub-acute setting, there is a requirement to address the needs of patients 
referred by their GP where there is a pressing concern about emerging ischaemic heart disease (see 
Recommendation 5.8). Same-day specialist expertise and relevant diagnostic services are needed.
RECOMMENDATION 5.8
Hospitals admitting patients with acute cardiac conditions should have a protocol-driven 
assessment of patients with lower-risk chest pain to maximise detection of those with acute 
ischaemia and to minimise inappropriate admissions.
In tandem, priority ambulatory care must be formulated to deliver specialist expertise, ideally 
by the next working day or within 72 hours at the latest for GP-referred patients with acute 
or suspicious presentations. In addition, a specialist ambulatory focus for a number of clinical 
presentations should be considered so that appropriate expertise and techniques can be made 
available and used to maximum effect in the context of a rapidly changing clinical evidence base.
Lead organisation: HSE
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Heart failure care
This policy proposes a move from emergency in-hospital care to accessible ambulatory specialist care 
that supports proactive care by GPs and primary care teams (see Recommendations 5.9-5.11).
RECOMMENDATION 5.9
All hospitals evaluating patients with heart failure should restructure in-hospital and  
out-patient cardiac care to allow for specialist heart failure ambulatory services that  
support the key role of the GP and primary care team.
Lead organisation: HSE
RECOMMENDATION 5.10
Models of shared care of patients with heart failure should be established, based on agreed 
national guidelines and on models currently being elaborated in Ireland and internationally.
Lead organisation: HSE, in association with Irish College of General Practitioners and Irish Heart 
Foundation
RECOMMENDATION 5.11
ICT-enabled communication between hospitals and GPs or primary care teams should be 
actively used to support shared heart failure care.
Lead organisations: HSE and Department of Health and Children
Organisation of cardiac services into networks
Specialist cardiac services should be organised into population-based regional networks, as envisaged 
in the recent ESC STEMI Guidelines (Van de Werf et al, 2008), in order to deliver a full range of cardiac 
services (see Recommendation 5.12). Central to the network concept is the principle that every hospital 
delivers a full range of cardiac services either on-site (comprehensive centres) or in formal partnership 
with others (general centres); acute and national specialty services are provided in a smaller number of 
comprehensive centres. Ongoing care and rehabilitation and liaison with primary care are recognised 
as important components of these services.
RECOMMENDATION 5.12
specialist cardiac services should be organised into population-based cardiac networks, with 
network hospitals designated as (i) General Cardiac Centres or (ii) Comprehensive Cardiac 
Centres.
A broad plan for service reconfiguration needs to be developed. This should identify general 
and comprehensive cardiac centres and allow service planning – involving workforce and 
emergency service development in particular – to evolve within the new network structure.
Lead organisation: HSE
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Cardiac surgery and transplantation
Recent changes in medical practice and patient demographic profiles have had a major impact on 
cardiac surgical practice. Patients now present with more complex conditions. There is very little 
spare capacity in the operating time currently available for cardiac surgery in Ireland. Numbers of 
existing and approved consultant surgeon posts are adequate, but availability of dedicated cardiac 
surgical intensive care beds represents a serious challenge to effective cardiac surgery activity (see 
Recommendations 5.13 and 5.14). In addition, the main barrier to thoracic organ transplantation in 
Ireland is availability of donor organs (see Recommendation 5.15).
RECOMMENDATION 5.13
Cardiac surgical units should have a dedicated Intensive Cardiac Care unit, with adequate 
numbers of beds (the majority to be provided in single rooms). 
Lead organisation: HSE
RECOMMENDATION 5.14
All consultant anaesthetists and intensivists providing care to cardiac surgery patients 
should have specialist training.
All anaesthetists providing cardiac anaesthesia should carry out at least one cardiac surgery list 
per week. A dedicated cardiac anaesthetic on-call rota should be established in each hospital 
providing cardiac surgery.
Lead organisations: HSE and relevant postgraduate training bodies
RECOMMENDATION 5.15
solutions to maximise access to donor organs for transplantation should be explored.
Specific initiatives will be informed by the work of the Organ Donation and Transplantation 
Unit, to be established within the HSE’s existing national structures and resources.
Lead organisations: Department of Health and Children and HSE
Congenital heart disease
While figures for surgical and waiting lists are adequate, access to operating theatre time, together 
with insufficient ICU beds, means that approximately one-third of surgical procedures for congenital 
heart disease take place outside of normal working hours, with resultant impact on staff, patients 
(mostly children) and their families (see Recommendation 5.16).
RECOMMENDATION 5.16
A review of service needs and availability for GuCH patients (Grown-up Congenital Heart 
disease) should be carried out in the context of international trends, followed by a service 
development plan for this expanding population of patients.
Lead organisation: HSE
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ACuTE sTROkE CARE
Acute stroke care pathway
Stroke services are much less developed than cardiac services in Ireland. The first Irish National Audit of 
Stroke Care (INASC), carried out in 2006-07, found that there were less developed acute services across 
12 identified markers of quality care compared to those in the UK (Horgan et al, 2008).
stroke units
Stroke units are the foundation of timely and comprehensive stroke care in hospital and are a 
minimum standard internationally for audit and accreditation of stroke services. Many acute hospitals 
in Ireland already have several elements of the staffing and infrastructure required to create a stroke 
unit. Thus, it is expected that implementation of stroke unit care can be substantially achieved even in 
economically challenging times (see Recommendations 5.17 and 5.18).
RECOMMENDATION 5.17
All hospitals admitting patients with acute stroke should have a stroke unit, as defined by the 
European stroke Organisation.
Each stroke unit should have sufficient capacity to admit patients directly from the emergency 
department and the rapid access TIA clinic, to accept transfers from other hospitals within the 
stroke network when required, and to provide care for all stroke/TIA patients for their hospital 
stay. This should be a key priority for the hospital reconfiguration programme.
Lead organisation: HSE
RECOMMENDATION 5.18
stroke units should have adequate and appropriate staffing.
This includes a designated lead consultant stroke physician working within a stroke network 
group. In addition, stroke units should have adequate multidisciplinary teams of staff to 
cater for the complex needs of patients with stroke, many of whom will have high levels 
of dependency. Such teams should include physiotherapy, occupational therapy, speech 
and language therapy, social work, clinical nutrition and dietetics, clinical psychology/
neuropsychology, and specialist nursing.
Lead organisation: HSE
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Emergency care, including thrombolysis
Stroke thrombolysis confers substantial benefits in terms of survival and disability. Providing 
emergency stroke evaluation, followed by thrombolysis within 180 minutes of stroke onset as the 
standard of care for eligible patients will require reconfiguration to provide access to brain imaging 
and a consultant stroke physician on a 24-hour 7-day basis (see Recommendations 5.19 and 5.20).
RECOMMENDATION 5.19
Emergency stroke treatment by a consultant stroke physician should be available on a  
24-hour, 7-day basis to all acute stroke patients within each stroke network.
When it is not feasible to transport the patient within the timeframe for emergency evaluation 
and treatment with thrombolysis, tele-medicine supported by an on-call consultant stroke 
physician should be available. This emergency treatment will be developed on an incremental 
basis.
Lead organisation: HSE
RECOMMENDATION 5.20
Each stroke network should agree a model of service delivery to meet the need for a  
24-hour 7-day thrombolysis service.
Clear protocols and patient pathways should be identified, implemented and reviewed on a 
regular basis.
Lead organisation: HSE
Hospital in-patient stroke rehabilitation
Stroke rehabilitation starts soon after admission and should occur in a stroke unit as an integrated 
component of the work of the unit (see Recommendation 5.21). This permits the multidisciplinary team to 
care efficiently for patients across the spectrum – from emergency assessment to discharge from hospital.
RECOMMENDATION 5.21
Evidence-based guidelines and protocols of care should be developed and adopted for acute 
and rehabilitation management of stroke patients.
Lead organisation: Irish Heart Foundation, in association with Department of Health and Children, 
HSE and HIQA
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Discharge from the acute hospital
For stroke patients, the timing of discharge from hospital and requirements for continuing care are 
closely related to functional recovery and residual impairment and independence, or potential to 
regain independence, in activities of daily living (see Recommendation 5.22).
RECOMMENDATION 5.22
Patients should have a full needs assessment prior to admission to hospital, aiming to 
support discharge home or to their place of residence.
Placement in long-term care should only be considered on the basis of medical or social need, 
rather than as a result of inadequate community services and facilities.
Lead organisation: HSE
Transient ischaemic attacks
Transient ischaemic attacks (TIAs) are an important warning symptom of stroke and an opportunity to 
intervene to prevent the condition developing into a full stroke. Same-day assessment and treatment 
by a consultant stroke physician-led team can prevent a subsequent stroke (see Recommendation 5.23).
RECOMMENDATION 5.23
Patients experiencing transient ischaemic attacks (TIAs) should be referred to consultant-
led, same-day, rapid-access TIA/stroke prevention clinics with appropriate diagnostic 
and management facilities, including secondary prevention advice, pharmacological 
management and access to vascular surgery, where needed, within 2 weeks.
Clear pathways of referral and use of risk stratification are needed to identify high-risk patients 
and aid ‘immediate admission’ decisions to be made in primary care and in emergency 
departments.
Lead organisation: HSE
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Carotid stenosis and carotid endarterectomy
Research evidence strongly supports the benefits of surgery over medical management alone in 
symptomatic moderate-to-severe carotid stenosis in order to reduce the incidence of recurrent 
neurovascular events (TIA and stroke). Asymptomatic carotid artery disease is also a risk factor for 
stroke. Selection of high-risk patients will ensure most benefit from surgical intervention  
(see Recommendation 5.24).
RECOMMENDATION 5.24
Clinical management of carotid disease should involve the following:
• All patients with recent TIA or non-disabling stroke should have urgent ipsilateral carotid 
assessment by Doppler ultrasound or CTA/MRA. Carotid endarterectomy should be offered 
to all patients with symptomatic moderate-to-severe (70%-99%) carotid stenosis and 
performed within 2 weeks of symptoms.
• Patients with asymptomatic moderate-to-severe carotid stenosis should be considered for 
carotid endarterectomy on a case-by-case basis and have a full risk assessment, including 
TCD monitoring/intima medial thickness measurement.
Organisational management at stroke network level should involve the following:
• Defined care pathways with vascular surgery units experienced in performing carotid 
endarterectomy.
• Access to expertise in carotid imaging and vascular surgery.
• Decision-making forum about surgical intervention to incorporate multidisciplinary 
neurovascular meetings involving geriatricians/stroke physicians, neurologists, vascular 
technicians, neuroradiology and vascular surgeons.
• Regular audit of carotid interventions to ensure high standards; this could contribute to a 
national register of carotid surgery.
Lead organisation: HSE, in collaboration with Irish Association of Vascular Surgeons and other 
relevant professional organisations
Organisation of stroke services into networks
Stroke services will be configured into stroke networks, with a number of hospitals working together 
to provide the comprehensive range of services needed for optimal stroke care and working closely 
with community services (see Recommendation 5.25). The stroke network will comprise a series 
of General Stroke Centres with associated Comprehensive Stroke Centres. One or more hospitals 
(comprehensive centres) within the partnership will provide acute services for the network, i.e. 
services that are not expected to be available at all hospitals. 
Services provided on a network basis will include a stroke prevention service and a same-day TIA service, 
thrombolysis, advanced diagnostics, vascular surgery and comprehensive rehabilitation. Networks may 
involve tele-medicine support for hospitals serving remote areas and off-site rehabilitation. Certain 
services will be provided on a national or regional level, such as vascular neurosurgery, interventional 
radiology, neuropathology and the services of the National Rehabilitation Hospital.
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RECOMMENDATION 5.25
specialist stroke services should be organised into population-based stroke networks, with 
network hospitals designated as (i) General stroke Centres or (ii) Comprehensive stroke 
Centres.
A broad plan for service reconfiguration needs to be developed. This will identify general 
and comprehensive stroke centres and allow service planning – involving workforce and 
emergency service development in particular – to evolve within the new network structure.
Lead organisations: HSE and Department of Health and Children
Emergency response services
The importance of transfer to specialist services and rapid onset of treatment in acute cardiac and 
stroke settings (in particular concerning thrombolysis and primary PCI) cannot be overstated. Much 
progress has been made on reconfiguration of services and training in emergency medical response 
since the 2006 report by the Task Force on Sudden Cardiac Death (Department of Health and Children, 
2006). Although strategic deployment of advanced paramedics, pre-hospital thrombolysis and 
information systems to capture pre-hospital demands has been developed regionally, such resources 
are not yet deployed nationally (see Recommendation 5.26).
RECOMMENDATION 5.26
This policy endorses the recommendations of the Task Force on sudden Cardiac Death (2006) 
for the development of emergency medical service capacity to respond and deliver timely 
acute cardiovascular care.
The following initiatives are seen as having the highest priority within the new network structures:
• Strategic deployment of advanced paramedics and implementation of pre-hospital triage 
and cardiac thrombolysis nationally.
• Prioritised national roll-out of the electronic patient-care record in order to guide 
emergency medical services in the collection, collation and analysis of pre-hospital data.
• National roll-out of information systems, including the out-of-hospital cardiac arrest register, 
the register of sudden cardiac deaths in young people, and the general patient electronic 
patient-care record.
• Integration of emergency medical service activities through coordinated approach to the 
participation of auxiliary and voluntary services, Gardaí and retained fire services.
• Improved first response and therefore survival from cardiac arrest through development, 
coordination and integration of the emergency medical service with co-responder networks 
(auxiliary and voluntary services, Gardaí and retained fire services) and community first-
responder programmes across the country.
Lead organisation: HSE, in association with Irish Heart Foundation
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Public awareness and response
The public are an unrealised asset in acute cardiovascular care. Greater public awareness is needed 
about the warning signs of cardiovascular emergencies. In tandem, current training activities need 
to be extended in the skills of basic life support, first-responder programmes and use of automated 
external defibrillators (see Recommendation 5.27).
RECOMMENDATION 5.27
Increase the proportion of the public who are aware of the major signs and symptoms 
of acute cardiovascular events (e.g. ACs, TIA and stroke), who know the importance of 
immediately contacting ambulance services and who are skilled in basic life support.
A public education campaign should be undertaken to raise awareness of the symptoms of 
acute cardiovascular events and of the need to take urgent and appropriate action. In parallel, 
basic life support training in schools could help develop an upcoming generation with greater 
awareness and skills in this area.
Lead organisation: HSE, in association with Irish Heart Foundation
CARDIAC AND sTROkE REHAbILITATION AND CONTINuING CARE (CHAPTER 6)
Cardiac and stroke rehabilitation services are delivered within both hospital and community settings. 
The purpose of all rehabilitation is to help the individual and their families return to as good a quality 
of life as possible by addressing deficits promptly and thoroughly. This can be achieved by establishing 
patterns of care, including self-care, that will delay or prevent further cardiovascular events.
Cardiac rehabilitation
The effectiveness of cardiac rehabilitation programmes is well established in clinical trials. Cardiac 
rehabilitation was addressed in the first national cardiovascular strategy, Building Healthier Hearts 
(1999), with substantial growth achieved during the past decade in the availability of rehabilitation 
programmes, to a point where all relevant public hospitals now have access to such a service. Further 
improvements can, however, be made (see Recommendations 6.1 and 6.2).
RECOMMENDATION 6.1
Ensure adequate and equitable coverage of cardiac rehabilitation for all eligible patients 
through investment in staffing and facilities in all relevant hospitals.
Eligible patients (i.e. ACS or coronary intervention patients and patients with heart failure 
and peripheral arterial disease) should be offered cardiovascular rehabilitation services. All 
programmes should have adequate facilities and be delivered by a multidisciplinary team, in 
accordance with agreed national standards.
Lead organisation: HSE
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23
RECOMMENDATION 6.2
Cardiac rehabilitation should be an integral part of the spectrum of cardiac services in public 
and private healthcare settings.
Cardiovascular rehabilitation services are not routinely provided in private hospitals or 
reimbursed for private patients in public hospitals. This has significant implications for 
capacity and for access of patients in private hospitals to evidence-based care. A requirement 
for rehabilitation service provision, as a core component of evidence-based care, should be 
included in the HIQA-managed licensing requirements for acute hospitals.
Lead organisation: HIQA
Demand for cardiac rehabilitation services has increased since services were first developed. Thus 
services are overstretched and many eligible patients cannot avail of rehabilitation, while others wait 
longer than desirable to commence out-patient programmes after hospital discharge. In addition, 
cardiac rehabilitation programmes now need to accommodate increasing numbers of patients with 
heart failure or peripheral arterial disease, in addition to post-myocardial infarction, revascularisation 
and surgical patients (see Recommendation 6.3).
RECOMMENDATION 6.3
Cardiac patients should have timely access to cardiac rehabilitation services.
Active early rehabilitation should commence in line with international professional guidelines. 
The early rehabilitation challenge is to deliver appropriate and adequate rehabilitation advice 
and support in the ever-shortening phase before hospital discharge of cardiac patients. 
The next main challenge is to commence Phase III cardiac rehabilitation as soon as possible 
– approximately one month post-discharge to optimise benefits. All cardiac patients should 
leave hospital with a formal plan for subsequent rehabilitation activities.
Lead organisation: HSE
Coordinated community-based lifestyle and risk factor management is highly desirable. The ongoing 
support needs of the hospital-treated cardiovascular patient fit well with the support needs of the 
high-risk cardiovascular patient identified through primary care. The concept of prevention services 
in the community, to promote and maintain cardiovascular health, would serve the needs of both 
established and high-risk patients, and would provide hospital and primary care staff with a common 
focus for community support.
At present, there are a number of models of service delivery. A common programme of audit would 
assess whether all eligible patients have access to services and would identify gaps in service provision 
to inform planning, but also to evaluate the achievement of key secondary prevention outcomes by 
different models of service provision (see Recommendations 6.4-6.6).
Executive Summary
Changing Cardiovascular Health:  National Cardiovascular Health Policy 2010 – 2019
24
RECOMMENDATION 6.4
Equity of access to services and models of care: A menu-driven system of delivering 
rehabilitation should be established to support equitable access for groups vulnerable to 
exclusion from traditional programmes.
Age, gender, education, income, distance from specialist services and transport availability,  
all mitigate against equitable access to cardiac rehabilitation programmes. Rehabilitation 
services must ensure that the particular physical, psychological, vocational and social needs  
of differing groups of patients are addressed.
Lead organisation: HSE
RECOMMENDATION 6.5
Models of care and patient preferences: Criteria should be established for the endorsement 
of different models of programme delivery, based on delivery of agreed cardiovascular 
targets.
A number of models of programme delivery exist, with variations on programme duration 
and emphasis. This is an area of ongoing debate and innovation. From a service perspective, 
all models of programme delivery should audit their output against agreed short-term targets 
(programme end) and long-term targets (one year).
Lead organisations: HSE and Irish Association of Cardiac Rehabilitation
RECOMMENDATION 6.6
Ensure that cardiac rehabilitation services are effective and efficient through regular 
evaluation, with robust ICT systems and appropriate governance.
Eligible patients (i.e. ACS or coronary intervention patients and patients with heart failure 
and peripheral arterial disease) should be offered cardiovascular rehabilitation services. All 
programmes should have adequate facilities and be delivered by a multidisciplinary team, in 
accordance with agreed national standards.
Lead organisation: HSE, in association with Irish Association of Cardiac Rehabilitation
stroke rehabilitation
Multidisciplinary rehabilitation can benefit all who experience a stroke. The multidisciplinary nature 
of stroke rehabilitation includes numerous specialties, primarily neurological and geriatric, and 
rehabilitation medicine specialists in hospital, with GP support in the community. The essential allied 
health professional staffing for hospital and community services includes nursing, physiotherapy, 
occupational therapy, speech and language therapy, neuropsychology, dietetics and medical social work.
The first Irish National Audit of Stroke Care (INASC), carried out in 2006-07, documented major 
inadequacies in the provision of stroke rehabilitation services (Horgan et al, 2008). The stroke unit is 
the starting point for delivery of organised stroke rehabilitation services (see Recommendation 6.7).
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RECOMMENDATION 6.7
A multidisciplinary assessment of rehabilitation needs, using a formal procedure or protocol, 
should be completed within 5 working days of admission for stroke. An appropriate service 
plan should then be commenced.
Lead organisation: HSE
Early Supported Discharge (ESD) seeks to facilitate successful discharge from the acute stroke service. 
Successful ESD needs high-intensity inputs from community nursing and multidisciplinary teams. 
Guaranteeing rapid access to high-quality multidisciplinary stroke rehabilitation in the community pays 
dividends for the person with stroke and facilitates early supported discharge (see Recommendation 6.8).
RECOMMENDATION 6.8
For patients with stroke who are suitable for early supported discharge, resources and 
systems should be in place to facilitate early rehabilitation in a community setting, delivered 
by a multidisciplinary team with input from rehabilitation and geriatric medicine. This should 
begin with a full needs assessment.
Lead organisation: HSE
People with less severe stroke who rapidly exit the hospital service can be lost to rehabilitation 
support because most community services have limited capacity. In addition, people with severe 
disability currently experience delay accessing specialist in-patient and out-patient programmes. 
Frequently there are unacceptable delays in transfer from an acute hospital bed to the acute and 
secondary rehabilitation phases, and long delays in accessing residential care. In the community, 
the major rehabilitation resource for older people is through Day Hospital services, which are 
widely available. Services are needed that are accessible to younger people, to those with mobility 
impairments and to those with transport problems.
The forthcoming National Policy and Strategy for the Provision of Neuro-Rehabilitation Services in Ireland 
2010-2015, to be published in 2010 by the Department of Health and Children/HSE, will address the 
complex neuro-rehabilitation needs of patients who require these services and provide guidance on 
how they should be integrated.
Enhancing quality of life in the community after a disabling stroke remains a challenge (see 
Recommendations 6.9-6.11). Services such as the Volunteer Stroke Service (VSS) have considerable 
experience in this area and a major expansion of this organisation would facilitate greater community 
integration for people with stroke. Vocational rehabilitation for people with stroke is still very limited.
RECOMMENDATION 6.9
A partnership framework should be developed between the HsE and the voluntary sector to 
enable expansion of stroke rehabilitation support services and the provision of services, such 
as transport, where needed.
Lead organisations: HSE and Local Authorities
Executive Summary
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RECOMMENDATION 6.10
All stroke patients should have access to appropriate levels of rehabilitation, regardless of 
age or residential location.
Lead organisation: HSE
RECOMMENDATION 6.11
stroke rehabilitation services should be patient-centred, to include individual assessment 
of need and ongoing review, and coordinated by a key worker to ensure that rehabilitation 
is available as required on an ongoing basis. There needs to be a continuum of care from 
hospital to community. stroke rehabilitation services should be consistent with the broader 
neuro-rehabilitation service requirements as identified in the forthcoming National Policy 
and Strategy for the Provision of Neuro-Rehabilitation Services in Ireland 2010-2015.
Lead organisation: HSE
Successful integration of acute hospital and community services for cardiac and stroke rehabilitation 
(i.e. cardiovascular rehabilitation) is needed in the medium term if best use is to be made of personnel, 
expertise and facilities. Development of senior posts with responsibility for clinical services across 
community and hospital, and across cardiac and stroke is recommended as a mechanism to foster 
more successful integration across these services (see Recommendations 6.12-6.14). Integrated 
education will further support this initiative.
RECOMMENDATION 6.12
There is a need to establish or redirect services to address effectively the common 
rehabilitation goals of all cardiovascular patients.
Lead organisation: HSE
RECOMMENDATION 6.13
There is a need to deliver a structured training and leadership system for professionals 
involved in cardiovascular rehabilitation.
Lead organisations: Irish Heart Foundation (IHF), Irish Association of Cardiac Rehabilitation and 
IHF Stroke Council, in association with professional and educational bodies
RECOMMENDATION 6.14
Primary care teams and cardiac and stroke rehabilitation services need to be developed to 
deliver integrated, shared care between hospitals and the community.
Lead organisation: HSE
Support for patients following stroke and their families starts in the acute setting, with an urgent need 
for clear and accessible information. In addition, psychosocial support for patients and carers is also 
needed across the continuum of care (see Recommendations 6.15-6.18).
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RECOMMENDATION 6.15
Information and education should be provided for patients, their families and caregivers. 
Information should be timely, up to date, accessible and responsive to the needs of the 
particular patient and family.
Lead organisation: HSE, in partnership with Irish Heart Foundation and other voluntary agencies
RECOMMENDATION 6.16
Access should be provided to comprehensive psychosocial support, including management 
of depression, for cardiovascular patients and their families.
Lead organisation: HSE
RECOMMENDATION 6.17
Families and carers should be provided with the appropriate information, support, training, 
appliances and facilities, including respite care, to enable them to contribute to their 
relative’s care in a way that optimises quality of life and supports independent living for 
relative and family.
Lead organisation: HSE
RECOMMENDATION 6.18
Each cardiac and stroke network should have access to a comprehensive specialist palliative 
care service and should actively seek to incorporate hospice and end-of-life care principles 
into its routine practice.
A proportion of cardiovascular patients will need palliative care services. Palliative care should 
be incorporated into care pathways and protocols for all patients with end-stage cardiovascular 
disease. Many patients with heart failure, for example, will have a palliative care phase, with 
disimproving health and risk of death, during which patients and carers will need to be 
supported. Care structures, processes and services need to be put in place, or be adapted, to 
meet these needs.
Lead organisation: HSE
Executive Summary
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WORkFORCE PLANNING (CHAPTER 7)
This national cardiovascular health policy envisages new or adapted roles within existing services as 
the basis for its delivery. Additional capacity will be needed to deliver on duty of care commitments 
to best practice. Workforce planning to achieve this capacity will require several measures including 
complete and updated documentation on the cardiovascular health workforce and on staffing needs 
by discipline and location within each network. It will also require measures to support continuing 
professional development for cardiovascular health professionals (see Recommendation 7.1).
RECOMMENDATION 7.1
Workforce planning for cardiovascular services needs to be integrated effectively with service 
planning, liaising closely with education and training bodies.
Training and development must be considered a continual process, encompassing continuing 
professional education, personal development planning and management development. 
An annual audit of cardiovascular services should include information on workforce needs, 
in line with the current national cardiovascular health policy, and on training and continuing 
professional development needs in order to deliver an integrated cardiovascular service.
Lead organisations: Department of Health and Children and HSE
Cardiology – Hospital consultants
The final report of the Joint Working Group to review consultant cardiology requirements in 2004 
recommended a consultant cardiology ratio of 1 per 48,000 population, giving a total complement of 
81 posts at that time. In 2008, there were 56 established consultant posts, not including those working 
in the private system. In tandem, there are specialist needs in paediatric, congenital heart disease, 
hypertension, preventive cardiology and rehabilitation, heart failure and peripheral arterial disease 
(see Recommendation 7.2). Numbers of cardiac surgeons in post or approved are deemed adequate to 
meet current cardiac surgical demand.
RECOMMENDATION 7.2
The Joint Working Group on consultant cardiology requirements (2004) should be used as a 
guide to consultant cardiology workforce planning in future national service plans.
Decisions on the appropriate level of consultant cardiology staff to deliver the expanded 
emergency PCI and other cardiac services as set out in Chapter 5 of this policy should involve 
a gap analysis at each cardiac network level with reference to the above guidelines and taking 
into consideration any effective developments in medical technology and good practice in this 
and related areas since 2004.
Lead organisation: HSE
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stroke – Hospital consultants
The majority of stroke patients have substantial medical co-morbidities. Co-morbidities and 
complications of stroke require consultant/specialist input throughout the care pathway. There is a 
requirement to provide acute stroke care as well as ongoing care provided in the community. Stroke 
positions with specific expertise in cerebral vascular disease come from a variety of backgrounds, 
including consultant geriatricians, neurologists, pharmacologists and rehabilitation medicine 
specialists. 
Total stroke consultant requirements
It is difficult to plan future workforce requirements given the changing nature of stroke care. The 
British Association of Stroke Physicians estimate that a typical hospital serving a population of 350,000 
and admitting approximately 600 acute stroke patients per year would require 3.3 consultants with 
a sub-specialty stroke interest. This equates to 5 consultants in a network serving a population of 
500,000. The additional service requirements identified in this policy (such as rapid access TIA clinics, 
atrial fibrillation management and other aspects of stroke care) would include an additional 2 or 3 
consultants per network and additional rehabilitation physician expertise to meet the ongoing stroke 
care needs (see Recommendation 7.3).
Several existing consultant appointments where stroke expertise and partial stroke service delivery 
exist may be reconfigured to create full-time stroke specialist posts, with the non-stroke duties of 
these existing consultants being assigned to additional incoming consultant staff. Some posts should 
be reserved to boost the number of consultants in centres providing a tele-medicine support service.
It is expected that stroke consultants will engage in dual/sub-roles: two to act as network clinical 
co-directors and one to have a role as director for each of the following areas – the stroke unit in the 
comprehensive centre, community liaison/integration, tele-medicine, preventive medicine including 
management of atrial fibrillation and TIA, and education within the network. To ensure an appropriate 
mix of skills within each stroke network, appointments should be balanced between geriatric 
medicine and neurology with a special interest in stroke. The consultant neurologist appointments 
are additional to those recommended previously by Comhairle and others since stroke services were 
specifically excluded from the terms of reference of these reports. 
RECOMMENDATION 7.3
The staffing ratios and roles outlined in this policy should be used as a guide to consultant 
appointments and workforce planning in formulating future national service plans.
This will require an appropriate level of consultant neurologists, geriatricians and 
rehabilitation medicine specialist stroke staff to meet the need for stroke units, emergency 
thrombolysis, rapid access TIA clinics and other elements of stroke care as set out in Chapters 
5 and 6 of this policy. This should involve a gap analysis at the stroke network level so that 
staffing levels are compatible with the comprehensive range of stroke services outlined 
previously. Consultant workforce for stroke services should be reviewed midway through 
implementation of this policy. 
Lead organisation: HSE
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Non-consultant Hospital doctors
An adequate supply of dedicated non-consultant hospital doctors is essential to support the 
consultant-provided services in an expanding scheme of consultant appointments and to build 
capacity for the next generation’s consultant workforce in cardiovascular disease. 
Nursing roles
The development of nursing roles will enable further specialisation in cardiovascular services, 
including more integration of skills across previously separate roles in cardiac and stroke care (see 
Recommendation 7.4). A clinical nurse specialist should form part of every specialist cardiac and stroke 
multidisciplinary team, with a view to expansion to advanced nurse practitioner level. Other nursing 
roles will also evolve in line with implementation of this policy, including practice nurses, community 
and public health nurses, and nursing roles across the cardiovascular rehabilitation spectrum.
RECOMMENDATION 7.4
Workforce planning is needed to ensure adequate development and provision of 
cardiovascular clinical nurse specialists and other specialist cardiovascular nursing roles to 
ensure adequate provision of personnel in line with best practice guidelines.
Development of a group of cardiovascular clinical nurse specialists will be an important 
resource in delivering on this policy. Training and recruitment should prioritise a community 
liaison role for some of this expanding group of specialists.
Lead organisation: HSE, in association with nursing training organisations
Multidisciplinary teams and technical support staff
Input from a multidisciplinary team is a basic requirement to provide quality care. Management of 
cardiac and stroke patients requires specialist teams led by clinicians with differing relevant expertise 
(see Recommendation 7.5). The core cardiovascular multidisciplinary team should include consultant 
cardiovascular-related physicians, non-consultant hospital doctors, clinical nurse specialists and 
technical support staff (including a database manager), as well as access to a range of therapy services 
(e.g. speech and language therapist, physiotherapist, occupational therapist) and the expertise of 
dieticians, pharmacists, psychologists/neuropsychologists and social workers. Each team should also 
have a community liaison coordinator. Technical support staff for existing and emerging diagnostic 
and procedural work must also be factored into workforce planning if services are to be delivered to 
the maximum potential of other medical and nursing team members.
RECOMMENDATION 7.5
Workforce planning is needed to ensure adequate development and provision of 
cardiovascular nursing, health and social care professionals, and related clerical and technical 
support personnel in line with best practice guidelines.
Appropriate representation is needed within multidisciplinary teams, covering a range of 
nursing, health and social care professionals, and clerical and technical support staff. Assistant 
or support grades of health and social care professionals are also needed to help increase 
efficiency of service provision. An annual review of workforce issues will assist in planning.
Lead organisation: HSE, in association with Department of Health and Children
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Primary care teams
The development of primary care teams can become a major driver of this national cardiovascular 
health policy. Support for primary care team members will be required to enable effective 
management of patients with chronic cardiovascular disease and high cardiovascular risk. Structured 
care services, such as heart failure services, will require re-organisation in conjunction with hospital 
services and development of specialist nursing and multidisciplinary care roles. Current roles may 
need to be reconfigured to support cardiovascular prevention activities, including the development of 
prevention services in community settings (see Recommendation 7.6).
RECOMMENDATION 7.6
Planning and coordination is needed to ensure that the community healthcare workforce 
addresses the cardiovascular prevention and rehabilitation recommendations of this policy.
Lead organisation: HSE
voluntary bodies
Voluntary sector involvement must be considered within the overall context of cardiovascular care 
delivery. Formal voluntary sector organisations, such as the Irish Heart Foundation, play a pivotal role 
in patient support, advocacy and empowerment.
NATIONAL FRAMEWORk FOR QuALITY IN CARDIOvAsCuLAR HEALTH 
(CHAPTER 8)
A national framework for the delivery of high-quality care in cardiovascular services is outlined 
here. Requirements include information and communications technology (ICT), workforce planning 
and investment, alongside a programme of continuing professional development. Staff will need 
support to integrate rapidly changing evidence-based practices and methods of team-working into 
everyday practice. 
Policy on cardiovascular health is developed by the Department of Health and Children and delivered 
through a range of agencies, primarily the Health Service Executive (HSE) and the Health Information 
and Quality Authority (HIQA). Mechanisms include the annual National Service Plan between the 
Department of Health and Children and the HSE. Evaluation is an integral component of this national 
cardiovascular health policy and a Cardiovascular Policy Monitoring Group will be set up, to meet 
twice a year to review progress and advise the Department of Health and Children on the achievement 
and implementation of policy objectives. A major mid-term review of progress will be completed in 
Year 5 of the policy (2014).
Key components of delivering high-quality healthcare are effectiveness, patient-centeredness, 
timeliness, safety, efficiency and equitable access. To ensure a whole-systems approach in delivering 
these components, committed governance and clinical leadership are necessary. 
Executive Summary
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National standards of cardiovascular health services
Cardiovascular health services in Ireland should be based on international best practice and deliver 
the best possible health return on investment. Plans for systematic development of cardiovascular 
health services need to be developed and delivered in a quality framework, with guidance and 
accountability. This will involve development of evidence-based guidance, performance indicators 
relating to guidance and national standards for quality and safety, and information and data 
requirements (see Recommendation 8.1).
The HSE, through the National Directorate of Quality and Clinical Care, is responsible for oversight 
of the disease management programmes within the HSE, for developing clinical guidelines and for 
providing clinical leadership in this area.
RECOMMENDATION 8.1
Evidence-based guidelines and standards should be agreed, with appropriate performance 
indicators identified and reporting structures established.
Lead organisations: Department of Health and Children, HIQA and HSE
Cardiovascular health surveillance
A systematic surveillance approach needs to be implemented as a matter of urgency to facilitate the 
collection and use of patient-based data for surveillance, audit and research (see Recommendation 8.2). 
Development and implementation of common data standards and a unique patient identifier are 
essential to surveillance. A comprehensive system should also deliver information on equity regarding 
access to services and on disease prevalence.
RECOMMENDATION 8.2
A comprehensive cardiovascular health services information system should be developed as 
a priority to enable the implementation of this policy.
This will entail agreement on systematic data collection methods and analytic standards across 
healthcare pathways nationally to ensure coordinated collation, analysis and evaluation of data.
Lead organisation: HSE
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Registers, information systems and data standards
Comprehensive and interpretable data on service provision and information on patient care 
pathways cannot be achieved without the development of nationally comprehensive and compatible 
cardiovascular information systems, including patient registers (see Recommendation 8.3). There is 
a need to develop a comprehensive Cardiovascular Disease Registry, similar to the National Cancer 
Registry model.
RECOMMENDATION 8.3
Minimum cardiovascular-specific datasets should be agreed and mechanisms established 
for collection of this information as part of routine care and in a manner that enables ready 
collation of national profiles.
Lead organisations: Department of Health and Children, HIQA (standards) and HSE (audit system)
Population health surveys
Population health data on cardiovascular targets, such as lifestyle, can be achieved through regular 
national health surveys. Over the 10-year lifetime of this national cardiovascular health policy,  
high-quality population-based data will be essential in measuring its challenges and achievements, 
and in directing resources to best realise improvements (see Recommendation 8.4).
RECOMMENDATION 8.4
Regular population-based surveys should be conducted to establish health profiles in adults 
and children.
Challenges in delivering such surveys need to be addressed promptly to enable ongoing 
delivery of high-quality and robust data for service planning. At least two national adult and 
child surveys are needed during the 10-year lifetime of this policy.
Lead organisations: Department of Health and Children and HSE
Audit
Clinical audit involves structured review against agreed standards in order to promote improvements 
in healthcare and public health. A routine national audit system for all aspects of cardiovascular care 
is needed (see Recommendation 8.5). Since this will take time to establish, it is important that plans 
commence from the start of this policy (2010).
RECOMMENDATION 8.5
An annual audit of cardiovascular networks should be conducted to assess volume and 
quality of service delivery and to aid in service planning.
Lead organisations: Department of Health and Children and HSE
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Role of information and communications technology
Information and communications technology (ICT) systems should support the management and 
delivery of patient care services, as well as their quality assurance, through audit, accreditation and 
other processes (see Recommendation 8.6).
RECOMMENDATION 8.6
Information and communications technology (ICT) infrastructure, capacity and training 
should be developed. This should include the implementation of patient identifier and 
electronic health records as a matter of urgency.
Enhanced electronic communication methods are needed to support new models of health 
service delivery. Information systems and technology need to be developed within and across 
secondary and primary care settings.
Lead organisations: HIQA (enabling mechanisms) and HSE (systems)
Research and evaluation, including health technology assessment
A research climate in the health services is fundamental to improving quality by contributing to policy 
development and planning efforts. A key component of evidence-based practice is the use of health 
technology assessment to ensure that health service resources are used effectively by assessing the 
clinical and cost-effectiveness of the medicines, devices, diagnostics and health promotion used 
across the health system. A coordinated research agenda is vital to ensure the projects needed to 
inform this policy are prioritised (see Recommendation 8.7). The research supported in the lifetime of 
this policy will provide the treatments and insights to inform the next policy.
RECOMMENDATION 8.7
A national group representative of stakeholders should be convened to determine priorities 
for research and health technology assessment in cardiovascular care.
Tasks include ensuring that enabling research support skills in areas such as biostatistics and 
health economics are developed and that the information needs of this policy are enabled 
through research.
Lead organisation: Health Research Board to coordinate and involve key stakeholders, i.e. policy, 
service, academic and public representatives 
In sum, the aim of this policy is to guide and drive change – to deliver a Changing Cardiovascular 
Health – such that the Ireland of 2020 will be a healthier place for all its citizens.
CHAPTER 1     INTRODUCTION
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1.   INTRODuCTION
CARDIOvAsCuLAR HEALTH POLICY GROuP
The Cardiovascular Health Policy Group was established by Ms. Mary Harney, TD, Minister for Health 
and Children. It had its first meeting in September 2007, with the following terms of reference:
Having regard to the audit of the implementation of the cardiovascular health strategy, 
Building Healthier Hearts, and the audit of stroke services, Irish National Audit of Stroke Care, 
and consistent with developments in relation to the management of chronic diseases and 
the Primary Care Strategy, to develop a policy framework for the prevention, detection and 
treatment of cardiovascular disease, including stroke and peripheral arterial disease, which 
will ensure an integrated and quality-assured approach in their management.
bACkGROuND
Cardiovascular diseases include conditions such as coronary heart disease and congestive cardiac 
failure (heart failure); cerebral (brain) conditions such as stroke; and peripheral (limb) conditions such 
as peripheral vascular disease. The main underlying cause of cardiovascular disease is atherosclerosis, 
a process where blood vessels are narrowed or become completely blocked. It is most serious when it 
affects blood supply to the heart, causing angina or heart attack, or to the brain, causing stroke. 
Cardiovascular disease is the main cause of death in Ireland. While there have been substantial 
improvements in recent decades, death rates for cardiovascular disease continue to compare 
unfavourably with other developed countries and thus contribute substantially to our shorter lifespan 
compared to that of many neighbouring countries. Chapter 2 of this report outlines the current profile 
of cardiovascular disease and its management in Ireland.
This new cardiovascular policy, Changing Cardiovascular Health covering the period 2010-1019, comes 
a decade after the first national cardiovascular health strategy, entitled Building Healthier Hearts, was 
published by the Department of Health in 1999. The new policy is timely at this 10-year point given 
the accelerating pace of change in scientific development and medical practice internationally, the 
substantial changes in health service structures in Ireland within the last decade and the influences 
on individual and population health behaviours and healthcare practices and expectations. Much of 
our capacity to reflect on changes over this time derives from research conducted at population level 
through national health and lifestyle surveys, including the Survey of Lifestyle, Attitudes and Nutrition 
(SLÁN) for adults in 1998 (Friel et al, 1999), 2002 (Kelleher et al, 2003) and 2007 (Morgan et al, 2008); 
the Health Behaviour in School-aged Children (HBSC) Survey for children and adolescents aged 10-17 in 
1998 (Friel et al, 1999), 2002 (Kelleher et al, 2003) and 2006 (Nic Gabhainn et al, 2007); and at a service 
level by audits on cardiac care (Ireland: Take Heart – HSE, 2007) and stroke care (Irish National Audit of 
Stroke Care (INASC) – Horgan et al, 2008). The overall message from these studies and from routinely 
collected data is that there has been a steady decline in age-adjusted death from cardiovascular 
disease, coupled with an increasing level of health service delivery in Ireland. 
However, poor risk factor profiles, such as increasing obesity and diabetes in the population, now 
signal a potential reversal of the previous decade’s mortality achievements. In parallel, comparison of 
service delivery against recommended targets demonstrates substantial capacity for improvement.
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In sum, the cardiovascular mortality reductions seen in the last decade cannot be maintained, nor 
can acceptable levels of service delivery be assured, without significant complementary investment 
in the prevention and management of cardiovascular disease. This will require additional financial 
investment, but also, more importantly, a re-engineering of existing services and work practices 
to address cardiovascular health as a resource to cultivate and cardiovascular disease as a chronic 
condition to manage across the spectrum of services pertaining to health. Thus, at this time, we need 
an integrated approach to the promotion and protection of cardiovascular health as a key national 
resource.
A vIsION FOR CARDIOvAsCuLAR HEALTH
Ireland has already provided leadership in areas of cardiovascular disease management. Ireland’s first 
cardiovascular health strategy – entitled Building Healthier Hearts (Department of Health and Children, 
1999) – was among the first of the national strategies launched internationally. Regarding legislation, 
Ireland became the first country in the world to introduce a ban on smoking in the workplace in 
2005 – a ban that has been replicated in many countries since then. Politically, when Ireland held 
the Presidency of the European Union (EU) in 2004, cardiovascular disease was prioritised and the 
EU adopted Council Conclusions calling on the European Commission and Member States to ensure 
that appropriate action was taken to address cardiovascular disease. This was an important political 
catalyst for a series of EU events that ultimately resulted in a European Parliament Resolution to tackle 
cardiovascular disease. In 2007, a European Heart Health Charter was launched (see www.heartcharter.
eu), with the following vision: ‘Every child born in the new millennium has the right to live until the age of 
at least 65 without suffering from avoidable cardiovascular disease.’
This commitment has been endorsed by many countries and professional bodies across Europe, 
including Ireland. The sentiments expressed in the European Heart Health Charter have a particular 
resonance in the Irish context at this time. We have had a decade of unprecedented economic success, 
yet our cardiovascular health profile is poor in comparison with most of our European counterparts. 
We are also approaching the 100th anniversary of the 1916 Rising, a pivotal historic period that led to 
the establishment of the Irish Republic. On the verge of a period of centennial reflection on the origin 
and direction of the State, it is also noteworthy that in the next few years, and for the first time in the 
history of the Irish Republic, the number of children in Ireland will approach one million. The European 
Heart Health Charter signals the need to work throughout the lifespan, from childhood, to promote 
and protect cardiovascular health. It also signals a commitment to social solidarity in identifying 
cardiovascular health as a right of all citizens. In sum, it is a very fitting commitment to adopt as the 
overall vision for this new national cardiovascular health policy, entitled Changing Cardiovascular 
Health. The policy will adopt a proactive approach to actively changing cardiovascular health for 
the better. This challenge is being met in quite different and disimproved national and international 
economic circumstances, where policy-led investment and service delivery will be all the more 
necessary to achieve benefit.
This new cardiovascular health policy is seen as an important framework for developments in the 
coming decade. While many of the specifics in terms of treatment possibilities a decade hence cannot 
now be even envisaged, their potential can be considered in a broad framework of safe, effective and 
equitable service delivery, within an overarching commitment to prevention and early management 
of cardiovascular health problems. The more specific focus of this policy in the first 5 years of its 
lifetime (2010-2014) reflects in part the need to focus on early achievements in this uncertain 
economic period, but also the need to take stock of the impact of changes in service delivery and    
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technological possibilities within a reasonable timeframe in order to further refine policy priorities in 
the second half of the 10-year policy period. The policy will be established alongside and complement 
other recently developed health-related policies, including policies on obesity, alcohol and chronic 
disease prevention and management. It will also work with existing and proposed service delivery 
frameworks of the Health Service Executive (HSE), in particular the hospital reconfiguration agenda, 
the critical care review, the consultant workforce developments, the establishment of primary care 
teams, the proposed new general practitioner contract, and the framework of the recently launched 
report Building a Culture of Patient Safety by the Commission on Patient Safety and Quality Assurance 
(Department of Health and Children, 2008b).
The policy is being launched in a climate of severe economic constraints. There is little likelihood, 
therefore, of immediate additional resources being available to fast-track delivery of the policy. 
Nonetheless, much can be done in the short to medium term in tandem with other policies and 
current and planned service delivery frameworks. A number of important recommendations which 
can be prioritised for early attention relate to achieving professional consensus on guidelines 
and protocols to inform service delivery. These can be achieved without significant investment 
and there is already evident professional enthusiasm to do so. Where resources are necessary for 
early implementation, these will have to come from existing initiatives, such as the HSE hospital 
reconfiguration programme and the development of primary care teams. Over the longer term, the 
requirement for additional resources in support of the policy will have to be balanced against service 
priorities, potential savings from staff redeployment and the reorganisation of the HSE resources. It is 
envisaged that these will be specified in future national service plans.
Cardiovascular disease prevention and management covers all aspects of health and healthcare – from 
childhood through old age, and from prevention through emergency care, rehabilitation and palliative 
care. Lifestyle is the overriding contributor to cardiovascular health and its maintenance. Changes 
in health behaviour – smoking, physical activity, healthy eating, weight management and moderate 
alcohol consumption – benefit both cardiovascular health and also the prevalence of most other 
common chronic health conditions. Cardiovascular health and its maintenance is thus a microcosm 
of health more generally. A policy that can improve cardiovascular health and cardiovascular disease 
management will have beneficial effects for the whole healthcare system.
The first century of the Irish Republic witnessed a steady rise in mortality from cardiovascular disease. 
As described in Chapter 2, there is some evidence of a reversal in this pattern over the last two 
decades. Recent population health behaviour profiles, however, give cause for serious concern that 
cardiovascular health may worsen, rather than improve, in the coming decades. If we are to truly 
commit to changing cardiovascular health, we must seize this opportunity at the start of the country’s 
second century to establish a robust prevention approach, ‘owned’ by its citizens and complemented 
by an effective and equitable health system to manage cardiovascular health problems.
sTRuCTuRE OF REPORT
The following chapters outline the current cardiovascular health status in Ireland (Chapter 2) and then 
describe a policy approach to prevention and health promotion (Chapter 3), primary care (Chapter 4), 
hospital and emergency care services (Chapter 5) and rehabilitation and continuing care (Chapter 6). 
Workforce capacity is then considered and the education implications of the plans outlined (Chapter 
7). Finally, a national quality framework for the policy is described, together with mechanisms to 
establish and monitor it over the 10-year period (Chapter 8).
CHAPTER 2      CARDIOVASCULAR DISEASE  
– TRENDS IN IRELAND
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2.   CARDIOvAsCuLAR DIsEAsE – TRENDs IN IRELAND
This chapter outlines trends in demography and in the epidemiology of cardiovascular disease in 
Ireland and highlights the difference between the period before the first national cardiovascular 
health strategy (Department of Health and Children, 1999) and the latest available statistics. It builds 
on the comprehensive update of the first strategy undertaken in 2007, Ireland: Take Heart (HSE, 2007).
LIFE ExPECTANCY AND HEALTHY LIFE YEARs
Life expectancy in Ireland has increased in the last decade, with improvements in cardiovascular 
health contributing to this situation. However, life expectancy at birth and at age 65 remains below 
the EU15 average for both men and women (WHO, 2008a). For example, between 2002 and 2006, life 
expectancy in Ireland at birth increased by 1.7 years for men and by 1.3 years for women (CSO, 2009). 
However, comparing life expectancy at birth with EU15 countries in 2006, Ireland ranked joint 12th 
for men (76.8 years; EU15 range 75.5 – 78.8 years) and ranked 13th for women (81.6 years; EU15 range 
80.7 – 84.4 years).
The concept of healthy life years (HLY) is a measure of the number of subsequent years that a person 
of a specific age is expected to live in a healthy condition, ‘healthy’ being defined as the absence of 
limitations in functioning/disability (Eurostat, 2008). HLY is based on the measurement of health-
related limitations in daily activities. It may be a particularly important indicator of the potential 
demand for health services and long-term care needs of the population. Irish scores on HLY are 
intermediate among the EU15 countries. However, HLY scores are lower for both men and women in 
Ireland than for other countries with similar and relatively low life expectancy. For example, men in 
Ireland at age 65 will spend 81.4% of their remaining years in good health, compared to 90.1% for men 
with similar life expectancy in Denmark. Similarly for women – women in Greece and the UK will spend 
82.3% and 80.1% respectively of their remaining years in good health, while the figure for women in 
Ireland is 78.4%.
Thus, EU comparative data indicate that despite improvements in Ireland in the past decade, we are 
notably behind our EU counterparts in both length of life and disability-free years of life.
CARDIOvAsCuLAR DIsEAsE
Cardiovascular disease mortality
Cardiovascular disease is the single largest cause of death in Ireland: in 2008, diseases of the 
circulatory system accounted for 9,883 (35%) of all deaths (CSO, provisional data). Of these, 5,188 were 
due to coronary (ischaemic) heart disease, 2,116 due to stroke and 2,579 due to other diseases of the 
circulatory system.
In terms of premature deaths (i.e. death in those under 65 years), 1,249 (20%) of all deaths were as 
a result of diseases of the circulatory system. Of these, ischaemic heart disease accounted for 727 
deaths, stroke for 223 and other diseases of the circulatory system for 299.
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Age-standardised mortality rates for cardiovascular disease
Over the last 30 years, age-standardised death rates from diseases of the circulatory system in Ireland 
have decreased by 67%. This is the case both for those under 65 years of age and for those aged 65 
and over (see Figures 1 and 2). The relative reduction has been highest in those younger than 65 years 
(a 75% decrease, see Figure 1). Most of the reduction comes from decreased coronary (ischaemic) heart 
disease mortality. In tandem with the decline in mortality from cardiovascular disease, the increasing 
workload for the health services is evident across hospital, primary care and prescribing sectors.
Comparing Ireland with other EU Member States from 2003 to 2007 across all ages:
• Ireland had, on average, 118 (age-standardised) deaths from ischaemic heart disease per 
100,000 population annually. This was higher than the EU151 rate of 80 deaths per 100,000 
and higher than the EU272 rate of 101 deaths per 100,000.
• Regarding premature deaths, ischaemic heart disease death rates annually in Ireland averaged 
25 per 100,000, compared to 18 deaths in the EU15 and 24 in the EU272.
• Ireland had, on average, 44 deaths from stroke per 100,000 population annually. This was 
lower than the EU151, at 50 deaths per 100,000, and lower than the EU272, at 66 deaths per 
100,000.
Figure 1: Age-standardised cardiovascular disease mortality rates per 100,000 population, 
aged 0-64 years (1980-2007)
Source: WHO Health for All Database, January 2010
1   EU15 data refers to 9 countries in 2007 and 12 in 2006 who had reported mortality data.
2   EU27 data refers to 19 countries in 2007 and 23 in 2006 who had reported mortality data.
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Figure 2: Age-standardised cardiovascular disease mortality rates per 100,000 population, 
aged 65+ years (1980-2007)
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Cardiovascular disease hospital discharges
The numbers of hospital discharges from all hospitals reporting to the Hospital In-Patient Enquiry 
(HIPE) with a diagnosis of cardiovascular disease has increased since the publication of the first 
national cardiovascular health strategy, Building Healthier Hearts (Department of Health and Children, 
1999) as shown in Tables 1 and 2, which compare 1998 and 2008 hospital activity.
Table 1 shows a very small increase in overall hospital discharges (1.1%) over the period, with 
substantial increases within conditions. For example, discharges from TIA and stroke increased by 
13.1% and 9.2% respectively, while heart failure discharges decreased by 5.4%.
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Table 1: Comparison of hospital discharges* for cardiovascular conditions (1998 and 2008)
1998 2008 1998 versus 2008  
Changes in discharge rates
In- 
patient
Day 
case**
Total In-
patient
Day 
case
Total %  
change 
In-patient
%  
change 
Day case
%  
change 
Overall
CHD 17,937 3,498 21,435 16,569 5,477 22,046 -7.6 56.6 2.9
Heart 
failure
20,825 1,248 22,073 19,400 1,472 20,872 -6.8 17.9 -5.4
PVD 6,819 594 7,413 7,019 721 7,740 2.9 21.4 4.4
Stroke 6,826 50 6,876 7,326 183 7,509 7.3 266.0 9.2
TIA 2,362 15 2,377 2,643 46 2,689 11.9 206.7 13.1
Total 54,769 5,405 60,174 52,957 7,899 60,856 -3.3 46.1 1.1
* Discharges relate to ‘Principal Diagnosis’ for stroke, TIA and CHD, and ‘Any Diagnosis’ for HF and PAD. See 
Appendix 1 for ICD codes.
** Standard HIPE definition used to define ‘Day case’ episodes of care.
Source: HIPE and NPRS Unit, ESRI, for all acute and non-acute HIPE-reporting hospitals
Table 2 shows a 3.9% increase in bed days used for cardiovascular disease in 2008 compared to 1998. 
This was largely as a result of increased bed use for all forms of cardiovascular disease, except coronary 
heart disease (CHD) where a substantial reduction in bed use was evident (23.8%). Coronary heart 
disease accounted for 23.7% of bed use in 1998 and 17.4% in 2008. This is despite a major increase in 
the numbers of procedures performed (see p. 44). In general, Table 2 shows the considerable increase 
in day case activity in recent years.
Table 2: Comparison of hospital activity for cardiovascular conditions and bed usage  
(1998 and 2008)
1998 2008 1998  
versus 2008
Total  
bed days
Median 
 length of stay
Total  
bed days
Median  
length of stay
% change  
bed days
CHD 156,231 6 119,059 4 -23.8
Heart failure 261,499 8 291,988 9 11.7
PVD 98,323 8 112,588 9 14.5
Stroke 127,672 10 145,510 10 14.0
TIA 16,236 5 16,419 4 1.1
Total 659,961 685,564 3.9
Source: HIPE and NPRS Unit, ESRI, for all acute and non-acute HIPE-reporting hospitals
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Table 3 compares in-hospital mortality over the past decade and as can be seen, mortality in recent 
years from cardiovascular disease is much reduced.
Table 3: Comparison of in-hospital mortality (1998 and 2008)
1998 2008
In-hospital mortality In-hospital mortality
CHD 6% 3.2%
Heart failure 16.7% 11.8%
PVD 12.4% 7.9%
Stroke 18.1% 14.7%
TIA 0.2% 0.3%
Source: HIPE and NPRS Unit, ESRI, for all acute and non-acute HIPE-reporting hospitals
Heart failure and stroke accounted for most bed use (42.6% and 21.2% respectively). Since the 
proportion of the population in older age groups had not changed substantially from 1998 to 2006 (and 
is very low, at 11%, by European standards), this increase in bed use will be greatly exaggerated in the 
coming decade, when the numbers of people aged 65 years and over are expected to increase by 41%. 
These figures, in what is one of the youngest populations in Europe, demonstrate how the status quo in 
terms of hospitalisation is unsupportable in the future and how treatment developments must address 
the numbers of cardiovascular disease patients in hospital, but more particularly their length of stay.
Cardiovascular disease procedures and interventions
Since 1998, two- to three-fold increases have taken place in coronary heart disease procedures, such 
as angiography and angioplasty procedures. For example, angiography rates increased from 8,174 
procedures in 1998 to 15,467 in 2006 (an increase of 89%). In the same time period, angioplasty 
procedures increased from 1,478 to 4,537 (a 207% increase) and coronary artery bypass graft increased 
marginally, from 1,017 to 1,049 (a 3% increase). These figures – which do not include cardiovascular 
procedures completed in an increasing number of private hospitals – represent in part changing 
cardiology practice over the period and in part the significant increase in consultant cardiologist and 
related workforce numbers and facilities arising from investment supporting the previous national 
cardiovascular health strategy (1999).To comprehensively document changes in healthcare delivery, 
such as intervention volume, there needs to be the capacity to capture all private as well as all public 
healthcare activity in the coming years (see Chapter 7 on workforce planning).
Cardiovascular medication prescribing
From 1998 to 2006, two- to four-fold increases have occurred in prescribing medications for 
cardiovascular conditions in primary care. Trends in prescribing frequency over time (1998 to 2006) 
are presented in Figure 3, using data from the HSE’s Primary Care Reimbursement Services (PCRS, 
formerly the GMS Scheme). The entitlement to free general practitioner visits and the reimbursement 
of medicines for those aged 70 and over, as introduced in 2001, have further accelerated the already 
rising levels of prescribing of cardiovascular medications. Analysis of the prescribing database in the 
HSE’s PCRS Scheme shows significant gender, age and geographic variation, suggestive of inequitable 
prescribing (Bennett et al, 2002).
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The HeartWatch Programme of coronary heart disease management in primary care has demonstrated 
how structured chronic disease management also contributes to protocol adherence and increased 
medication prescribing (HeartWatch Programme, 2006). For example, in the prescribing of secondary 
preventive therapies after 2 years of the HeartWatch Programme, there was an absolute increase of:
• 7% in ACE inhibitors (from a 44% baseline);
• 4% in beta-blockers (from a 59% baseline);
• 11% in statin therapy (from a 78% baseline).
Figure 3: Prescribing frequency of cardiovascular medications in Ireland under the GMs 
scheme (1998-2006)
In terms of trends in cardiovascular risk factors, these are considered in Chapters 3 and 4. They include 
hypertension, atrial fibrillation, hypercholesterolaemia, diabetes and obesity. Key lifestyle factors 
affecting cardiovascular disease are also addressed in Chapter 3 – smoking, poor diet, salt intake, 
physical inactivity and excess alcohol use. Trends in the prevalence of cardiovascular disorders – heart 
failure, peripheral arterial disease, sudden cardiac death, congenital heart disease and diabetes – are 
outlined next.
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HEART FAILuRE
The prevalence of heart failure is increasing in Ireland, as elsewhere around the world. This increase 
is due to better survival following acute coronary events, longer survival after diagnosis of coronary 
heart disease, continuing high prevalence of cardiovascular risk factors, and the ageing population. 
Current data suggest a 2% prevalence of symptomatic heart failure in the general population 
in Ireland, with a further 2% having left ventricular systolic dysfunction at risk of progressing to 
symptomatic failure. It is estimated that 10% of the population over 75 years of age have heart failure 
and that over 10,000 new cases are diagnosed each year (Irish Heart Foundation, 2002). Heart failure is 
thus more common than most cancers.
Heart failure is now the only major cardiovascular disease on the increase in Europe (Dickstein et al, 
2008). It is predicted that by 2010 there will be a 70% increase from 2005 levels (Remme et al, 2005) 
in the number of cases in Europe. The number of people living with heart failure in Ireland can be 
estimated by applying prevalence rates to population projections from the Central Statistics Office 
(CSO). A best case scenario of sustained prevalence of 2% would result in an increase of approximately 
8.5% in the number of people with heart failure over the next 10 years. A more likely scenario of 
prevalence increasing by 1% to 3% would result in a 63% increase in heart failure by 2019. If the 
number of people with asymptomatic (impending) heart failure is included, then the numbers are 
much greater. The Irish Heart Foundation has predicted that by 2010, 300,000 people in Ireland will be 
affected by heart failure (Irish Heart Foundation, 2002).
The personal burden of heart failure is great, with patients experiencing high levels of physical, 
functional and emotional distress. Life expectancy for patients with chronic heart failure has also been 
poorer than for most of the common cancers (Stewart et al, 2001). However, advances in treatment 
means that survival is improving and the disease can be controlled for many years in an increasing 
number of patients (Murphy et al, 2004; Dickstein et al, 2008).
Figure 4 shows the proportions of the population in Ireland in 2007 estimated to have symptomatic 
heart failure (13,000), those stable at present with episodic deterioration (77,000) and those with 
impaired left ventricular dysfunction, or impending heart failure, and living in the community 
(160,000) (McDonald, 2008). More than 10,000 new cases of heart failure are estimated each year and 
it is rapidly becoming one of the most common reasons for emergency admission to hospitals.
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Figure 4: Estimated prevalence of heart failure (HF) in Ireland (2007)
PERIPHERAL ARTERIAL DIsEAsE
Peripheral arterial disease (PAD) is a considerable, but poorly quantified healthcare burden in Ireland. 
Those with diabetes are at particular high risk of developing PAD. While PAD accounted for only 12% 
of cardiovascular disease hospital discharges in HIPE in 2006, this represented 15% of bed days (over 
100,000 bed days) – an increase of 4% from 1998 (see Tables 1 and 2).
The prevalence of coronary heart disease in patients presenting with PAD has been reported to be as 
high as 85%-90% (Fowkes, 2001). Carotid artery disease is present in 26%-50% of patients presenting 
with symptoms of intermittent claudication, a precursor to the diagnosis of PAD. The 15-year mortality 
rate for patients with intermittent claudication is approximately 70%.
Even in patients with asymptomatic peripheral arterial disease, there is a two-fold increased risk 
of cardiovascular death (Garg et al, 2000). It is therefore important to improve management of 
peripheral arterial disease in order to protect patients from an increased risk of coronary (ischaemic) 
cardiovascular events.
In recognition of the emergence of PAD as a significant healthcare problem, an information pack for 
GPs – entitled Peripheral Arterial Disease: A Management Guide for General Practice – was produced in 
2005 by the Irish Heart Foundation, the Irish Association of Vascular Surgeons and the Irish College of 
General Practitioners. Its aim was to provide doctors with the latest information and developments 
on PAD, thereby enabling them to better detect and treat the condition. An Irish Heart Foundation 
Council on Peripheral Arterial Disease was also formed.
Cardiovascular Disease – Trends in Ireland
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suDDEN CARDIAC DEATH
Sudden cardiac death (SCD) is death due to natural causes within an hour of the onset of symptoms 
and assumed to have a cardiac cause in the absence of any other cause. The Report of the Task Force on 
Sudden Cardiac Death (Department of Health and Children, 2006) estimates that there may have been 
approximately 4,260 such deaths in Ireland in 2006. Approximately 5% of SCDs are unexplained and 
no structural abnormality is found at post-mortem (Chugh et al, 2004). The proportion of unexplained 
deaths rises to 20%-30% in those under the age of 35 (Doolan et al, 2004).
This national cardiovascular health policy endorses the recommendations of the Task Force on SCD 
with regard to public education and emergency service use (see Chapter 5, Recommendation 5.26).
CONGENITAL HEART DIsEAsE AND GROWN-uP CONGENITAL HEART (GuCH) 
DIsEAsE
The incidence of congenital heart disease in Ireland is approximately 540 births per year, or about 1% 
of live births. Many of these children can now be successfully treated surgically and the majority will 
survive into adulthood. This has resulted in a rapidly growing population of adolescents and young 
adults with grown-up congenital heart (GUCH) disease. It is estimated that there were over 13,000 
adults in Ireland with GUCH in 2008, with numbers expected to reach 15,000 by 2010.3
Most of these young people will need medical attention throughout their adult life. Some will 
require repeat cardiac surgery and a proportion will need a heart or heart–lung transplant. While 
endorsing the need for further consultant expertise for this adult population (see Chapter 7), 
additional requirements for GUCH are beyond the scope of this policy document. However, dedicated 
investigation is warranted by a specialist sub-group to inform and plan for GUCH service development 
in line with international practice, with particular reference to European and UK guidelines (see 
Chapter 8 for research and policy development priorities) (Deanfield et al, 2003; Department of Health 
[UK], 2006).
DIAbETEs
Diabetes is a condition with significantly increased risk of developing cardiovascular disease. Patients 
with diabetes have a two- to four-fold risk of cardiovascular disease compared to others. Type 1 
diabetes is estimated to affect approximately 0.4% of the population in Ireland. Type 2 diabetes is 
thought to affect at least 4.3% of adults (Balanda et al, 2006), but its true prevalence is almost certainly 
underestimated. This is because many cases go undiagnosed. Hyperglycaemia develops gradually and 
is often not severe enough in the earlier stages for a person to notice any of the classic symptoms of 
diabetes. 
The prevalence of diabetes in Ireland is increasing due to ageing of the population and increased 
rates of obesity. Prevalence of the condition is predicted to increase by 37% over the 10-year period 
2005-2015 (Balanda and Wilde, 2001). This has significant implications for cardiovascular statistics and 
services.
3   Estimates combining HIPE data, CSO birth-rate data and Our Lady’s Hospital, Crumlin, cardiac database: acknowledgement 
Mater Hospital GUCH Services.
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CARDIOvAsCuLAR TARGETs AND TRENDs IN RIsk FACTOR PREvALENCE
National targets for the reduction of cardiovascular disease mortality, referred to in Building 
Healthier Hearts (1999), have been reached and exceeded according to the audit of progress on 
the implementation of the strategy over the period 1999-2005 (HSE, 2007). In addition, a reduction 
in cardiovascular risk factors for the adult population has contributed to the decline in coronary 
heart disease mortality (see below). However, overall, the change in prevalence of risk factors for 
cardiovascular disease has been variable, with some improvements in smoking in the past decade, but 
a deterioration in levels of obesity, physical activity and diabetes. Alcohol consumption also increased 
dramatically in the late 1990s, but there are some recent signs of modest improvements.
Findings from SLÁN 2007 (Morgan et al, 2008) highlight the poor risk factor profile of the general 
population, as seen in Figure 5 (see also Chapter 3 for further details):
• While smoking in 2002 decreased from the 1998 levels of 33%, no significant further 
reduction has occurred between the SLÁN surveys of 2002 (27%) and 2007 (29%).
• The prevalence of overweight and obesity is increasing. In SLÁN 2007, over one-third of the 
population (38%) were objectively assessed as overweight, as measured by Body Mass Index 
(44% men and 34% women). A further 23% of the population were assessed as being obese 
(22% men and 24% women). This compares with 39% overweight and 1% obese in the 1999 
North/South Ireland Food Consumption Survey (Irish Universities Nutrition Alliance, 2001).
• In 2007, more than one-fifth of adults (22%) were physically inactive, with little evidence of 
change in levels of physical activity since 1998. 
• In 2007, 28% of adults reported excessive drinking (i.e. having 6 or more standard drinks on 
one occasion), compared to 45% in 2002.
Figure 5: Profile of adult risk factors in Ireland – lifestyle health determinants  
(sLÁN 2007)
Source: Morgan et al (2008)
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It is important to note that cardiovascular disease and its underlying health determinants are 
distributed unevenly in society. Differences in mortality across socio-economic groups as a 
consequence of cardiovascular conditions are evident in research conducted in Ireland (Balanda and 
Wilde, 2001). Considering mortality from major diseases, the greatest inequality across socio-economic 
groups is present in cardiovascular disease, consistent with international research (Mackenbach et al, 
2000). In Ireland, the age-adjusted rates of cardiovascular deaths are now almost 4 times higher (368%) 
in the lower social groups than in the higher ones. Rate ratios (RR) represent the mortality gradient 
between higher and lower socio-economic groups. In younger groups – those aged 15-64 – the gap is 
highest: the all-cause mortality RR = 3.6 (CI: 3.57, 3.63), cardiovascular disease RR = 4.68 (CI: 4.16, 4.7) 
and cancer RR = 2.53 (CI: 2.48, 2.58). Even in older groups – those aged 65 and over – the risk of dying 
at a specific age in lower social groups is more than double that from higher social groups: all-cause 
mortality RR = 2.2 (CI: 2.19, 2.22), cardiovascular RR = 2.35 (CI: 2.32, 2.37) and cancer RR = 1.81 (CI: 1.78, 
1.84). This gap appears to be widening – the most recent analysis covering the period 2000-2006 by 
Smyth et al (forthcoming) represents an increase of 156% in the gap between higher and lower  
socio-economic groups since the previous 1989-1999 analysis (Balanda and Wilde, 2001).
The lifestyle factors leading to cardiovascular disease are also distributed unevenly across society – in 
particular, smoking, alcohol consumption, diet and physical activity (see Chapter 3). The overall impact 
of lifestyle changes and treatment provision on cardiovascular disease mortality is now considered,  
using statistical modelling to determine relative impact.
ExPLAINING CHANGEs IN CARDIOvAsCuLAR MORTALITY FROM 2000-2006
An IMPACT statistical modelling exercise, assessing population contributions to the falling 
cardiovascular disease mortality rates in Ireland for the period 1985-2000, showed that based on 
1985 profiles, death rates were 47% lower in 2000 than could have been expected. About half of the 
reduction was as a result of preventive measures, such as reduced cholesterol and smoking, and half 
as a result of treatments, such as surgery and medication (Bennett et al, 2006).
A similar analysis was conducted for this national cardiovascular health policy for the period  
2000-2006, using newly available SLÁN 2007 data on major risk factors and health behaviours. 
Findings show that between 2000 and 2006 there was a further 45% decline in coronary heart disease 
mortality rates in Ireland, similar among men and women (see Appendix 2). If coronary heart disease 
mortality rates in 2000 had persisted to 2006, there should have been 5,561 deaths from coronary 
heart disease in those aged 25-84 in 2006, given the increased population over this time. However, 
3,246 deaths were observed, giving 2,315 fewer deaths than expected, or ‘deaths prevented or 
postponed’ (DPPs), between 2000 and 2006.
The majority of the explained decline could be attributed to improvements in the uptake of 
treatments and to reductions in population cholesterol (see Appendix 2). However, these positive 
effects were offset by the increasing coronary heart disease mortality attributable to increasing levels 
of diabetes and obesity, which negated almost half of the benefits of reductions in cholesterol. Overall, 
almost half (48%) of the change was explained by treatments and 16% only by preventive activities. 
While the overall rate of decrease in cardiovascular disease mortality has accelerated since 2000 
(averaging 251 per year in 1985-2000 and 386 per year in 2000-2006), on average 165 lives per year 
were saved through prevention pre-2000 and 83 through treatment. Since 2000, these figures have 
been reversed – to 62 per year explained through prevention and 185 per year through treatment.
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While there are limitations to modelling exercises (based on assumptions made and the accuracy and 
quality of the data available), it is clear that there has been a substantial reduction in both relative and 
absolute numbers of lives saved through prevention. Nonetheless, the more recent IMPACT figures for 
prevention are disappointing given the potential for further reductions in mortality if risk factors such 
as smoking cessation and obesity could be addressed. The dramatic increases in lives saved through 
treatment may be attributed to increases in both cardiac procedures and prescribed medication.
POPuLATION PROJECTIONs AND EMERGING CARDIOvAsCuLAR DIsEAsE 
TRENDs
The cardiovascular disease risk profiles outlined above, and their impact on healthcare and other 
aspects of society, must be considered in the context of Ireland being a relatively young population 
compared to many European countries (only 11% of Irish people were aged 65+ in 2006). Over the next 
10 years, conservative estimates indicate an expected 9% increase in the total population, with a 41% 
increase in the number of those aged 65+. This older group will comprise 15% of the total population 
by 2019 (CSO, 2008a). This proportion is predicted to rise more rapidly and double in the following 20 
years, resulting in the 65+ age group comprising 23% of the total population by 2038. Hence, there 
needs to be a serious policy approach to shift the prevalence and management of cardiovascular 
disease in advance of the doubling of the over-65 age group in Ireland in the next 30 years.
In tandem with this anticipated population change, there are worrying international signals that the 
pattern of reducing cardiovascular mortality is coming to an end, particularly in younger groups (Ford 
and Capewell, 2007; O’Flaherty et al, 2008). Cardiovascular profiles in mid-life are powerful predictors 
of mortality and morbidity in early old age (Clarke et al, 2009; Sun et al, 2009). The concern is that 
there will be a reversal of the cardiovascular disease mortality patterns if current risk factor and health 
behaviour profiles (including obesity, smoking and alcohol consumption) are not addressed across all 
ages in society. 
COsTs
Cardiovascular disease cost the European economy €192 billion in 2006, with an estimated 57% 
directly linked to healthcare, 21% to productivity losses and 22% to the cost of informal care 
provided by relatives and friends (European Heart Network, 2008). Evaluation of EU health spending 
on cardiovascular health suggests that Ireland fares poorly relative to its EU counterparts in the 
proportion of its total spend attributed to cardiovascular disease. A 2006 comparison of the 27 
EU Member States reported that, on average, 10% of the total healthcare budget was spent on 
cardiovascular diseases and that the comparative Irish figure was 6% (European Heart Network, 2008). 
While evidence on the costs of cardiovascular disease to the Irish economy, both in direct costs and 
in productivity and informal care costs, is not currently available, it is reasonable to assume that the 
Irish economy is significantly affected by the cardiovascular disease burden. A much greater level 
of analysis and discourse about cardiovascular and other health spending (and potential saving) is 
needed to inform discussions about service investments and value for money over the timeframe of 
this policy. The findings of an Expert Group on Resource Allocation and Financing in the Health Sector, 
recently established by the Minister for Health and Children and due to report in mid-2010, should 
provide an important framework for such discussions.
Cardiovascular Disease – Trends in Ireland
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suMMARY
This overview on the trends of cardiovascular disease in Ireland documents the substantial 
improvements in mortality over the last decade and the increased volume of service delivery. 
However, current cardiovascular disease risk profiles in Ireland, coupled with international trends, must 
now provide a national ‘wake-up call’ to the health sector and beyond – that the cardiovascular health 
of the nation is in a precarious state.
Cardiovascular health needs to be robustly addressed at both population and individual level. 
Cardiovascular health management constitutes a national development investment, as important 
as current national infrastructural developments. Yet, we appear to spend little of our healthcare 
budget, relative to our EU counterparts, on cardiovascular health. We are at an important decision 
point in terms of a future – a future where we have either invested significantly to ensure that the 
cardiovascular health of the nation continues to improve, or a future where we did not seize the 
opportunity and so reflect back to this time as a turning point in terms of deterioration in national 
cardiovascular health. 
The following chapters set out population and service approaches aimed at improving the 
population’s cardiovascular health status.
CHAPTER 3       PREVENTION AND  
HEALTH PROMOTION
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3.   PREvENTION AND HEALTH PROMOTION
Core concepts of disease prevention and health promotion were addressed in the first National 
Cardiovascular Health Strategy, Building Healthier Hearts (Department of Health and Children, 1999). 
Among the core concepts was the distinction between population-based approaches, which target the 
entire population, and high-risk approaches, which focus on individuals in contact with health services:
• Population-based preventive strategies combine elements of wider public policy (addressing 
the core determinants of health, such as poverty, education, food production and marketing, 
environment, transport policy) and primary prevention, which focuses on reducing the 
incidence of disease through factors that increase risk, such as cigarette smoking and high 
blood pressure. 
• High-risk strategies incorporate secondary prevention, or the detection and treatment of 
disease at an early asymptomatic stage, and tertiary prevention, which focuses on minimising 
the progression and/or complications of established disease. 
A combination of these approaches is essential, with prevention seen as a continuum if progress is to 
be made on reducing cardiovascular disease in Ireland.
Prevention has traditionally been characterised as having three levels, namely:
• primary prevention, which seeks to prevent the onset of disease;
• secondary prevention, which aims to halt the progression of the disease;
• tertiary prevention, which is concerned with rehabilitation and minimising the impact of 
complications.
These strands permeate the approach taken in this new cardiovascular health policy – from the macro 
level involving intersectoral action for health improvement, to care provided for individuals, whether it 
is in a primary care or acute hospital setting.
The critical role of healthy public policy was also highlighted in Building Healthier Hearts, in particular 
the need to acknowledge the basic social, economic, cultural and environmental determinants of 
health and well-being, and the need to place health on the agenda of policy-makers in all Government 
departments and all sectors of society. The challenge, in essence, is to create in Ireland a health-
sustaining environment that supports individuals, families and communities in their efforts to avoid 
premature death and ill-health, and to promote positive health and well-being.
The Department of Health and Children’s Policy Framework for the Management of Chronic Disease 
(2008a) recommends a ‘national focus on population-directed disease prevention and health promotion’ 
as a best practice principle of chronic disease management. Cardiovascular health promotion and 
disease prevention also contribute to healthy ageing, which adds to the number of healthy years 
of life and improves the functional capacity of the older population. As described in Chapter 2, the 
generation of young adults beginning their working lives about now will face retirement in a country 
with over twice the percentage of older people (and also over twice the absolute number of older 
people). Thus healthy ageing is a personal and population imperative.
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RIsk FACTORs FOR CARDIOvAsCuLAR DIsEAsE
Cardiovascular health is a subset of general health and well-being, and is moderated by the wider 
socio-economic, cultural and environmental conditions within which the individual lives. The Dahlgren 
and Whitehead (1991) model of health determinants provides a valuable bridge that links the social 
patterning of the many determinants of health with their consequent distribution of health effects 
among different population groups. Cardiovascular health, as well as the risk factors that contribute 
to cardiovascular disease, is moderated by those wider socio-economic, cultural and environmental 
conditions within which the individual lives.
There is an uneven distribution of the factors that lead to the development of ill-health and chronic 
disease throughout the population. The burden of cardiovascular diseases and the lifestyle factors 
that contribute to them is borne disproportionately by those in the lower socio-economic groups. 
There are strong links between mental and physical health, with both related through common 
determinants such as low income, poor housing, poor nutrition, poor education and common risk 
factors such as smoking, high alcohol consumption and physical inactivity. As an example, the diets 
of those in lower socio-economic households are more likely to provide energy from fats, sugar, 
potatoes, fatty meats and fast foods, compared to more affluent groups (Drewnowski, 2007).
Differentials in cardiovascular disease across population groups are created across the lifecycle. The 
foundations of adult health are laid down in early life. For example, the babies of very young mothers 
and those with lower educational achievement are more likely to be of low birth weight, less likely to 
be breastfed and have increased risk of long-term conditions, including cardiovascular disease. The 
workplace is another key determinant of lifestyle and patterns of ill-health. Opportunities exist to 
reduce differentials in such life settings.
At the level of population, a small number of avoidable risks cause most of the burden of chronic 
disease. The World Health Organization (WHO) has attributed 60% of the disease burden in Europe to 
7 leading risk factors, namely: hypertension, tobacco, alcohol, cholesterol, overweight, low fruit and 
vegetable intake, and physical inactivity (WHO, 2006). WHO estimates that 90% of Type 2 diabetes, 
80% of coronary heart disease and 33% of cancers could be avoided by a healthier diet, more physical 
activity and smoking cessation.
Research demonstrates that the combined impact of a small number of risk factors can have a 
significant effect on dying at an early age. For example, a recent study of over 20,000 adults in the UK 
showed that engaging in 4 moderate ‘protective’ health behaviours (i.e. not smoking, being physically 
active, moderate consumption of alcohol and eating 5 or more daily servings of fruit and vegetables) 
resulted in a four-fold difference in mortality for both men and women, equivalent to an extra 14 years 
of life (Khaw et al, 2008).
Even modest changes in risk factor levels among the population will bring about important 
improvements in people’s health. Importantly, the negative impacts of these risk factors for chronic 
disease can be quickly reversed and most benefits will accrue within a decade. To ensure a reversal of 
these negative impacts, a coordinated intersectoral approach to addressing the health determinants 
and health inequalities is required, led by Government through the Department of Health and Children.
Prevention and Health Promotion
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The individual determinants of cardiovascular health and disease are similar to those relating to 
overall disease burden – smoking, raised blood pressure, raised blood cholesterol, physical inactivity, 
obesity and diabetes mellitus are the major factors that increase the risk of cardiovascular disease. 
Dietary fat is the major determinant of raised cholesterol in developed countries. Thus, saturated fats 
from foods such as fatty meats, dairy products, cakes and biscuits increase cholesterol levels, as do 
trans-fats from oils used in fast-food cooking. Replacement of such fats with monounsaturated and 
polyunsaturated fats in vegetable oils decreases cholesterol levels. Conversely, fruit and vegetables 
contain antioxidants that have a protective effect on the formation of atherosclerosis in arteries.
There is good evidence of the association between dietary energy and higher rates of obesity, 
diabetes and cardiovascular disease. Excess salt and alcohol intake and obesity raise blood pressure. 
High blood pressure contributes to coronary heart disease and is the main risk factor for stroke.
Obesity is one of the main drivers of cardiovascular disease through its effects on blood pressure, 
blood cholesterol and risk of Type 2 diabetes. The increasing prevalence of obesity throughout the 
world is regarded as one of the major challenges to global health. Internationally, there is increasing 
awareness of the link between obesity and the climate change agenda (Foresight Programme, 2007; 
McMichael et al, 2007). In essence, obesity represents an energy supply problem – an imbalance 
between energy expenditure through physical activity and dietary calorie intake. Reliance on 
fossil fuels has subsidised (through intensive farming and other mechanisms) the production of 
low-cost, calorie-dense food. It also sustains transport policies that are not supportive of regular 
physical activity. There are potential synergies in addressing the prevention of obesity, diabetes and 
cardiovascular disease and in the reduction of fossil fuel emissions, including through the promotion 
of activity-friendly transport policies.
IMPACT OF HEALTH bEHAvIOuR PATTERNs ON RIsk OF CARDIOvAsCuLAR 
DIsEAsE
The health behaviour profile and resultant cardiovascular risk illustrated in the most recent  
SLÁN 2007 Survey requires a major readjustment in perceptions of disease patterns and the factors 
that contribute to these patterns (Morgan et al, 2008). For two decades, Ireland has enjoyed important 
reductions in cardiovascular disease mortality, including from coronary heart disease and stroke  
(see Chapter 2).
Research has indicated that approximately half of the decrease in coronary heart disease mortality 
in Ireland from 1985-2000 was attributed to prevention and control of risk factors, while the other 
half was due to treatments for these conditions (Bennett et al, 2006). A more recent analysis for this 
policy, using updated results from SLÁN 2007, has demonstrated a reversal in this pattern: for coronary 
heart disease mortality in 2000-2006, the mortality reduction was largely a result of treatment 
for conditions such as chronic angina and heart failure. However, while half of the reduction was 
explained by prevention and control of risk factors in 1985-2000, these accounted for only 16% of 
mortality reduction in the 2000-2006 analysis. This is as a result of increases in obesity, diabetes and 
hypertension, and a lack of progress in smoking cessation. If these patterns continue, decreasing 
mortality from cardiovascular disease and stroke may, in fact, be reversed and the burden of managing 
cardiovascular and other chronic conditions will certainly increase.
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TARGETED HEALTH bEHAvIOuR INTERvENTIONs
Health behaviour and risk factor modification require a two-pronged approach: a population approach, 
which requires intersectoral action focused on reducing the level of key risk factors in the population, 
and a high-risk approach, which targets individuals who are at greater risk for cardiovascular disease. 
This is addressed in Chapters 4, 5 and 6.
Population interventions for consideration include tobacco control, reducing consumption of saturated/
trans-fats and sugary/sweetened foods, reducing salt and alcohol intake, reducing body weight and 
increasing physical activity. Targets are considered below for key population health behaviour indices. 
(Specific targets for blood pressure and cholesterol are not proposed, although it is to be expected 
that changes in underlying health behaviours will impact on the levels of these two markers of 
cardiovascular risk.) Before details on the current status and population health targets are presented, the 
wider population context must be considered as the enabler of effective delivery of targets. The issues of 
equity, including health literacy, and of intersectoral action are thus considered next.
Equity and health literacy
Substantial improvement in population health targets is only possible if many individuals can achieve 
even modest changes. Any recommendations of measures to increase population health must thus 
permeate across all socio-economic groups. Citizens in more vulnerable groups, such as those of lower 
socio-economic status, need to be empowered to achieve the same relative benefit from each of the 
proposed health changes as those in less vulnerable groups (e.g. higher socio-economic groups).
Given the documented inequity in cardiovascular health and risk factor profiles in Ireland, specific 
measures must be taken to target vulnerable groups for each health behaviour. Alongside tackling 
broader social determinants to create a more equitable distribution of health in society, individuals 
can be empowered to protect their own health and that of their families by increasing health literacy 
in vulnerable groups. This policy document has been developed in accordance with the broad 
principles of social inclusion. 
Health literacy is the ability to make reasonable healthcare decisions based on the individual’s capacity 
to obtain, analyse and understand basic healthcare information and available services. It goes beyond 
the ability to read. Those with lower health literacy have less knowledge about health, receive less 
preventive care, exhibit worse control of chronic illness and have more emergency department visits 
and hospitalisations. Therefore, all means of communication used in the provision of cardiovascular 
health information should be designed to be accessible to all (Greene et al, 2005; Williams et al, 1998). 
Vulnerable groups include older adults, minority and immigrant populations, those earning a low 
income and people with chronic psychological and/or physical health conditions. In 2002, the National 
Adult Literacy Agency’s Health Literacy Policy and Strategy Report (NALA, 2002) estimated that up to 
53% of the population in Ireland experience literacy difficulties. 
Measures to improve equity, including health literacy, with a specific focus on improving access to 
cardiovascular health-related resources, should underpin the approach to cardiovascular prevention 
and treatment. Such measures would include public awareness campaigns on cardiovascular 
health that are accessible to all; specific interventions for vulnerable groups aimed at promoting 
and improving cardiovascular health; that health literacy principles are applied to information 
relating to cardiovascular health; and that programmes are delivered in accordance with the broad 
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principles of social inclusion and should be evaluated. These principles will be included in the major 
recommendations to follow.
POPuLATION HEALTH TARGETs TO ADDREss CARDIOvAsCuLAR DIsEAsE
This national cardiovascular health policy proposes the setting of a series of cardiovascular-related 
population targets, based on current health behaviour profiles in Ireland and on international health 
recommendations for:
• maintaining a healthy body weight; 
• healthy eating and physical activity;
• reducing salt intake;
• refraining from or quitting smoking;
• consuming alcohol responsibly.
Underpinning these targets are a number of intersectoral actions relating to nutrition and diet, 
physical activity, tobacco and alcohol (see Recommendation 3.1). Targets are set over a 10-year 
timeframe in line with international practice. An evaluation of progress will be completed during the 
first 5 years of this policy (by 2014).
RECOMMENDATION 3.1
The Department of Health and Children should prioritise actions that promote the health 
behaviour profiles underpinning cardiovascular health, with specific targets to actively 
pursue and achieve within a 10-year period.
The prioritised areas are: 
• maintaining a healthy body weight;
• healthy eating and physical activity;
• reducing salt intake;
• refraining from or quitting smoking;
• consuming alcohol responsibly.
Actions will include fostering intersectoral support for initiation of activities promoting health and 
prohibition of activities that will maintain or foster unhealthy behaviours. Details on how to achieve 
these targets are contained in a range of recent Government policies. Reductions in inequalities in 
cardiovascular health across society must be an underlying principle in achieving improvements in 
health behaviour.
Lead organisation: Department of Health and Children
It is to be expected that some targets may change in line with evolving research evidence and 
upcoming national and international guidelines. It is important to note that differing health targets 
will be interlinked in ways that are often poorly understood. They merit formal assessment to increase 
our understanding of success and failure in approaches to behaviour change. For example, it is unclear 
if and how healthy eating and physical activity practices can stimulate and support each other. 
Distinctions between food energy and total energy (food and alcohol-related) need to be considered. 
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The targets as planned from current guidelines are outlined below in 7 health behaviour profiles, 
along with key strategies to address each target and the agency or agencies having primary 
responsibility for implementing the strategies. The strategies prioritised are those identified as having 
most relevance for cardiovascular health. They are not intended to be comprehensive national health 
promotion guidelines for all purposes. For example, dietary advice has been limited to nutrient-
based recommendations for reducing salt and fat (foods from the ‘top shelf’ of the Food Pyramid) and 
increasing intake of foods from ‘lower’ shelves, especially fruit and vegetables. It is acknowledged that 
these recommendations should be part of a wider food-based approach to nutrition. These issues will 
be addressed in detail in the forthcoming National Nutrition Policy.
HEALTH bEHAvIOuR PROFILEs IN IRELAND
The current trends in health-promoting and health-risk behaviours that contribute to overall health 
in Ireland are described first, followed by an outline of targets and measures planned to improve the 
situation during the timeframe of this national cardiovascular health policy (see Tables 4-9).
body weight
FACT: Over half of the adult population in Ireland have an unhealthy body weight – 38% of 
the population are classified as overweight and a further 23% as obese, using independently 
measured body Mass Index (bMI).
Body weight reflects nutrition and physical activity, and is a key risk factor for cardiovascular disease and 
diabetes. The prevalence of overweight and obesity is high in Ireland and is increasing. The SLÁN 2007 
Survey provides the first national assessment of measured BMI in adults, aged 18 and over (Morgan et al, 
2008; Harrington et al, 2008). Overall, 38% of the population were identified as being overweight (44% 
men and 31% women) and a further 23% were identified as being obese (22% men and 23% women). 
These figures are similar to rates in England and Scotland, and approximately 5% lower than rates in the 
USA. Findings from SLÁN 2007 also demonstrate that the trend in obesity is greatest in the lower socio-
economic groups. Regarding waist circumference as an important marker of cardiovascular risk, the 
majority of SLÁN 2007 respondents (60%) had a mean waist circumference exceeding the threshold for 
central obesity. Women were more likely (70%) to be centrally obese than men (49%).
The best estimate of change in adult body weight over time is a comparison of SLÁN 2007 with the 
1999 North/South Ireland Food Consumption Survey (Irish Universities Nutrition Alliance (IUNA), 
2001). The IUNA study estimated that 39% of Irish adults were overweight (46% men and 33% women) 
and 18% were obese (20% men and 16% women). Thus the percentage of the population that is 
overweight or obese has risen from 57% to 61% in less than a decade, with all of the change reflecting 
a move towards increasing obesity. 
Among children, there is also evidence of increasing obesity. The 2004 National Children’s Food Survey 
found that 11% of children aged 5-12 were overweight (11% boys and 12% girls) and a further 11% 
were obese (9% boys and 13% girls). The HSE and Department of Health and Children, working with 
the National Nutrition Surveillance Centre, recently completed research as part of the WHO Childhood 
Obesity Surveillance Initiative (WHO, 2008c). Assessing 7-year-olds, they found that 27% of girls and 
18% of boys measured were overweight or obese (McGloin et al, 2009).
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Evidence also suggests that a substantial number of Irish adults underestimate their body weight.  
For example, findings in SLÁN 2007 show that 42% of those actually measured as ‘obese’ reported  
their own weight and height as ‘overweight’, while 31% of those actually measured as ‘overweight’  
self-reported figures suggesting a normal, healthy weight. This indicates a need for a better  
awareness of body weight and the risks associated with obesity.
Table 4: 10-year targets for body weight, to reduce overweight and obesity
HEALTHY bODY WEIGHT – TARGETs
Restore the BMI distribution of adults to levels as assessed 10 years ago (in 1999, 43% healthy 
weight; 39% overweight; 18% obese). This is to be achieved by:
• halting the current annual increase in the prevalence of overweight and obesity in the 
medium term (by 2014);
• achieving a modest reduction in prevalence of obesity within 10 years (by 2019).
Targets for adults over 10-year timeframe:
• Healthy weight: increase from 38% to 43%
• Overweight: maintain overall levels at 38%
• Obesity: decrease from 23% to 18%
Targets for children over 10-year timeframe:
• Healthy weight: increase from 78% to 84%
• Overweight: decrease from 11% to 7%
• Obesity: decrease from 11% to 9%
Nutrition
It is important to ensure a balance between nutrition and physical activity in order to maintain a 
healthy weight. Food and dietary research with both children and adults indicates that people in 
Ireland need to change their diet to achieve current healthy eating recommendations. The SLÁN 2007 
Survey reported that the adult diet is high in fats, saturates, salt and sugar, and low in iron, calcium, 
folate and vitamin D (Harrington et al, 2008).
Eating behaviour surveys have found that only one in five (20%) of children eat fruit more than once a 
day, while 40% eat sweets every day and more than one-quarter consume soft drinks on a daily basis. 
Among adults, while there has been an increase in the recommended consumption of 5 portions of 
fruit and vegetables a day, a major concern still exists in relation to the consumption of foods high in 
fats, sugar and salt (‘top shelf’ items on the Food Pyramid) – 86% of SLÁN 2007 respondents reported 
that they consume 3 or more servings of these foods each day (Harrington et al, 2008).
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Table 5: 10-year targets for healthy eating
HEALTHY EATING – TARGETs
• Increase by 20% the proportion of adults consuming the recommended 5 or more daily 
servings of fruit and vegetables (from 65% to 78%) by 2014.
• Ensure total fat provides less than 35% of dietary energy requirements. This is a ‘short-  
to medium-term’ goal, to be achieved by 2012. After 2012, the medium to  
long-term goal is less than 30% of dietary energy from fat by 10 years (2019).
• Reduce to less than 10% the dietary intake from saturated fats and trans-fatty acids.
• Reduce to less than 2% the dietary energy intake from trans-fatty acids.
• Reduce to less than 10% the dietary energy intake from foods with added sugars.
• Reduce to less than 3 daily servings those foods high in fats, salt and sugar from the  
‘top shelf’ of the Food Pyramid (e.g. oils, butter, cakes, soft drinks).
Note: Dietary energy does not include energy from alcohol.
In its 2005 report, the National Task Force on Obesity made over 90 recommendations (Department 
of Health and Children, 2005). A review of this report in 2009 found that there had been significant 
progress on many issues and that other areas should be progressed as a matter of priority in the short 
to medium term. These priority areas include measures to increase physical activity among children, 
control on the marketing and advertising of food and beverages aimed at children and improving 
awareness on the dangers of overconsumption of foods high in fats, sugar and salt.
The Department of Health and Children is currently developing a National Nutrition Policy, drawing 
on the earlier recommendations of the National Task Force on Obesity and aimed at achieving better 
nutritional health for the total population. It will have a particular focus on the nutritional health 
of children and young people, to help halt the increase in obesity and to reduce food poverty. This 
should form part of an overall Government strategy in relation to nutrition.
Physical activity
Levels of physical activity among the population are inadequate. For example, only 55% of SLÁN 2007 
respondents reported being physically active according to the following definition: ‘Taking part in 
exercise or sport 2-3 times per week for 20 or more minutes at a time or engaged in more general activities, 
such as walking, dancing or cycling, 4-5 times per week accumulating to at least 30 minutes per day’ 
(Morgan et al, 2008). Men were found to take part more frequently and in more strenuous physical 
activity than women. However, over one-fifth of adults (22%) reported being completely physically 
inactive, with lack of interest or ‘no time’ being given as the main reasons for this. There has been little 
change in the levels of physical activity over the 3 SLÁN surveys of 1998, 2002 and 2007. 
For children surveyed in HBSC 2006, slightly less than half exercised at least 4 times a week, with 
striking gender differences – 41% of adolescent boys and 28% of girls exercised 4 times or more a 
week (Nic Gabhainn et al, 2007).
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In June 2009, the National Guidelines on Physical Activity and accompanying Get Ireland Active website 
were launched (Department of Health and Children and HSE, 2009a). Based on best international 
practice, the guidelines specify the recommendations for physical activity for adults, children, young 
people and people with disabilities. The aims are:
• to highlight the importance of physical activity for people’s health;
• to outline the recommendations for physical activity for people of all ages and abilities;
• to provide information to support those promoting physical activity in their everyday work;
• to direct people to where they can access information and support to become more physically 
active.
Table 6: 10-year targets for physical activity
PHYsICAL ACTIvITY – TARGETs
• Increase by 20% the proportion of the population undertaking regular physical activity,  
i.e. increase proportion of physically active adults from 55% to 66% and children from 41% 
to 49% by 2019.
The Government is taking an intersectoral approach to tackling levels of physical activity, involving 
the related issues of the environment, obesity, transport and overall population health. For example, 
the Department of Health and Children participated in an inter-Departmental Group, lead by the 
Department of Transport, which helped to develop Smarter Travel – A Sustainable Transport Future,  
the transport and travel policy for the next decade. Under this policy, the concept of the ‘active 
commuter’ (i.e. walking, cycling and using public transport) is actively cultivated for the benefits of 
promoting both population health and the broader environmental impact. The Sustainable Travel 
Office of the Department of Transport is represented on the intersectoral group working on obesity. 
It published a National Cycle Policy Framework in 2009 and is working with the Department of Health 
and Children, among others, to develop a National Walking Policy. The Department of Health and 
Children is also working through the HSE to support community initiatives on increasing physical 
activity and with the Department of the Environment, Heritage and Local Government, together 
with local authorities, on prioritising pedestrians in urban planning and supporting the planning and 
development of exercise facilities in new housing estates and public spaces.
salt consumption
FACT: Daily salt intake is over 50% higher than recommended, with most coming from foods 
as purchased rather than from adding salt in cooking or at the table.
Salt is an essential nutrient. However, there is robust evidence for an association between excess salt 
consumption and hypertension (raised blood pressure). Hypertension is a major contributing factor 
to heart disease and stroke. A reduction of 3g/day salt intake would reduce stroke mortality by an 
estimated 13% and coronary (ischaemic) heart disease mortality by 10%, i.e. approximately 700 deaths 
per year in Ireland. The recommended daily allowance (RDA) of salt for adults in Ireland is 6g/day as a 
population goal, with targets for individuals in clinical settings of 4g/day (Irish Heart Foundation, 2009). 
Targets for children are proportionately lower (Scientific Advisory Committee on Nutrition, 2003). 
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Findings from SLÁN 2007 show that the average daily salt intake by men was 10g/day and by women 
9g/day, both significantly above the recommended amount of 6g/day. Furthermore, almost one-
third of adults usually or always add salt to their food, either in cooking or at the table, and this 
‘discretionary’ salt amounts to 20% of daily intake. However, most salt in the Irish diet comes from 
processed foods, with 80% of daily salt intake being ‘obligatory’ since it is added to manufactured 
foods during processing, preparation or preservation. Given this fact, ‘upstream measures’ – such as 
healthy policies for the production of food, food labelling, intelligent public procurement and direct 
engagement with the food industry – are all necessary to reduce the population’s salt intake.
Ireland is not unique in this respect and, along with other EU Member States, has now committed to 
the EU Salt Reduction Initiative (European Commission, 2008). The target is a 4% annual reduction on 
current salt consumption rates over a 4-year period to 2012, i.e. an overall 16% reduction. Supported by 
the Food Safety Authority of Ireland and the Food Safety Promotion Board, the Department of Health 
and Children is developing proposals on a salt reduction strategy for Ireland, encompassing a reduction 
of salt in processed foods, the labelling of salt content in pre-packaged foods in the retail sector in line 
with planned EU food-labelling legislation and a public awareness campaign on salt intake.
Table 7: 10-year targets to reduce dietary salt intake
sALT CONsuMPTION – TARGETs
• Reduce salt consumption as set out in the EU Salt Reduction Initiative, i.e. reduction by 
16% in 4 years (2008-2012).
• Achieve reduction to a target of no greater than 6g/day salt for adults within the lifetime of 
this policy.
• Particular attention to be given to salt reduction in children, with target setting as 
appropriate.
smoking cessation
FACT: The challenge of an adult smoking rate of 29%, despite a national workplace smoking 
ban, needs novel and sustained approaches to achieve meaningful reductions.
Smoking is the leading cause of preventable mortality. Ireland ranks 2nd highest in the EU15 for 
smoking-related causes of death (Brugha et al, 2009). Findings from SLÁN 2007 show that 29% of 
respondents were current cigarette smokers. While smoking has decreased since the SLÁN 1998 
level of 33%, no significant reduction has occurred between SLÁN 2002 (27%) and SLÁN 2007 (29%), 
despite the introduction of the ban on smoking in the workplace in 2005. Sub-groups of particular 
concern for smoking are young adults in the 18-29 age group (35% smoke) and those in the lower 
socio-economic groups (37% smoke). Encouragingly, SLÁN 2007 found that almost 10% of smokers 
were actively trying to quit and that 6 out of 10 households did not permit smoking on any occasion in 
their own homes.
A substantial proportion of adolescents in Ireland also smoke. The latest HBSC survey in 2006 showed 
that 25% of those aged 15-17 smoked regularly (23% boys and 28% girls). There was some evidence of 
lowered rates since HBSC 2002. Smoking initiation rates are an important marker of smoking trends. 
In the international HBSC survey, initiation rates by age 13 for those currently aged 15 has been taken 
as a marker of smoking status, early initiation being linked to the greater likelihood of continuing 
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smoking into adulthood. The Irish rate in HBSC 2006 was 31% of 15-year-olds (29% boys and 33% girls) 
had smoked cigarettes at or before the age of 13 years. 
Table 8: 10-year targets to reduce smoking
sMOkING REDuCTION – TARGETs
• Reduce overall population prevalence of smoking by 1% per annum (from 29% to 19%  
by 2019).
• Reduce the smoking initiation rates by 1% per annum (from 31% to 21% by 2019).
The Department of Health and Children will support the raising of taxes on tobacco products to a level 
that effects consumer change. It will also develop proposals on other measures to reduce smoking, 
such as the removal of VAT from tobacco cessation products, on specific activities to minimise 
initiation of smoking among young people and on the requirement for further legislation and 
enforcement of existing legislation regarding the promotion, sale and use of tobacco.
Alcohol consumption
FACT: Alcohol consumption is over 40% higher than the Eu average, with substantial 
numbers reporting excessive or risky drinking, or both.
Alcohol consumption in Ireland – especially relevant to population blood pressure and overweight/
obesity – has increased dramatically since the 1990s. The number of litres of pure alcohol consumed 
rose from 5 to 8 litres per capita (of those aged 15 and over) during the period 1971-1991, and then 
from 8 to 13.4 litres per capita in the 15-year period 1991-2006 (Hope, 2007). Alcohol consumption per 
capita decreased somewhat to 12.4 litres in 2008. The EU average is 9 litres per capita.
Findings from SLÁN 2007 show that, while 1 in 5 adults did not consume alcohol, 28% of adults 
reported risky or ‘binge’ drinking (i.e. consuming 6 or more drinks on one occasion) at least once a 
week (38% men and 17% women). In addition, 8% (11% men and 5% women) reported excessive 
drinking (consuming above the recommended units for men or women) (Morgan et al, 2009). In HBSC 
2006, the majority of school-going adolescents aged 15-17 reported having ‘been drunk’ on occasion, 
with approximately one-third having ‘been drunk’ in the past 30 days (Nic Gabhainn et al, 2007). There 
is anecdotal evidence that the risks of alcohol use are mostly seen to relate to public order effects 
(e.g. drunkenness, violence) and immediate health and social effects (e.g. hangovers, absenteeism), 
with less awareness of the longer term negative health effects (e.g. liver and cardiovascular health 
problems).
 
Table 9:         10-year targets to promote responsible alcohol consumption
ALCOHOL CONsuMPTION – TARGETs
Reinforce the Strategic Task Force on Alcohol (2004) consumption targets by:
• reducing the total per capita consumption of alcohol to 9 litres per annum  
(the EU average);
• reducing the harmful individual consumption of alcohol, especially related to risky  
and excessive drinking.
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The Department of Health and Children will support proposals to increase the cost of alcohol by 
raising tax/excise on alcohol and preventing low-cost selling. It will also support measures to reduce 
access to alcohol by restricting marketing, advertising, sponsorship and sale of alcohol. It will work 
closely with the Department of Justice, Equality and Law Reform on any legislative actions that are 
considered necessary.
blood pressure and cholesterol
FACT: Almost two-thirds of middle-aged and older adults in Ireland have at least 2 of 4 key 
risk factors for cardiovascular disease – raised blood pressure, raised cholesterol, obesity and 
smoking.
In SLÁN 2007, 1,207 adults aged 45 years and over took part in a physical examination, providing the 
first population profile of cholesterol and blood pressure in Ireland. About 60% of respondents had 
high blood pressure and over three-quarters (82%) had raised cholesterol. Most were either not on 
medication or had uncontrolled risk factors on medication. Almost all (94%) had 1 out of 3 risk factors 
(obesity, high blood pressure or cholesterol), 59% had 2 out of 3 risk factors, while 18% had all 3 risk 
factors. In addition, 20% were smokers. Management of blood pressure and cholesterol will in part 
be addressed by targeting the health behaviour profiles as outlined above and also by improving 
management in primary care (see Chapter 4). 
INTERsECTORAL WORk
The challenge for the health sector is the imperative to have action across multiple sectors of society. 
For example, in order to increase levels of physical activity, important partners for the healthcare 
sector would include the education sector, the sports and leisure sector, urban planning and 
construction, transport, agriculture, the private sector, the food industry and the media.
Effective prevention requires a shift of the entire distribution of a risk factor (e.g. raised cholesterol) to 
lower values. It should extend beyond a focus on high-risk individuals, utilising cholesterol-lowering 
therapies, to population-based approaches, preventing the development of the risk factors themselves. 
A population-based strategy may include, for example, programmes to reduce the consumption 
of energy-rich and fat-rich foods, including public education, legislation to eliminate misleading 
health claims for foods and reduction of fat in some foods. This could help reduce body weight in all 
segments of the population, while at the same time reducing levels of cholesterol, blood pressure 
and glucose. Overall, such an approach would reduce the number of people with raised cholesterol, 
raised blood pressure or diabetes, and would therefore have a much larger long-term impact than 
intervening only with high-risk individuals in middle age. 
Since the health status of the population is largely determined by factors outside the health sector, it 
is important that health policy interfaces with policies in sectors other than health. This approach is 
advocated in the European Commission’s White Paper on A Strategy for Europe on Nutrition, Overweight 
and Obesity related health issues (European Commission, 2007) and the World Health Organization’s 
policies on chronic diseases (WHO, 2005). In Ireland, the recently published Policy Framework for 
the Management of Chronic Disease (Department of Health and Children, 2008a) supports the 
establishment of an intersectoral committee through which health improvement actions will be 
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channelled (see Recommendation 3.2). The targets proposed above for specific health behaviours  
(e.g. smoking, salt intake) must be set in the wider context of a national health promotion policy, with 
intersectoral cooperation for initiatives, including legislation, to support them. It is acknowledged that 
there are already a number of initiatives by the Department of Health and Children on healthy eating, 
tobacco, alcohol and obesity, and that these will continue as before; these include the reports of the 
Alcohol Task Force (2007) and the Task Force on Obesity (2005). 
RECOMMENDATION 3.2
Intersectoral work should be given the priority it needs to deliver health-related benefit.
To achieve real change, actions should be led by the Department of Health and Children, 
reporting to Government on a regular basis through the Cabinet Committee on Health.  
A key deliverable in evaluating the success of this work will be reductions in inequality in 
cardiovascular health targets.
Lead organisation: Department of Health and Children
The population behavioural targets proposed earlier (see ‘Health behaviour profiles in Ireland’, pp. 59-65) 
should operate over a 10-year timeframe and form the basis for proposals on health improvement. 
It is acknowledged that public policies and healthcare programmes, promoting healthier lifestyles 
and improving the environments in which we live and work, will prevent the emergence of these 
risk factors and hence reduce diseases and the burden to families and society. While many sectors, 
agencies and individuals themselves have responsibility for the delivery of these targets, the 
Department of Health and Children should lead and develop proposals on healthier lifestyles, 
including programmes and legislation as appropriate. These will need to be addressed in the context 
of evolving evidence from Ireland and elsewhere on initiatives that deliver results. 
In this context, it is proposed that the targets outlined in this chapter form the basis for health 
improvement actions that will be the subject of proposals brought to the Cabinet Committee on 
Health. This work programme should be focused and identify priority future actions, including the 
development of screening tools to evaluate the health impact of relevant policy proposals being 
submitted to Government. Areas for early consideration should include:
• Diet, nutrition, physical activity and obesity – Considered as priority - should be the 
measures outlined early in relation to restricting the availability of energy-dense foods 
through marketing and advertising; labelling salt content of pre-processed foods; reducing 
energy, fats and salt content in food; and promoting physical activity and public facilities.
• Tobacco – Considered as priority – should be further consideration to taxation increases and 
other measures to restrict the availability of tobacco products and measures on pricing to 
inhibit smoking, especially among younger people.
• Alcohol – Considered as priority – should be proposals to restrict alcohol availability and to 
increase excise duties in order to lower consumption. Consideration should also be given 
to an advertising ban on alcohol, proposals to reduce alcohol sponsorship and labelling to 
include advice on pregnancy and drink–driving.
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4.   PRIMARY CARE
Primary care has a vital role to play in raising awareness of cardiovascular disease and in its prevention, 
early detection, emergency response, risk assessment, and management (including long-term 
management and rehabilitation). While there have been useful advances in the management of 
cardiovascular disease and cardiovascular disease risk in primary care, particularly through the 
implementation of the HeartWatch Programme as recommended by the first cardiovascular health 
strategy (Building Healthier Hearts, 1999), the full potential of primary care to contribute to the 
containment of cardiovascular disease morbidity and mortality has yet to be realised. 
This chapter addresses the need for population awareness of cardiovascular risk factors, including the 
key role of primary care in targeted education of individuals in their care. It then addresses general 
standards in cardiovascular risk assessment and management. Specific details are then discussed 
concerning established cardiovascular disease management and specific management of diabetes, 
stroke (including hypertension and arterial fibrillation), heart failure and peripheral arterial disease. 
Issues on funding eligibility for primary care management of chronic conditions are addressed 
separately, in Chapter 7.
PRIMARY CARE AND RIsk AWARENEss
There is a need to promote awareness in the population at large of the need for regular monitoring 
of blood pressure, cholesterol and the symptoms of diabetes (see Recommendation 4.1). Adults 
should know important numbers relating to their cardiovascular risk, such as blood pressure and 
cholesterol levels, through educational programmes such as ‘Know your numbers’. They should also 
be aware of relevant family history. There is a need to promote awareness of the early symptoms of 
and appropriate emergency response to heart, stroke and vascular disease and associated conditions 
so that effective interventions can be administered in a timely fashion to reduce morbidity. Reputable 
settings, such as GP practices and pharmacies, can make such information readily accessible.
RECOMMENDATION 4.1
Media and education campaigns should be undertaken to increase awareness by the general 
public of cardiovascular risk factors and levels of risk associated with them. This awareness 
should be reinforced in primary care settings, such as GP practices and pharmacies, by the 
HsE in partnership with voluntary agencies.
Such campaigns should include raising awareness of risk factors, symptoms and appropriate 
responses to heart attack, stroke, trans-ischaemic attack, heart failure, peripheral arterial 
disease and other vascular conditions. Given the primacy of awareness to attitude and 
behaviour change, a series of campaigns needs to commence immediately and in a phased 
manner, with interim evaluations guiding the next educational phase.
Lead organisation: HSE, in partnership with voluntary agencies
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PREvENTION – GENERAL PRINCIPLEs
Cardiovascular diseases are complex and multifactorial. Thus it is imperative that preventative 
strategies are similarly multifaceted. As recommended by the 2007 ESC Clinical Practice Guidelines 
by the Fourth Joint Task Force of the European Society of Cardiology [ESC] and Other Societies 
on Cardiovascular Disease Prevention in Clinical Practice (Graham et al, 2007), the objectives of 
cardiovascular disease prevention are:
1. To assist those at low risk of cardiovascular disease to maintain this state lifelong and to help 
those at increased total cardiovascular disease risk to reduce it.
2. To achieve the characteristics of people who tend to stay healthy, i.e.
• no smoking;
• healthy food choices;
• physical activity: 30 minutes of moderate activity a day;
• BMI <25kg/m2 and avoidance of central obesity;
• BP <140/90mmHg;
• total cholesterol <5mmol/L (-190mg/dL);
• LDL cholesterol <3 mmol/L (-115mg/dL);
• blood glucose <6mmol/L (-110mg/dL).
3. To achieve more rigorous risk factor control in high-risk individuals, especially those with 
established cardiovascular disease or diabetes:
• no smoking, with smoking cessation support and NRT if appropriate;
• blood pressure under 130/80mmHg if feasible;
• total cholesterol <4.5mmol/L (-175mg/dL);
• LDL cholesterol <2.5mmol/L (-100mg/dL), with an option of <2mmol/L (-80mg/dL)  
if feasible;
• fasting blood glucose <6mmol (-110mg/dL) and HbA1c < 6.5% if feasible.
4. To consider cardio-protective drug therapy in these high-risk individuals, especially those with 
established atherosclerotic cardiovascular disease.
The first cardiovascular health strategy, Building Healthier Hearts (1999), opted for a ‘high-risk’ approach 
rather than a general population approach, prioritising activities that were targeted at those patients 
with highest risk. The audit of the implementation of the strategy, Ireland: Take Heart (HSE, 2007), 
identified that most progress had been made in primary care on those interventions that involved 
pharmacotherapy. While lifestyle interventions are more desirable, for a variety of reasons, they tend to 
be less effective when applied at the individual level. Multisectoral and intersectoral interventions are 
required to have significant population impact. That said, evidence is emerging that multidisciplinary 
input into preventive cardiovascular disease programmes in high-risk individuals can also impact on 
lifestyle-related risk factors (Wood et al, 2008). As more of the multidisciplinary primary care team 
members become available in Ireland through primary care team establishment, they will need to 
be acutely involved in cardiovascular prevention so as to achieve greater impact on lifestyle-related 
factors. These team members include smoking cessation counsellors, dieticians and physiotherapists.
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MANAGEMENT OF HIGH RIsk, INCLuDING EsTAbLIsHED DIsEAsE
Chronic disease management is deliverable through a shared care model, facilitated by 
multidisciplinary teams with designated care pathways. Shared care models need to be expanded and 
developed in order to achieve optimum chronic disease management for patients with cardiovascular 
disease.
Strategies need to be developed and implemented to support a multidisciplinary team approach 
that promotes continuity of care. Patients should be provided with appropriate information about 
the disease, treatment options and expected outcomes, follow-up and support services to facilitate 
self-management of the physical, psychosocial and economic impacts of their condition. Self-
management education programmes also need to be developed, with access to these programmes 
and identification of support groups for patients, all of which will facilitate people to gain the 
knowledge, skills and confidence to ‘help themselves’. Teams should be charged with ensuring that the 
psychosocial needs of people with cardiovascular disease are met at the sequences of stages in their 
management. This model can be applied to the management of specific cardiovascular risks – such 
as hypertension and raised lipid levels – as well as to all types of vascular disease, including ischaemic 
heart disease, heart failure, stroke and peripheral arterial disease.
Such activities could be seen as part of the cycle of chronic disease management and provided in 
tandem with the ongoing education and support needed for patients with established cardiovascular 
conditions when transferred from focused early post-hospital discharge rehabilitation programmes 
into continuing care in the community. Both groups can be catered for by the same primary care 
personnel, with the same education and behaviour change support strategies, within a philosophy of 
prevention and in established ‘prevention services’ in the local community settings. The role of general 
practices, pharmacies and other centres in the community in supporting chronic disease management 
needs to be examined (see also Chapter 6).
HIGH RIsk
The definition of ‘high risk’ needs to be extended from just those who have had an event and/or a 
revascularisation procedure, and should include all patients in the priority groups listed below, as 
identified by the ESC Clinical Practice Guidelines (Graham et al, 2007):
• patients with established atherosclerotic disease;
• asymptomatic individuals who are at increased risk of cardiovascular disease because 
of multiple risk factors resulting in total cardiovascular disease risk (>5% 10-year risk of 
cardiovascular disease death);
• diabetes Type 2 and Type 1 with microalbuminuria;
• markedly increased single risk factors, especially if associated with end organ damage;
• close relatives of patients with premature atherosclerotic cardiovascular disease or those at 
particularly high risk.
The SLÁN 2007 data suggest that a large proportion of the population in Ireland has multiple risk 
factors and would be categorised as being at ‘high risk’. Building Healthier Hearts (1999) recommended 
that a risk assessment programme be piloted and implemented. This was developed through the 
HeartWatch Programme, but limited to a subset of patients with established heart disease in 20% of 
GP practices in Ireland. This risk assessment and management approach now needs to be extended 
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to include the list of high-risk individuals defined above. All groups of professionals addressing 
cardiovascular disease need to work to common definitions and guidelines. With regard to prevention 
in clinical practice settings, this policy recommends the ESC Clinical Practice Guidelines (now in its 4th 
version (Graham et al, 2007), with the 5th version due in 2011) for common professional standards 
across groups (see Recommendation 4.2).
RECOMMENDATION 4.2
Professional standards: The 2007 ESC Clinical Practice Guidelines should be adopted and a 
care protocol for primary care based on these guidelines should be developed. Protocols on 
best practice in cardiovascular clinical care should be agreed.
This extends the group of individuals considered at high risk and includes patients with 
established disease, close relatives of people with premature atherosclerotic disorders and 
individuals with multiple risk factors.
Lead organisation: HSE, in partnership with Irish Heart Foundation, Irish Cardiac Society,  
Irish College of General Practitioners, Department of Health and Children, and HIQA
The Fourth Joint Task Force of the European Society of Cardiology [ESC] and Other Societies on 
Cardiovascular Disease Prevention in Clinical Practice is supportive of an opportunistic approach 
to the detection of biological risk factors or lifestyles to detect people at high risk. The Task Force 
analysed barriers to implementing prevention in clinical practice. In an Irish context, this indicates the 
requirement to provide:
• routinely available, accurate and adequate systems of measurement;
• time for advice or treatment as appropriate;
• continuity of care;
• patient access to treatments, regardless of socio-economic status.
The ongoing establishment of primary care teams by the HSE provides a mechanism to deliver 
such services. The plan is to have over 500 teams in place by the end of 2011, each team to serve 
populations of up to 8,000 individuals. 
There is now compelling scientific evidence for the benefit of interventions for single targets listed 
above. This lays a foundation for multifactorial screening and intervention programmes, providing 
the programmes target people at high risk and include the necessary resources to respond to the risk 
factors identified (see Recommendation 4.3). The EuroAction study has shown that multidisciplinary 
cardiovascular prevention programmes targeted at those at high risk, although complex and resource-
intensive, are feasible and worthwhile (Wood et al, 2008).
Risk identification and management programmes involve ongoing monitoring of risk factors, 
including blood pressure, lipids, body mass index and blood glucose. Challenges such as familial 
hypercholesterolaemia need to be considered within the risk assessment programme. The 
interventions offered by such a programme need to be based on a single set of guidelines. 
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RECOMMENDATION 4.3
structured clinical care: Develop structured clinical care, which includes prevention of 
cardiovascular disease, in clinical practice.
This will provide targeted individualised assessment and management of cardiovascular 
disease in primary care, in accordance with the 2007 ESC Clinical Practice Guidelines,  
i.e. those at risk, those with established cardiovascular disease and selected family members. 
Structured clinical care is considered a key requirement to future general practitioner  
contract agreements.
Lead organisation: HSE, in conjunction with Irish College of General Practitioners
Proposal for action on opportunistic risk ascertainment
Since opportunistic risk ascertainment of cardiovascular disease has not yet been evaluated, it 
is proposed that a structured programme for cardiovascular risk ascertainment in primary care, 
with opportunistic recruitment of patients into the programme, be instituted within the context 
of a rigorous scientific study (see Recommendation 4.4). This work should be based on current best 
evidence on effective clinical interventions and healthcare delivery systems, and should be organised 
to determine clinical outcomes in terms of risk factor modification; to provide a detailed cost-
effectiveness evaluation; and to advise on process and organisational challenges of expanding the 
programme beyond this evaluation phase. The programme should be initiated with higher risk groups 
(e.g. older patients and patients from socio-economically deprived groups) whom existing evidence 
suggests are at highest risk and have the most to gain. This should be designed so as to determine 
the most cost-effective targeting of such a programme for extension to routine clinical practice. Given 
the large proportion of the adult population in Ireland that appears to be at cardiovascular risk (from 
recent evidence on lifestyle in SLÁN 2007), this work should be commenced without delay and the 
results acted on promptly to target cardiovascular risk in primary care in a cost-effective manner. 
RECOMMENDATION 4.4
Population approach: Evaluation of a structured programme for cardiovascular risk 
ascertainment and management in the primary care setting is required to inform the 
development of a model for the delivery of care.
A health technology assessment and clinical study will determine the health and economic 
benefits of such systematic risk ascertainment for different population groups (compared to 
usual care). As clinical and cost-effectiveness benefits become clear, implications for service 
development must be agreed and interventions targeted at relevant population groups 
implemented. The evaluation should be completed and recommendations delivered in the first 
half of the lifetime of this policy (2010-2014).
Lead organisation: Department of Health and Children, in association with HSE, HIQA and  
Health Research Board
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PREvENTION OF CARDIOvAsCuLAR DIsEAsE IN THOsE WITH DIAbETEs 
MELLITus
Those with Type 2 diabetes and those with Type 1 diabetes who have microalbuminuria are priority 
groups for the prevention, early detection and management of cardiovascular risk. Harkins’ (2008) 
A Practical Guide to Integrated Type 2 Diabetes Care provides detailed guidance on these aspects of 
the care of patients with diabetes in Ireland. The guidance also sets out a model for service delivery 
that is relevant to other patients at high risk of cardiovascular disease. The model of integrated care 
includes registration of those with the condition, initial assessment and review at regular intervals, 
and fast-tracking of patients requiring urgent assessment in the hospital diabetes centre. These 
guidelines should provide the basis for shared care for patients with diabetes who also present with 
cardiovascular disease (see Recommendation 4.5).
RECOMMENDATION 4.5
A protocol for the early detection and structured cardiovascular care of patients with 
diabetes should be agreed in order to manage this high-risk group.
Lead organisations: HSE and Irish Heart Foundation, in partnership with Irish Cardiac Society,  
Irish College of General Practitioners and Irish Endocrine Society
PREvENTION OF sTROkE IN PRIMARY CARE
In addition to the ESC Clinical Practice Guidelines on cardiovascular prevention, two aspects of 
prevention of particular relevance for the prevention of stroke are (1) the detection and management 
of raised blood pressure (hypertension) and (2) anti-thrombotic therapy for those with atrial fibrillation.
Assessment and management of hypertension
Guidelines on the management of arterial hypertension, from the Task Force of the European Society 
of Hypertension (ESH) and the European Society of Cardiology (ESC) (Mancia et al, 2007), recommend 
assessment of total cardiovascular risk in the management of arterial hypertension, rather than 
intervening on separate risk factors. However, elevated blood pressure has been considered the 
most important determinant of the risk of stroke due to cerebral infarction or haemorrhage, and thus 
warrants particular attention (Kuller, 2000). As age increases, over the age of 55, pulse pressure is 
increasingly associated with raised risk of death from stroke and coronary heart disease (Lewington  
et al, 2002).
Factors that are associated with raised blood pressure (such as obesity, increased consumption of salt 
and high alcohol intake) also increase the risk of stroke. Those with elevated blood pressure are more 
likely to have other risk factors for cardiovascular disease, such as diabetes, insulin resistance and 
dyslipidaemia. Even if blood pressure is only moderately raised, the presence of other risk factors may 
place an individual in a high-risk category. Findings from SLÁN 2007 highlight the high prevalence of 
raised blood pressure in adults, the low proportion of those in which it had been detected and the low 
proportion of those whose blood pressure control was satisfactory. 
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Repeated measurements are required to accurately characterise and assess blood pressure, with 
attention to the accuracy of the measurement device (Mancia et al, 2007). Ambulatory blood pressure 
measurement is of value to assess blood pressure over the course of the day and night, and is useful 
in predicting cardiovascular risk. The Rambler Study demonstrated the feasibility of ambulatory blood 
pressure measurement in general practice in Ireland and quantified its impact on prescribing to 
improve blood pressure control (Uallachain et al, 2006).
The overall contribution of ambulatory blood pressure monitoring to primary care detection and 
management of high blood pressure has yet to be fully ascertained. It is thus recommended that 
practices be encouraged to invest in this technology and further research be undertaken to determine 
the benefits of ambulatory blood pressure monitoring and the particular patient groups for which the 
benefits match or exceed the additional costs (see Recommendation 4.6).
RECOMMENDATION 4.6
Effective management of hypertension should be prioritised in primary care.
Guidelines are needed on standards of assessment, management and review of patients 
in primary care based on best practice and health technology assessments. In addition, 
general practices need to be supported to establish rigorous systems for blood pressure 
assessment, management and review for their population of patients. This requirement should 
be considered in the context of future arrangements pertaining to the general practitioner 
contract.
Lead organisation: Department of Health and Children, in partnership with Irish College of 
General Practitioners
Risk assessment of hypertension in the context of overall risk assessment
Risk assessment is relevant in those with elevated blood pressure or other identified risk factors. It also 
requires consideration of major risk factors such as smoking, blood cholesterol, diabetes and family 
history. Blood pressure is then managed in the context of the overall risk of cardiovascular disease. 
SCORE risk charts are used to estimate risk of fatal cardiovascular events. Absolute 10-year risk can 
be calculated or risk can be expressed as a relative risk in comparison to risk if different levels of risk 
factors pertained. 
All those who have had symptomatic cardiovascular disease are considered to be at high risk, 
warranting ongoing intervention to reduce risk of recurrence. Lifestyle interventions and prescription 
of medication should be managed with the patient, taking into account the person’s cardiovascular 
disease risk, health behaviours and socio-economic circumstances. Evidence in relation to 
interventions to improve blood pressure control concluded that ‘an organised system of regular 
review, allied to vigorous anti-hypertensive drug therapy, was shown to reduce blood pressure’  
(Fahey et al, 2006).
More generally, all aspects of non-pharmacological management of stroke prevention should be 
incorporated within the general plans for education of the public regarding risk factors and their 
management for cardiovascular disease. 
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Detection and management of atrial fibrillation
Atrial fibrillation is a common cardiac arrhythmia, occurring in 1% of the general population. The 
estimated prevalence is 4%-7% in women and men aged 65-74, increasing to 14%-19% in those aged 
85 and over (Fitzmaurice et al, 2007). It is a potent risk factor for stroke, increasing the risk five-fold. 
Irish and international data consistently show that stroke due to atrial fibrillation is more severe, 
leading to greater mortality and disability, increased lengths of hospital stay and greater requirements 
for long-term institutional care, compared to stroke in those without atrial fibrillation.
The risk of thrombotic complications, such as stroke, in patients diagnosed with atrial fibrillation 
can be dramatically reduced by treatment with anticoagulants. Up to 70% of stroke events can be 
prevented by warfarin anticoagulation. 40% to 60% of patients with atrial fibrillation are eligible 
for treatment with anticoagulants. The use of anti-thrombotic therapy must be balanced with the 
anticipated benefit of reduced thromboembolic complications and risk of bleeding in patients with 
atrial fibrillation. Assessment of thromboembolic risk is helped by several risk-stratification models. 
This predictive ability may allow clinicians to target high-risk patients for more aggressive intervention.
Despite the well-recognised association between atrial fibrillation and ischaemic stroke, and the 
benefits of anticoagulation therapy, a large proportion of patients with atrial fibrillation remain 
undetected or untreated. The reported overall rate of treatment with anticoagulants in patients with 
atrial fibrillation is approximately 31%, indicating substantial under-use of anticoagulants in these 
patients. For illustration, in the North Dublin Population Stroke Study (Kelly et al, 2009), less than 25% 
of individuals with stroke due to known atrial fibrillation were anticoagulated with warfarin prior 
to stroke onset. A previous study of general practice in Dublin showed a significant opportunity to 
increase prophylaxis in those known to have atrial fibrillation by their GPs given appropriate support 
(White et al, 2004).
One strategy to improve anticoagulation rates is to develop structured systems between primary 
care and the hospital setting, aimed at devolving anticoagulation monitoring to primary care with 
appropriate hospital support (see Recommendation 4.7). Anticoagulation can be managed effectively 
in primary care using near-patient tests to determine INR (international normalised ratio) and 
computerised decision support software. However, it is essential that hospital supports are provided 
for this service to operate effectively and safely. Shared decision-making and management would be 
required between GPs, hospital physicians and nurses based at anticoagulation clinics. An integrated 
model of hospital and primary care anticoagulation services is recommended to provide training for 
primary teams new to anticoagulation treatment provision and quality assurance of anticoagulation 
services. Furthermore, an integrated model would support the development of self-management 
options in suitable patients. This model has shown positive results, further complemented by 
improved patient education and knowledge about the risks and benefits of anticoagulation therapy, 
which can improve the safety and efficacy of such treatment.
Targeted resource provision with IT infrastructure would be required for participating GPs and hospital 
anticoagulation services. Dedicated resources would also be required to provide GP and primary care 
training to fulfil this role. 
A second strategy to improve anticoagulation rates is screening. An estimated 50% of individuals with 
atrial fibrillation remain undetected and at high risk of stroke (25%). There is evidence that detection 
of atrial fibrillation in general practice is improved by opportunistic case finding, prompted by flagged 
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case notes in those aged 65 and over. Atrial fibrillation lends itself to screening as it is relatively 
inexpensive to follow a suspected irregular rhythm during pulse-taking with a confirmatory ECG. It is 
proposed that a screening programme for atrial fibrillation, targeted at those aged 65 and over and 
those with existing coronary disease or heart failure, be implemented and evaluated. 
It is important that in parallel to screening for atrial fibrillation, anticoagulation treatment facilities 
continue to be developed to deal with anticipated increases in detected atrial fibrillation.
RECOMMENDATION 4.7
Anticoagulation service management should be formalised, including:
• Clinical leadership of integrated anticoagulation services: This must be established 
within service networks so that GPs and hospital staff (including stroke specialist 
consultants, consultant haematologists and nurse specialists) achieve and assure optimal 
care for all.
• structured anticoagulation services: These will have to be developed between and 
within primary care services and hospital anticoagulation clinics. This will necessitate 
appropriate resourcing being provided to participating practices (e.g. IT linkages to 
hospital/GP/pharmacy anticoagulation services, ‘near-patient’ anticoagulation testing, 
practice nurse appointments).
• A screening programme for atrial fibrillation: This should be established, with formal 
evaluation, to ensure an effective means of implementation for people aged 65 and over.
Lead organisation: HSE
HEART FAILuRE
There is an impending epidemic of heart failure in Ireland, with the projected prevalence expected 
to increase significantly during the next 10 years (see Chapter 2). The current pattern of care of heart 
failure patients often involves presenting acutely to an emergency department, being admitted for 
lengthy hospital stays and returning home to an environment with little support for complex chronic 
disease management, followed by a likely early readmission. This is neither desirable nor sustainable. 
Heart failure, being a chronic condition in a population of mainly older people, requires integrated 
community-based care, led by the general practitioner. A focus on keeping the person out of the 
hospital setting is paramount. 
To do this well, there is a need for a paradigm shift in care – from hospital to community base – with 
a reorientation from largely hospital care to increasing structured proactive care in GP and primary 
care, supported by specialist ambulatory services. Structured heart failure care modelled on evidence-
based therapy is clinically very successful in reducing hospital and emergency department use. It is 
also cost-saving and it improves quality of life for the patient (Conlon et al, 2006).
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The aims of treatment of heart failure (as set out in the ESC Guidelines on heart failure (Dickstein et al, 
2008) are: 
• prevention;
• prevention and/or reducing the prevalence of diseases leading to cardiac dysfunction and 
heart failure;
• prevention of progression to heart failure once cardiac dysfunction is established;
• maintenance or improvement in quality of life;
• improvement in survival.
Prevention and early detection of heart failure
The following categories of patients benefit from close follow-up:
• patients with established risk factors for ventricular dysfunction, such as hypertension and 
coronary heart disease;
• all survivors of myocardial infarction with significant ventricular damage;
• screening of relatives with genetically linked cardiomyopathies.
Treatment in primary care
There is a need to change the emphasis from reactive care of sick hospitalised patients to proactive 
care in the community (see Recommendation 4.8). This will be achieved by increasing and developing 
capacity in general practice and primary care to improve early detection and active treatment of 
patients with heart failure. This development should take place in the context of current developments 
in primary care teams and evolving supports for chronic disease management programmes. This will 
require: 
• Education of GP and practice nursing staff.
• Access to specialist opinion: Accurate diagnosis and specialist-initiated investigation and 
therapy is the cornerstone of best practice for this condition. This will necessitate easy 
availability for GPs to specialist opinion and diagnostics and 7-day specialist referral.
• Improved communication between community-based professionals and with supporting 
specialist services.
• Appointment and development of the role of specialist heart failure nurses. This role should 
be developed in the community setting, in cooperation with the GP, practice nurse and other 
nurses caring for patients with chronic diseases. 
• Additional capacity and development of the wider primary care team members to support 
the management of patients with heart failure. A multidisciplinary team approach will include 
nutritionists, psychologists, physiotherapists, occupational therapists and social workers, 
who are likely to be working with patients with other chronic conditions. The community 
pharmacist can have an important contribution in supporting adherence to medication in 
heart failure, alongside other chronic cardiovascular conditions.
• Management of multi-morbidity, such as diabetes and chronic obstructive airways disease.
• Information and communications technology (ICT) developments, to (a) facilitate registers  
for structured care; (b) ensure easy access to communication with hospital specialists,  
HF specialist nurses, etc. for shared care, virtual consultations; and (c) promote audit of care.
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• Development of tele-monitoring, to promote patient education and adherence to medication 
and also the other extensive set of self-care tasks advised. 
• Clarity on contractual arrangements for staff, including 7-day cover by specialists.
In order to facilitate this transition from hospital to community, models of care of patients with heart 
failure, based on agreed national guidelines, will need to be established. Local adaptation between 
GPs and multidisciplinary teams and hospital cardiology services would be possible within this 
framework.
Models of service delivery need to include:
• the care of patients at risk of ventricular dysfunction or with ventricular damage post-AMI who 
will benefit from early detection;
• the care of newly diagnosed patients;
• the care of patients with clinical deterioration;
• regular and annual review mechanisms;
• easy access to hospital-based heart failure services lead by a cardiologist or physician with 
an interest in heart failure, so that diagnostics, ambulatory assessment and 7-day specialist 
support are available;
• care of patients with heart failure living in long-stay institutions.
The provision of specialist palliative care for patients suffering from heart failure needs to be explored 
in the context of developments for non-cancer palliative care. This should also address the expected 
need for respite care. This will require a shift in thinking since patients with end-stage chronic diseases 
have a different illness course to patients with cancer.
RECOMMENDATION 4.8
A programme should be developed to increase and support the capacity of primary care to 
detect heart failure at an early stage and to provide proactive care, including:
• Education of the primary care team, particularly GPs and practice nurses, in accordance 
with agreed national guidelines across primary and secondary care providers.
• Agreement on and introduction of models of shared care, supporting the key role of 
the GP and primary care team (see Chapter 5, Hospital section).
• Deployment of specialist heart failure nurses within an integrated system to maximise 
the value of these nurses to work with GPs and primary care teams.
• Deployment of other staff to increase the capacity of primary care teams to support 
the community-based management of patients with heart failure, including specialist 
palliative care.
• staffing arrangements to provide 7-day access for heart failure patients with clinical 
deterioration.
• IT capacity to facilitate communication between primary and secondary care, including 
the establishment of heart failure registers and audits.
• Tele-monitoring to support patients in adopting and maintaining self-care. This will 
involve the adoption of agreed national guidelines across primary and secondary care 
providers.
• specialist palliative care for heart failure patients.
Lead organisation: HSE
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PERIPHERAL ARTERIAL DIsEAsE
While the main concerns associated with peripheral arterial disease (PAD) have traditionally been 
seen to be critical ischaemia and/or gangrene and their consequences, it is now recognised that these 
patients have a very substantial risk of other cardiovascular diseases (see Recommendation 4.9). Up 
to 30% of patients with established peripheral arterial disease will die within 5 years, mainly from 
associated coronary or cerebrovascular disease. Peripheral arterial disease typically presents with pain 
in the calf, thigh or buttock brought on by exercise and relieved by rest. Many patients with symptoms 
fail to present as they may attribute symptoms to normal effects of ageing or physical inactivity. 
Greater public awareness is needed regarding this disorder. The recommended assessment strategy 
for peripheral arterial disease is the arterial brachial index (ABI). Measurement of the ABI enables lower 
limb systolic blood pressures to be compared with normal brachial blood pressure. The ratio of the 
two gives the ABI which if less than 1 is indicative of some degree of peripheral arterial disease.  
By convention, a scale of circulatory impairment is agreed such that:
>1.10  normal (although if higher may indicate incompressible/calcified arteries)
0.90 – 1.10  normal range
0.70 – 0.89  mild-to-moderate PAD
<0.70  moderate-to-severe PAD
It has been recommended that ABI measurements should be undertaken in the following groups of 
patients:
• any patient with absent peripheral (dorsalis pedis or posterior tibial) pulse;
• any patient with symptoms of peripheral arterial disease;
• men older than 55 years with significant risk factors for cardiovascular disease;
• women older than 65 years with significant risk factors for cardiovascular disease.
Patients with absent pulses and/or other indications of peripheral ischaemia require referral to 
a vascular surgeon – those with critical ischaemia will require urgent referral. For asymptomatic 
patients, treatment is focused on the management of cardiovascular risk factors, including lifestyle 
modifications (stopping smoking, losing weight, increasing physical activity) and pharmacotherapy, 
such as anti- platelets, lipid-lowering therapy and anti-hypertensives as appropriate.
RECOMMENDATION 4.9
A protocol for risk assessment and management of patients with suspected peripheral 
arterial disease (PAD) should be developed and evaluated in primary care.
Lead organisation: HSE, in partnership with Irish College of General Practitioners and  
Royal College of Physicians in Ireland
Primary Care
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INFORMATION sYsTEMs IN PRIMARY CARE
Reiterating the recommendation of the Primary Care Strategy (Department of Health and Children, 
2001), general practices need to be supported to establish population and disease registers that 
will support cardiovascular disease management. Information systems are needed to support risk 
assessment and intervention programmes. This includes data standards to record and calculate risk 
factors and scores for patients, and to incorporate follow-up protocols. The HeartWatch dataset has 
demonstrated the feasibility of implementing structured data collection systems in general practice in 
Ireland. Other systems such as SCORECARD, used in a number of European countries, provide models 
for quantified delivery of care. Routine recording of an adequate minimum dataset as part of clinical 
practice must be the aim of any system introduced. The shift towards structured care emphasized 
in this policy depends on a systematic patient recall system. These systems can support shared care 
protocols within a chronic disease management model (e.g. for heart failure) and will also provide 
mechanisms for audit of such care (see Chapter 8 for further discussion).
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5.   HOsPITAL AND EMERGENCY CARE sERvICEs
This chapter addresses hospital care for cardiovascular conditions, including emergency and acute 
cardiac and stroke care, and related pre-hospital emergency services; and the non-emergency role of 
hospitals concerning surgery and management of heart failure, peripheral arterial disease and grown-
up congenital heart (GUCH) disease. 
The approach taken for acute cardiac and stroke services is:
• to outline service delivery imperatives based on best practice guidelines for emergency and 
acute settings;
• to outline a network model of service reconfiguration and development to deliver these 
services;
• to specify pre-hospital emergency service priorities in line with this model;
• to outline the role of hospital care for heart failure, peripheral arterial disease and grown-up 
congenital heart disease.
Some general consideration of the role of cardiovascular care pathways is provided before moving 
on to discuss cardiac-specific and stroke-specific aspects of acute care pathways. The models of acute 
care presented here reflect best international practice with respect to the organisation of services and 
the nature of clinical care provided. While this chapter focuses on the acute services, clinical pathways 
also relate to how cardiovascular disease is prevented, its early detection, its ongoing treatment, 
rehabilitation and palliative care. One of the key objectives of this policy is to provide evidence-based 
recommendations on optimal cardiovascular care pathways; to reflect on the organisation of the 
current health services in Ireland and the capacity of healthcare professionals; and then to identify 
conditions for successful implementation of these proposals. 
Within the current resource framework, there is much that can be done to improve clinical care 
and outcomes, particularly for emergency patients, as well as to reduce costs without sacrificing 
quality. The HSE’s 2007 Ireland: Take Heart was an audit of progress on the implementation of the first 
cardiovascular health strategy, Building Healthier Hearts (1999) and it reported that good progress 
had been achieved generally. There remains, nonetheless, healthcare variation across the HSE due 
to a variety of causes, including how services are organised and the application of resources across 
the system. There is much that can be put in place by way of organisational change, applying best 
practice procedures, developing new cardiovascular models of care and the introduction of clinical 
pathways that stress the improvement of clinical processes in cardiovascular care to enhance clinical 
effectiveness and efficiency. The introduction of these clinical pathways and cardiovascular models 
of care will provide an effective strategy for the HSE to develop better care and reduce clinical 
performance variations across the system. These new cardiovascular pathways are an evidence-
based response to specific care needs and go beyond practice guidelines because they build on the 
organisational change already underway. In tandem with the development of clinical networks and 
with appropriate managerial support, such pathways will enable more effective cardiovascular care,  
in particular for patients who require emergency treatment. 
It is acknowledged that significant reconfiguration and restructuring is already underway within the 
HSE. At the centre is the requirement to provide more effective healthcare while maximising the use 
of scarce resources, such as facilities and specialist healthcare staff. This is against a backdrop where 
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the burden of chronic diseases is likely to continue to increase and the current system of clinical care 
will need to change if patient needs are to be met. Secondary specialist services will need to adapt and 
provide more support to primary healthcare providers. Emergency care facilities are often at capacity 
due to lack of alternative care pathways to manage patients referred from the community. Technology 
has also changed and new models of care for cardiac conditions and stroke mean that, in effect, many 
cases of stroke and acute coronary syndrome can be prevented. 
These changes are already taking place in some hospitals and regions throughout the country. If 
these benefits are to be realised, however, the new cardiovascular care pathways and models of 
care will need to be implemented on a systematic basis across the HSE. This will have to occur in an 
economic environment where there is likely to be no additional specified resources dedicated to this 
new cardiovascular health policy in the short term. Instead, it is proposed that the development of 
new emergency models of care and new clinical networks will take place within current resources. 
This policy will, however, inform future service and staffing developments (e.g. the deployment of 
additional medical consultant staff) and future capital developments subject to resource availability. 
Many of the steps for development of these pathways of care and emergency care models are, or 
can be put, in place at present. This work and policy should inform the existing reconfiguration 
programme and new work practices that emerge. 
Changing the cardiovascular model of care is considered to be a priority in the way we plan and 
deliver services in order to avoid potential risks in how services are currently provided. In terms of 
implementation of the hospital and emergency care service recommendations of this policy, the 
first stages should include the adoption of the new care pathways for cardiac conditions and stroke, 
particularly in emergency settings. This should be complemented by the development of hospital 
networks to support this care. Many of these elements are already in place. On an incremental basis, 
the HSE should implement these new policy requirements subject to the reconfiguration programme 
and to developments that are planned and agreed in the national service plans. 
ACuTE CARDIAC CARE PATHWAYs
1.  Emergency care pathway for acute myocardial infarction
Survival followed by speedy reperfusion is the goal of emergency care. For acute myocardial infarction 
(AMI) patients who present with ST elevated AMI (STEMI), thrombolysis within the treatment time 
window has been the mainstay of emergency reperfusion to date. 
Mechanical reperfusion through primary percutaneous intervention (PCI) has a major advantage over 
thrombolytic therapy. It achieves full reperfusion in over 90% of patients soon after the initiation of 
the procedure, without an increase in the risk of hemorrhagic stroke. Overall, the benefits of primary 
angioplasty – as shown in major studies (Anderson et al, 2003; Aversano et al, 2002; Widimsky et al, 
2003) – are a reduction in mortality, re-infarction, stroke and recurrent ischaemia. More specifically, a 
meta-analysis comparing the outcome of thrombolysis and PCI at 30 days post-infarction found that PCI 
prevented 20 deaths, 40 re-infarctions and 10 strokes for every 1,000 patients treated (Keeley et al, 2003). 
Organisationally, potential benefits are reduced thrombolytic medication use, reduced hospital stay 
(since angioplasty is undertaken shortly after hospital admission) and reduced need for cardiac surgery. 
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Effectiveness of both primary PCI and thrombolysis depends on timeliness of delivery (the concept 
of ‘time is muscle’). PCI (angioplasty/stenting) delivered within 120 minutes of first medical contact is 
now the ESC recommendation for maximal reperfusion of blocked coronary vessels (Van de Werf  
et al, 2008). Where this is not feasible, thrombolysis delivered as early as possible using pre-hospital or 
hospital facilities will restore perfusion in about half of patients. Early catheterisation and intervention 
with thrombolysed patients is then required at the earliest possible time within the following 24 hours.
The decision tree for management of acute cardiac care, as outlined in the ESC STEMI Guidelines  
(Van de Werf et al, 2008), is presented in Figure 6.
Figure 6: Decision tree for management of acute cardiac care
Source: Van de Werf et al (2008). Reproduced with permission of the copyright owner.
PCI must be delivered in accordance with international standards relating to the staff providing the 
service and the facilities where the services are delivered. Criteria are specified in Box 1. Where patients 
cannot reach PCI services within the time specified for safe and effective care, early reperfusion is to 
be provided by building up services that have well-resourced and trained pre-hospital emergency 
facilities and staff. A balance of primary PCI facilities and pre-hospital services to complement existing 
primary cardiac centres providing thrombolysis will provide the widest and most equitable coverage 
of these services to the public in Ireland (see Recommendations 5.1-5.5).
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box 1: Focus on requirements for primary PCI programmes
A range of programme requirements is specified by the ACC/AHA criteria for competency per 
year. Core requirements are related to volume per operator and throughput per institution annually. 
Key points are summarised:
• Physicians performing primary PCI should complete 75 or more total PCI cases per year.
• Institutions providing primary PCI should:
• admit a minimum of 60-65 and optimally 85-90 or more acute ST-segment 
elevation MIs annually;
 • perform a minimum of 36 and optimally 49 or more primary PCIs annually.
These requirements are likely to change in this rapidly evolving area of practice. Irish standards 
should adjust to new recommendations as required.
For patients who present with acute ischaemia without evidence of STEMI, the ESC Guidelines on heart 
failure (Dickstein et al, 2008) recommend early angiography and relevant intervention following risk 
assessment. Five recommendations are made below on acute management (see Recommendations 5.1-5.5).
RECOMMENDATION 5.1
Patients with sT elevation myocardial infarction should be treated with primary 
percutaneous intervention (PCI) as first-line therapy, in accordance with the 2007 ESC  
Clinical Practice Guidelines if the time from first medical contact to primary PCI can be 
achieved within 120 minutes.
Optimal treatment under this development will require an emergency medical system to link a 
network of hospitals having cardiac facilities, with a clear designation of geographic coverage, 
shared risk stratification protocols for pre-hospital diagnosis and triage, and fast transport in 
appropriately equipped ambulances or helicopters.
Lead organisation: HSE
RECOMMENDATION 5.2
If PCI cannot be provided within 120 minutes of first patient contact, the patient should be 
assessed for thrombolysis as soon as possible. Treatment options should include pre-hospital 
thrombolysis in addition to the in-hospital service, depending on patient presentation.
Protocol-driven emergency thrombolysis should be provided in either pre-hospital or hospital 
settings. The priority in service development will be to deliver the fastest service to the widest 
range of patients and this should be reflected in future service plans. Pre-hospital thrombolysis 
has been incorporated in the advanced paramedic scope of practice by the Pre-Hospital 
Emergency Care Council and a supporting clinical practice guideline has been published. 
A programme to train GPs for appropriate roles in pre-hospital emergency care, including 
thrombolysis in certain rural areas, is also underway.
Lead organisation: HSE
continued
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RECOMMENDATION 5.3
Emergency PCI services should be delivered on a 24-hour 7-day basis in a small number of 
centres, sited to maximise patient access and workforce expertise and coverage.
Some centres which do not provide emergency services may be able to provide PCI for 
patients presenting directly to them during restricted hours, provided that there is a sufficient 
throughput to maintain expertise.
Lead organisation: HSE
RECOMMENDATION 5.4
Patients assessed as having forms of acute myocardial ischaemia other than sT elevation 
myocardial infarction should be taken to the nearest acute medical facility, triaged at the 
emergency department, treated and stabilised, moved to the nearest acute coronary care 
setting and then transferred within 24 hours to the nearest comprehensive cardiac centre.
Most of these patients will require diagnostic angiography and some will require early 
intervention. These recommendations refer to patients transferred to hospital by ambulance. 
The same diagnostic and treatment protocol applies for those patients (currently approximately 
50%-55%) who arrive at hospital independently of the emergency services.
Lead organisation: HSE
RECOMMENDATION 5.5
Designation of cardiac networks providing diagnostic and interventional services should 
include non-invasive diagnostic imaging facilities, in addition to echocardiography, 
catheterisation and angiography.
Pragmatically, a minimum of two investigative/angiographic laboratories are needed in each 
centre providing the service to deliver on a timely basis. Furthermore, the period of changeover 
from a largely thrombolysis-based reperfusion service to a primary PCI needs to be carefully 
monitored to ensure that standards of patient care are maintained in the transition period. 
Network development is a core first step in the implementation of this policy.
Lead organisation: HSE
2.   Intensive cardiac care
The work undertaken by coronary care units has changed significantly in recent years. Rates of 
acute ST segment myocardial infarction are falling, while the presentation of other acute coronary 
syndromes is increasing. Other activity suited to these units includes management of potentially life-
threatening arrhythmias, severe or resistant heart failure, haemodynamically controlled interventions 
in acute heart failure and the management of unstable patients with cardiac problems transferred 
from other disciplines. The Coronary Care Unit now needs to evolve to become an Intensive Cardiac 
Care Unit (ICCU), functioning in close liaison with the emergency department while remaining under 
the control of the cardiology service (as described in the ESC STEMI Guidelines – Van de Werf et al, 
2008) (see Recommendation 5.6).
ICCUs will continue to be responsible for the management of all forms of acute ischaemic heart 
disease. As this is now largely intervention-based, patient stay is shortened and there is often 
insufficient time for patient education about their disease and its long-term management. Protocols 
87
 Hospital and Emergency Care Services
must ensure that individualised patient treatment plans, including adequate patient education, are 
formulated and put in place before discharge (see Recommendation 5.7). This is essentially Phase I of an 
integrated rehabilitation programme and needs to commence during hospitalisation (see Chapter 6 on 
rehabilitation). 
With a shift to primary PCI in a small number of comprehensive cardiac centres, ICCUs in smaller 
general centres will care for a different case mix of patients, with a greater focus on high-dependency 
patients (such as those with heart failure and rhythm disorders) as well as lower risk acute coronary 
syndrome patients. A review of the need for, and supply of, this type of cardiac care is necessary to 
inform service reconfiguration.
RECOMMENDATION 5.6
The current Coronary Care unit should be substantially reconfigured, following needs 
assessment, to become an Intensive Cardiac Care unit (ICCu), meeting the changing clinical 
profile of the patients now encountered.
A review of the changing pattern of need and supply for acute cardiac care is required to 
underpin this reconfiguration.
Lead organisation: HSE
RECOMMENDATION 5.7
Protocols need to be developed to ensure provision of individualised patient treatment plans 
in Intensive Cardiac Care units, incorporating education of patients within a tailored, phased 
rehabilitation framework.
It is acknowledged that new procedures and increased efficiency, resulting in shorter stays in 
hospital, challenge the traditional model of patient education and early rehabilitation at this 
point. New ways to achieve the same effects are needed.
Lead organisation: HSE
3.   Emergency and ambulatory care of patients with chest pain
There are two components to efficient and effective assessment and management of patients with 
chest pain: (1) care of acute presentation to an emergency department and (2) sub-acute presentation 
in ambulatory settings, usually following referral by a GP.
In the acute setting, the goal is to triage the high-risk patient for urgent treatment of acute coronary 
syndrome and to assess the lower risk patient, so that those with ischaemic heart disease are identified 
and treated, while those without are discharged (see Recommendation 5.8). Such a service, in or 
near an Emergency Department or Medical Assessment Unit or CCU, has been established in many 
countries. It is based on a focused and protocol-driven assessment, and has been found to be rapid, 
safe and cost-effective, with reduction in litigation, on the one hand, and reduction in inappropriate 
admissions, on the other.
In the sub-acute setting, there is a requirement to address the needs of patients referred by their GP 
where there is a pressing concern about emerging ischaemic heart disease. To meet the needs of 
this group of patients, there is a requirement to provide same-day specialist expertise and relevant 
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diagnostic services. This can be achieved by reorganising out-patient clinics to accommodate urgent 
evaluation. In some countries, this urgent ‘one-stop’ assessment has been fashioned into a specific 
model (e.g. the Rapid Assessment Chest Pain Clinic). An example of an algorithm developed in the 
Irish setting is included in Appendix 3.
Other aspects of ambulatory care include the evaluation of patients with acute dyspnoea, tachycardia 
or bradycardia, suspected cardiogenic syncope and suspected acute or increasing heart failure. This 
requires timely access to the relevant diagnostic tests and specialist expertise.
Specific clinical presentations benefit from specialised ambulatory focus. These include conditions such 
as heart failure, pacing, hypertension and lipid disorders. Certain conditions are concentrated in specific 
centres, e.g. follow-up of grown-up congenital heart (GUCH) disease. Evidence on emerging investigative 
techniques needs ongoing monitoring to inform necessary evolution of ambulatory care services.
RECOMMENDATION 5.8
Hospitals admitting patients with acute cardiac conditions should have a protocol-driven 
assessment of patients with lower-risk chest pain to maximise detection of those with acute 
ischaemia and to minimise inappropriate admissions.
In tandem, priority ambulatory care must be formulated to deliver specialist expertise, ideally 
by the next working day or within 72 hours at the latest for GP-referred patients with acute 
or suspicious presentations. In addition, a specialist ambulatory focus for a number of clinical 
presentations should be considered so that appropriate expertise and techniques can be made 
available and used to maximum effect in the context of a rapidly changing clinical evidence 
base.
Lead organisation: HSE
4.   Heart failure care
There were over 18,000 hospitalisations in Ireland in 2006 as a result of heart failure. Approximately 
1 in 5 of the population with heart failure will be admitted to hospital in any one year and many 
will be readmitted. The adoption of a structured approach to heart failure is proposed in Chapter 3, 
as embodied in the ESC Guidelines on heart failure (Dickstein et al, 2008). Structured heart failure 
programmes can achieve significant reductions in rehospitalisation rates, improve patient quality of 
life and prognosis, and have been shown to be cost-effective. 
This model requires a move from emergency in-hospital care to accessible ambulatory specialist care 
that supports proactive care by GPs and primary care teams (see Recommendations 5.9-5.11). The 
HSE’s (2007) Ireland: Take Heart report found that two-thirds of relevant acute hospitals had initiated a 
structured heart failure service. 
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key requirements for a specialist heart failure ambulatory service
Personnel:
• Cardiologist with an interest in chronic disease management.
• Specialist heart failure nurses and appropriate cardiac technician support. 
• Access to other members of a comprehensive multidisciplinary team. 
• Administrative support to help coordinate the interface between hospital and community.
Facilities and organisation:
• Timely diagnostics in support of diagnosis and care.
• Ambulatory care based on 5-day open or appointment-based access clinic, with arrangements 
for 7-day cover for clinical deterioration.
• Designated consultant(s) and service specialising in heart failure in each hospital where heart 
failure services are provided.
• Quality control, support, rapid transfer when needed and protocol supervision by the heart 
failure cardiologist specialist(s) at the network cardiac referral centre.
• Appropriate rehabilitation programmes for heart failure patients (see Chapter 6 on 
rehabilitation).
shared heart failure care between hospital and community services
Agreed models of shared care for patients with heart failure should be developed for:
• patients at risk of ventricular dysfunction or with ventricular damage post-AMI who will 
benefit from early detection;
 • newly diagnosed patients;
 • patients with clinical deterioration.
Local adaptation of guidelines between GPs/multidisciplinary teams and hospital cardiology services 
should be possible. Effective shared care requires developments in ICT to facilitate communication 
between hospital and community, including to minimise unnecessary referral and expedite needed 
referral.
RECOMMENDATION 5.9
All hospitals evaluating patients with heart failure should restructure in-hospital and  
out-patient cardiac care to allow for specialist heart failure ambulatory services that support 
the key role of the GP and primary care team.
Lead organisation: HSE
RECOMMENDATION 5.10
Models of shared care of patients with heart failure should be established, based on agreed 
national guidelines and on models currently being elaborated in Ireland and internationally.
Lead organisation: HSE, in association with Irish College of General Practitioners and Irish Heart 
Foundation
continued
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RECOMMENDATION 5.11
ICT-enabled communication between hospitals and GPs or primary care teams should be 
actively used to support shared heart failure care.
Lead organisation: HSE
ORGANIsATION OF sPECIALIsT CARDIAC sERvICEs
Specialist cardiac services should be organised into regional networks, as envisaged in the recent 
ESC STEMI Guidelines (Van de Werf et al, 2008), in order to deliver a comprehensive range of cardiac 
services. Proposed cardiac networks will be based on an approximate ratio of 1 network per 500,000 
population, depending on geography and population density (see Recommendation 5.12). Partner 
hospitals within each network will work collegially in order to provide a comprehensive and equitable 
service to all in the region and in some cases providing national specialty care. Central to the network 
concept is the principle that every hospital delivers a comprehensive range of cardiac services, either 
on site or in formal partnership with others. Acute and national specialty services are provided in a 
smaller number of regional centres to ensure the high volume 24-hour 7-day throughput needed for 
rapid, responsive and accessible high-quality care. Non-acute and out-patient services are core aspects 
of specialist cardiac care. They are provided at both general and comprehensive cardiac centres (as 
defined in Box 2, see p. 91) to facilitate patient access.
RECOMMENDATION 5.12
specialist cardiac services should be organised into population-based cardiac networks, with 
network hospitals designated as (i) General Cardiac Centres or (ii) Comprehensive Cardiac 
Centres.
A broad plan for service reconfiguration needs to be developed. This should identify general 
and comprehensive cardiac centres and allow service planning – involving workforce and 
emergency service development in particular – to evolve within the new network structure.
Lead organisations: HSE and Department of Health and Children
Specialist cardiac services provided on a network basis will include an intensive cardiac care unit, a 
heart failure service, arrhythmia management service, invasive and non-invasive diagnostic services, 
out-patient services, rehabilitation, teaching, management functions, in-patient care for chronic 
cardiovascular disorders, sub-specialist clinics where appropriate and, in many cases, sub-specialist 
electrophysiological services. Hospitals must be staffed by medical, nursing and allied health 
professionals to an appropriate level, in conformity with recognised professional standards (see 
Chapter 7). Ongoing care and rehabilitation and liaison with primary care are recognised as important 
components of these services (see Chapter 6). Every cardiac specialist, whatever the individual’s sub-
specialty interest, will be a member of the regional network and will be allocated specific responsibility 
for services at a hospital within the network. Every network should have a cardiologist, whose primary 
function is the organisation of preventive services and liaison with primary care and GP services.
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Every cardiac specialist within the network, irrespective of the location of their main workplace, will 
have parity of esteem and equal access to appropriate facilities and services within the network. 
Services for certain areas – such as primary PCI, surgery, specialist electrophysiology and grown-up 
congenital heart disease – may be provided in partnership with other cardiac centres. In addition, 
each network must provide facilities, either within the network or by direct partnership arrangements 
with national centres, for the management of grown-up congenital heart disease, peripheral arterial 
disease facilitation of paediatric cardiological assessment and assessment of families at risk of sudden 
cardiac death. The aim of the network will be to provide the same level of service for all who need 
it, incorporating a seamless service with appropriate inter-hospital transfer for acute, sub-acute 
and chronic care across the network. Box 2 provides a summary of the range of services available at 
network level.
box 2:   Cardiac networks – Roles of hospitals designated as general and comprehensive 
cardiac centres
GENERAL CARDIAC CENTREs
Role: To provide sub-acute and chronic care services.
services provided:
•      Liaise with pre-hospital emergency services to determine reperfusion type and treatment 
location appropriate to individual patient circumstances.
•      Triage and transfer eligible on-site acute myocardial infarction patients for primary PCI.
•      Provide thrombolysis where appropriate and where primary PCI is not feasible.
•      Provide diagnosis and treatment of sub-acute presentations of cardiac disease and chronic 
cardiac conditions.
•      Provide heart failure services.
•      Provide rapid access chest pain services.
•      Provide cardiac rehabilitation and palliative care services.
•      Provide out-patient cardiac care services in liaison with primary care services. This may  
include rapid access chest pain clinics depending on regional need.
•      Provide primary management of rhythm disorders.
•      Promote preventive services in the community in liaison with primary care staff.
Facilities needed:
•      24-hour 7-day emergency services, including chest pain assessment service.
•      Intensive cardiac care unit.
•      Cardiac rehabilitation facilities.
•      Specialist cardiology consultant and multidisciplinary support staff.
•      Diagnostic and treatment support for sub-acute and chronic cardiac disease.
•      Community-based facilities and resources to deliver preventive cardiology services  
in tandem with primary care staff.
continued
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COMPREHENsIvE CARDIAC CENTREs
Role: To provide acute care services.
services provided:
•      All will provide interventional (cardiac catheterisation, stenting) and non-interventional 
investigation and treatment over the working day.
•      Some will provide 24-hour 7-day catheterisation, including stenting/PCI for acute MI 
(estimated at approximately one centre per 500,000 population).
•     All will provide specialist heart failure services.
•     All will provide rapid access chest pain services.
•     All will provide management of rhythm disorders.
•     All will provide treatment of peripheral arterial disease.
•      Some will provide designated national sub-specialties, including electrophysiology,  
cardiac surgery, congenital heart disease services and transplantation.
•      All will coordinate aspects of the cardiac network, to include identification of community 
liaison staff and network facilitation through use of ICT.
Facilities needed (in addition to those for general cardiac centres):
•     Two cardiac catheter laboratories as a minimum, with 24-hour 7-day availability.
•     Electrophysiology laboratory.
•      National or regional sub-specialty services, including cardiac surgery, transplantation, 
congenital heart disease to be available in some units.
•     Vascular surgery.
CARDIAC suRGERY
surgery for acquired heart disease in adults
Recent changes in medical practice and patient demographic profiles have had a major impact 
on cardiac surgical practice. Changes in the profile of patients seen in Ireland reflect international 
experience. Fewer patients are now referred for cardiac bypass grafts (CABG) due to the increased 
use of drug-eluting stents for multi-vessel coronary artery disease. Patients presenting for surgery 
are now older due to improved life expectancy and raised quality of life expectations in older adults. 
Patients have more co-morbidity and present with more complex case mixes. Procedures now include 
combined valve and grafts, double valve procedures, grafts with carotid endarterectomy and a greater 
proportion of ‘second time’ or repeat procedures. Thus, although fewer operations are being carried 
out, there is very little spare capacity in the operating time currently available for cardiac surgery in 
Ireland.
Future demands on cardiac surgery are anticipated with the projected ageing population, as outlined 
in Chapter 2. The increased immigrant population in recent years, some with genetic backgrounds 
that will influence the spectrum and severity of disease, will also have an effect in time. Overall, the 
decrease in number of cases of CABG surgery will be offset by the changing patient profile, including 
more complicated case mixes.
box 2: Cardiac networks (continued)
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bed demands
While there is consensus that the numbers of existing and approved consultant surgeon posts are 
adequate to meet demand at present and into the immediate future, availability of intensive care 
beds represents a serious challenge to cardiac surgery activity. Average length of stay in ICU has been 
significantly prolonged because of a combination of the increasing age of patients, the increase in co-
morbidities and the more complex case mix. Lack of availability of intensive care beds is a rate-limiting 
step for scheduled cardiac surgery. This is true for both adult and paediatric cardiac surgery. For the 
years 2006 and 2007, approximately 2,000 cases needed to be carried out annually. The four adult 
surgery units carried out on average 1,400 cases; a further 300 were performed through the National 
Treatment Purchase Fund and carried out in the private sector; and the combined waiting list was 
about 300 cases. Dedicated cardiac surgical intensive care units, separate from the general intensive 
care delivery, are needed in all hospitals. Specifically, a dedicated unit for paediatric cardiac surgery is 
needed. There is also a shortage of intensive care beds in some of the established units. Because of the 
increasing problems encountered with hospital-acquired infection in Ireland, there is also a need for 
more single/isolation rooms. Almost all new beds should be single-room beds (see Recommendation 
5.13).
RECOMMENDATION 5.13
Cardiac surgical units should have a dedicated Intensive Cardiac Care unit, with adequate 
numbers of beds (the majority to be provided in single rooms). 
Lead organisation: HSE
Anaesthetic and intensive care
Another area of change in the delivery of cardiac surgery today is the model of anaesthetic and 
intensive care in individual units. It has been shown that optimal outcomes are achieved when 
consultant anaesthetic staff with specialty training in cardiac anaesthesia are available for all  
cardiac surgery procedures, whether carried out during the routine working day or on-call  
(see Recommendation 5.14).
RECOMMENDATION 5.14
All consultant anaesthetists and intensivists providing care to cardiac surgery patients 
should have specialist training.
All anaesthetists providing cardiac anaesthesia should carry out at least one cardiac surgery list 
per week. A dedicated cardiac anaesthetic on-call rota should be established in each hospital 
providing cardiac surgery.
Lead organisations: HSE and relevant postgraduate training bodies
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Transplantation
The current demand for heart transplants is up to 20 patients per year and for lung transplants 
(including single lung, double lung and heart–lung) is up to 30 patients per year. In terms of waiting 
lists, there were 18 patients awaiting heart transplantation and 33 awaiting lung transplantation in 
mid-2008. A significant barrier to thoracic organ transplantation in Ireland is availability of suitable 
donor organs for current matching recipients. The selection criteria for thoracic donor organs are 
more complex than for other organs, resulting in additional constraints on access to adequate 
numbers of organs. While Ireland has a very good deceased donor rate compared to some other 
countries, improved access to an adequate number of organs is needed (see Recommendation 5.15). 
The Minister has agreed with the Health Service Executive, as part of its 2010 Service Plan, that the 
HSE will establish an Organ Donation and Transplantation Unit within its existing national structures 
and resources. This unit will provide a national focal point for reporting, monitoring and assessing 
organ donation and transplantation activities. It is appropriate that these functions be carried out at a 
national level, on the basis of regular, comprehensive performance data provided by all the transplant 
centres. This approach will provide a sound basis for evaluating performance and examining other 
issues related to transplantation.
RECOMMENDATION 5.15
solutions to maximise access to donor organs for transplantation should be explored.
Specific initiatives will be informed by the work of the Organ Donation and Transplantation 
Unit, to be established within the HSE’s existing national structures and resources.
Lead organisations: Department of Health and Children and HSE
Congenital heart disease and grown-up congenital heart (GuCH) disease
All paediatric surgery for congenital heart disease in Ireland is carried out in Our Lady’s Hospital for 
Sick Children in Crumlin (OLHSC). The waiting list for routine surgery is now about 3 months, with 
approximately 90 children waiting. While these surgical and waiting list figures are satisfactory, 
inadequate access to operating theatre time and insufficient ICU beds mean that approximately 
one-third of these procedures takes place outside of normal working hours, i.e. in the evenings or at 
weekends. Operations may be cancelled or postponed at short notice, creating difficulties for children 
and their families and a challenging work environment for the staff involved.
The population of children surviving into adulthood with congenital heart disease is increasing. Many 
of these patients will require further surgery as adults, as outlined in Chapter 2. In 2007, 70 operations 
were undertaken. The prediction is that this number will more than double within 5 years, i.e. by 2014 
(see Recommendation 5.16). This type of surgery is usually much more complex than conventional 
adult cardiac surgery. For these reasons, GUCH procedures are associated with a greater use of facilities.
RECOMMENDATION 5.16
A review of service needs and availability for GuCH patients (Grown-up Congenital Heart 
disease) should be carried out in the context of international trends, followed by a service 
development plan for this expanding population of patients.
Lead organisation: HSE
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Cardiac-related surgery
Decisions concerning recommendations for screening and surgical repair of aortic aneurysm are not 
considered here, but should be considered further as part of general policy requirements for health 
screening.
ACuTE sTROkE CARE
There is substantial evidence of improved outcomes with organised and dedicated facilities and 
systems to care for patients with stroke. This includes admission to rapid access trans-ischaemic 
attack (TIA) clinics for those with suspected TIA, a major risk for subsequent stroke; timely access to 
stroke thrombolysis with onset of ischaemic attack for suitable patients in order to improve overall 
clinical outcome; and delivery of care for those with stroke in a stroke unit setting with adequate 
rehabilitation throughout recovery following discharge. The first Irish National Audit of Stroke Care 
(INASC), carried out in 2006-07, found that stroke services in Ireland require substantial development 
to meet international standards of care (Horgan et al, 2008).
There are 4 acute stroke care pathways, described below.
1.   stroke unit care
Stroke units are the foundation of timely and comprehensive stroke care in hospital and are a 
minimum standard internationally for audit and accreditation of stroke services. Expert guidelines 
from groups such as the European Stroke Organisation (ESO), the UK’s National Institute for Clinical 
Excellence (NICE) and the Irish Heart Foundation recommend that a stroke unit exist in every acute 
hospital admitting stroke patients.
The benefits of stroke unit care, compared to care on a general medical ward, have been extensively 
studied. A recent summary of 23 randomised clinical trials reported a highly significant reduction in 
death and dependency by one-fifth of patients (22%) receiving stroke unit care. Results indicated 
that one death or dependency was prevented for every 16 patients treated in a stroke unit, and one 
extra patient was returned to independent community living for every 20 patients treated (Stroke Unit 
Trialists’ Collaboration, 2007).
The goal of stroke unit care is to organise hospital stroke care in a specialised area with immediate 
access to specialist medical, nursing and rehabilitation health professionals, providing efficient and 
coordinated stroke care that is focused on the patient and family. 
The European Stroke Organisation (ESO) defines a stroke unit as follows: ‘A stroke unit consists of a 
discrete area of a hospital ward that exclusively or nearly exclusively takes care of stroke patients and 
is staffed by a specialist multidisciplinary team. The core disciplines of the team are medicine, nursing, 
physiotherapy, occupational therapy (OT), speech and language therapy (SLT) and social work. The 
multidisciplinary team should work in a coordinated way through regular meetings to plan patient 
care. Programmes of regular staff education and training should be provided’ (ESO, 2008).
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The first Irish National Audit of Stroke Care (INASC), carried out in 2006-07, found that only one acute 
hospital (3% of acute hospitals) in Ireland operated a stroke unit in 2006 (Horgan et al, 2008). While 
this number has since increased, it remains very far behind neighbouring systems.4 For example, 96% 
of hospitals in England and 92% in Northern Ireland have such units. Scotland, with 34 acute hospitals 
serving a population of 5 million, has a stroke unit in 24 hospitals (70%). It is estimated that universal 
introduction of stroke units in Irish hospitals would prevent 445 deaths or dependent outcomes each 
year and allow 356 extra survivors to return to independent community living who would otherwise 
require long-term care. It is also likely that stroke units reduce mean length of stay in hospital. For 
example, in the UK, stroke unit care was associated with an 18% reduction in length of stay between 
2001 and 2004 (National Audit Office [UK], 2005).
As many acute hospitals in Ireland already have several elements of the staffing and infrastructure 
required to create a stroke unit, it is expected that widespread implementation of stroke unit care in 
the acute hospital system could be achieved with relatively little effort (see Recommendation 5.17). It 
would require re-organisation of existing services and targeted investment, including the strategic 
appointment of stroke-trained consultant geriatricians and neurologists to provide on-site clinical 
leadership and the appointment of specific nursing and rehabilitation staff (e.g. speech therapists) 
where service gaps exist in particular hospitals.
The establishment of stroke units requires designation of protected beds for stroke care, as a separate 
ward or within a defined area on an existing ward. The number of beds required will depend on 
the population served, the number of patients admitted annually (inflow) and the availability 
of post-acute rehabilitation and community support services (outflow). The Stroke Unit Trialists’ 
Collaboration (1997) recognised that in-patient care for acute stroke may be provided in an acute 
unit, a rehabilitation stroke unit or a unit combining both acute care and rehabilitation. Stroke units 
must be adequately resourced, with sufficient capacity to admit patients directly from the emergency 
department, rapid access TIA clinics and transfers from other hospitals within the stroke network, and 
to treat all stroke/TIA patients for most of their hospital stay.
RECOMMENDATION 5.17
All hospitals admitting patients with acute stroke should have a stroke unit, as defined by the 
European stroke Organisation.
Each stroke unit should have sufficient capacity to admit patients directly from the emergency 
department and the rapid access TIA clinic, to accept transfers from other hospitals within the 
stroke network when required, and to provide care for all stroke/TIA patients for their hospital 
stay. This should be a key priority for the hospital reconfiguration programme.
Lead organisation: HSE
4   There were 11 stroke units in place in 2009, although not all of these were fully staffed and equipped. A thrombolysis service 
has commenced in 10 hospitals, with a service on weekdays in a further 5 hospitals.
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The majority of stroke patients have substantial medical co-morbidities and most mortality is from 
medical complications of stroke. The co-morbidities and complications of stroke require consultant 
stroke specialist input throughout the care pathway of stroke. Stroke physicians with specific expertise 
in cerebrovascular disease come from a variety of backgrounds, including consultant geriatricians, 
neurologists, pharmacologists and rehabilitation medicine (see Chapter 7 for workforce implications of 
developing stroke services).
Specialist stroke nursing care and multidisciplinary stroke rehabilitation must be available to stroke 
patients according to need in the acute and non-acute phases of their illness, on discharge to the 
community and in continuing care (see Recommendation 5.18). Care should be integrated across 
disciplines and care locations, with regular review of the needs of each individual patient. Stroke 
patients are physiologically vulnerable and often highly dependent in terms of mobility, feeding and 
communication, making adequate staffing a priority.
RECOMMENDATION 5.18
stroke units should have adequate and appropriate staffing.
This includes a designated lead consultant stroke physician working within a stroke network 
group. In addition, stroke units should have adequate multidisciplinary teams of staff to 
cater for the complex needs of patients with stroke, many of whom will have high levels 
of dependency. Such teams should include physiotherapy, occupational therapy, speech 
and language therapy, social work, clinical nutrition and dietetics, clinical psychology/
neuropsychology, and specialist nursing.
Lead organisation: HSE
stroke unit facilities should include:
• Capacity for intensive monitoring of physiological variables.
• A clinical workstation and networked computers, ideally allowing on-site review of brain scan 
images.
• A well-equipped assessment area and rehabilitation gym close to, or incorporated within, the 
stroke unit.
• On-site CT brain scanning, with access on- or off-site to MRI scanning.
• Same-day availability of essential routine investigations, particularly carotid artery imaging, 
with early access to cardiac investigations.
stroke unit care typically includes:
• Medical assessment and diagnosis, including imaging (CT and MRI) and early assessment 
of patient’s neurological, surgical, neuroradiological, pharmacological, nursing and therapy 
needs.
• Early multidisciplinary team assessment and management, including positioning/
seating, swallow, nutritional and communication assessment, venous thromboembolic 
prophylaxis and early mobilisation, prevention of complications and treatment of hypoxia, 
hyperglycaemia, pyrexia and dehydration.
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• Acute medical treatment – Almost 2 out of 3 patients will develop neuromedical 
complications within one week that can adversely affect recovery. Stroke unit management 
includes prevention, assessment and treatment of infection, pain, progressive stroke, 
thromboembolism, arrhythmias, myocardial infarction, seizures and depression.
• Rehabilitation planning and initiation, involving coordinated multidisciplinary team care, 
assessment of pre-morbid and current function, treatment of spasticity and pain, initial 
goal-setting with patient and family, and early assessment of patient and family needs after 
discharge.
Comprehensive guidelines for the acute hospital care of patients with stroke are in development by 
the Council on Stroke of the Irish Heart Foundation, with the intention of agreeing and disseminating 
guidelines appropriate to Ireland. Protocols of care will support the implementation of guidelines, 
laying the foundations of quality of care and risk management, with evaluation through clinical audit.
The phases of acute care – emergency evaluation and treatment followed by the initiation of  
in-hospital rehabilitation – are described next.
2.   Emergency stroke treatment with thrombolysis
Acute stroke is a medical emergency. Thrombolytic therapy is of proven benefit for selected 
patients with ischaemic stroke. In patients with acute ischaemic stroke (approximately 70% of all 
stroke patients), delivery of emergency stroke thrombolysis within 180 minutes of the onset of 
stroke symptoms improves overall clinical outcome, i.e. ‘time is brain’ (see Recommendation 5.19). 
In some patients, this treatment can cause complete early recovery from their stroke or substantial 
improvement with rehabilitation. The benefit is greatest for patients treated earliest after symptoms 
begin. Thrombolysis is an internationally recommended standard of care for appropriate patients 
in the early hours of stroke and is cost-effective. The evidence from clinical trials is that stroke 
thrombolysis confers substantial benefits after stroke, with one patient recovered or improved for 
every 3 patients treated. However, recent Irish studies (Kelly, 2009; Horgan et al, 2008) found that 
less than 1% of Irish stroke patients received emergency stroke thrombolysis in 2005 and 2006. By 
comparison, some centres in the UK and Europe report thrombolysis rates of 15%-20%.
Stroke thrombolysis carries a risk of brain haemorrhage. Therefore, international and EU guidelines 
dictate that stroke thrombolysis can be administered only under the direct supervision of a stroke 
physician, specifically trained and experienced in emergency stroke treatment. Access to CT or MRI 
neuro-imaging is required in order to exclude those at risk of further clinical deterioration due to brain 
bleeding or swelling with the treatment. A HSE National Hospitals Office survey in 2008 found that CT 
scanning was available in 32 of the 36 hospitals surveyed (27 had 24-hour 7-day services; 4 had a  
day-time service; and one had a half-time service). MRI scanning was available on a 24-hour 7-day 
basis in 19 of the 36 hospitals surveyed, with 2 having MRI on 2 days per week.
Acute stroke patients should be pre-triaged by ambulance paramedical staff, using recognised 
assessment tools, and transported as quickly as possible to an acute hospital providing emergency 
stroke treatment delivered by a consultant stroke physician and immediate brain imaging by CT or 
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MRI. Clinical practice guidelines have been developed by the Pre-Hospital Emergency Care Council 
for responders (cardiac first responders, occupational first aiders, emergency first responders) and 
practitioners (emergency medical technicians, paramedics and advanced paramedics) to recognise 
and appropriately respond to stroke patients.
RECOMMENDATION 5.19
Emergency stroke treatment by a consultant stroke physician should be available on a  
24-hour, 7-day basis to all acute stroke patients within each stroke network.
When it is not feasible to transport the patient within the timeframe for emergency evaluation 
and treatment with thrombolysis, tele-medicine supported by an on-call consultant stroke 
physician should be available. This emergency treatment will be developed on an incremental 
basis.
Lead organisation: HSE
The introduction of emergency stroke thrombolysis within 180 minutes of stroke onset as the standard 
of care for eligible patients will require a reconfiguration of services in order to provide access to brain 
imaging and a consultant stroke physician within 180 minutes of the onset of symptoms on a 24-hour 
7-day basis. While some acute general hospitals may provide a partial stroke thrombolysis service (e.g. 
9-5pm, Monday-Friday), it is unlikely that the capacity to provide 24-hour 7-day consultant-delivered 
thrombolysis will exist at most general stroke centres. For audit and quality assurance purposes, and 
because future emergency treatments may require sophisticated brain imaging unavailable at these 
hospitals (e.g. diffusion-perfusion MRI), joint provision of emergency stroke care by a network of 
hospitals acting as general and comprehensive stroke centres is considered to be the optimal model 
of care (see Recommendation 5.20). Proposals to deliver this service may include rotation across the 
network, specialist-supported tele-medicine and out-of hours regionalisation. Future delivery of a  
24-hour 7-day emergency stroke thrombolysis service will require formal agreement and clear 
protocols within each stroke network. The most suitable model for such a development will depend 
on factors such as geography and location of hospitals.
RECOMMENDATION 5.20
Each stroke network should agree a model of service delivery to meet the need for a  
24-hour 7-day thrombolysis service.
Clear protocols and patient pathways should be identified, implemented and reviewed on a 
regular basis.
Lead organisation: HSE
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3.   Hospital in-patient stroke rehabilitation
Reviews of stroke rehabilitation provide firm evidence that organised, specialist in-patient care, such 
as provided in a stroke unit, is associated with improved outcomes (Young and Forster, 2007; Stroke 
Unit Trialists’ Collaboration, 2001). Stroke rehabilitation is addressed in Chapter 6, but some issues are 
highlighted here in relation to acute hospital care.
Stroke rehabilitation starts soon after admission and should be continued throughout the patient’s 
hospital stay. Early rehabilitation for all stroke patients should occur in a stroke unit, as an integral 
component of the work of the unit. This permits the multidisciplinary team to efficiently care for 
patients across the spectrum – from emergency assessment to discharge from hospital. The team can 
also act as a locus of expertise on stroke care for the population it serves.
Where the capacity of the unit providing emergency and early acute care is not adequate to 
accommodate early hospital in-patient rehabilitation, the stroke rehabilitation unit should be located 
as near as possible to the acute unit, using integrated care protocols and holding regular patient-
focused multidisciplinary team meetings. These principles are particularly important where this phase 
of hospital in-patient rehabilitation is provided off-site.
Rehabilitation involves speech therapy, occupational therapy and physiotherapy working as a 
team, building on assessments done soon after admission, setting goals and reviewing them along 
with medical and nursing staff during meetings of the multidisciplinary team. Integrated care 
should be provided by the multidisciplinary team, implementing localised protocols of care (see 
Recommendation 5.21). Protocols for multidisciplinary team care should include acute assessment and 
early mobilisation. Goals for rehabilitation should be discussed with the patient and progress reviewed 
at multidisciplinary team meetings.
Rehabilitation provides opportunities for communication about stroke and about the person’s 
progress towards recovery. The provision of information should be addressed in care protocols and 
recorded to ensure that patients and carers are provided with timely and appropriate advice on all 
aspects of the patient’s condition, including:
• aetiology and prevention of stroke;
• basic care, such as lifting and management of medication;
• management of disabilities, use of equipment, communication difficulties;
• finance and access to additional information;
• further rehabilitation and care when the patient leaves the acute hospital.
Guidelines on the location and delivery of early assessment and in-hospital rehabilitation are 
described further in Chapter 6.
RECOMMENDATION 5.21
Evidence-based guidelines and protocols of care should be developed and adopted for acute 
and rehabilitation management of stroke patients.
Lead organisation: Irish Heart Foundation, in association with Department of Health and Children, 
HSE and HIQA
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Discharge from the acute hospital
While most patients with stroke are discharged to their own home, some are transferred to another 
in-patient setting, either for intermediate rehabilitation or for long-stay care in a nursing home or 
long-stay hospital. The place to which the patient is transferred depends on the level of residual 
impairment, but also on the availability of carers and on the suitability and potential for adaptation of 
the patient’s home.
The transition from the care of the staff in the acute hospital is a major landmark in the journey to 
recovery for the patient with stroke. The timing of discharge and requirements for continuing care 
are closely related to functional recovery and residual impairment and independence, or potential to 
regain independence, in activities of daily living. The Irish National Audit of Stroke Care (INASC) found 
that many patients and carers did not know who to contact in the hospital if problems arose after 
the patient left hospital (Horgan et al, 2008). Protocols of care should include providing details to 
patients of who to contact (e.g. a stroke liaison nurse) should they require help in the early days and 
weeks after leaving hospital. Preparation for discharge should begin as soon as the likely discharge 
scenario is apparent (see Recommendation 5.22). Clear structures and protocols should be in place 
for collaboration between stroke network staff who are hospital-based and those in the community, 
including staff in primary care teams. Community liaison staff are required in each stroke centre, 
including a medical social worker and stroke liaison nurse.
RECOMMENDATION 5.22
Patients should have a full needs assessment prior to admission to hospital, aiming to 
support discharge home or to their place of residence.
Placement in long-term care should only be considered on the basis of medical or social need, 
rather than as a result of inadequate community services and facilities.
Lead organisation: HSE
4.   Transient ischaemic attack
Transient ischaemic attack (TIA) represents an important warning symptom of stroke and an 
opportunity to intervene to prevent the condition developing. Up to 30% of stroke patients have a TIA 
before their stroke, the majority in the preceding week. The risk of stroke after a TIA may be as high 
as 8% in the first week and 20% at 90 days. Approximately 2,500 patients are assessed in hospitals in 
Ireland each year with suspected TIA (as estimated from HIPE and the North Dublin Population Stroke 
Study data). Symptoms can be difficult to recognise for patients and carers, and can be a diagnostic 
challenge for staff. Because pain is not a feature of TIA, it may often be dismissed or its significance 
misunderstood by patients. However, early investigation and treatment of TIA can prevent stroke.
Available evidence suggests that same-day assessment and treatment by a consultant stroke 
physician-led team can prevent stroke and this is now a European Stroke Organisation standard 
of care (see Recommendation 5.23). Same-day rapid access TIA clinics allow appropriate diagnosis 
and risk stratification of suspected minor stroke and TIA. This service model has substantial proven 
benefits in preventing stroke in high-risk ambulatory patients, often avoiding hospital admission. 
These patients must be treated according to evidence-based protocols and pathways, and have access 
to specialist opinion, carotid imaging, other diagnostic investigations and facilities for immediate 
hospital admission when required. Where daily clinics are not possible in a hospital, rotating the clinics 
Changing Cardiovascular Health:  National Cardiovascular Health Policy 2010 – 2019
102
between hospitals in the stroke network is a possible solution. If appropriately resourced rapid access 
TIA clinics are not available, patients with suspected TIA should be admitted to hospital.
After clinical and diagnostic assessment, patients should be given a diagnosis, commenced on anti-
platelet medication where appropriate and have their vascular risk factors identified and treated. Access 
to early carotid endarterectomy is essential for symptomatic carotid artery stenosis in cases of TIA and 
minor stroke, requiring clear pathways of referral to vascular surgery units and operations completed 
within 2 weeks. All patients with a recent TIA should have access to lifestyle advice, including healthy 
diet and exercise, and where required smoking cessation support and treatment. In addition, all TIA 
patients should be advised not to drive or fly until it is formally deemed medically suitable to do so.
RECOMMENDATION 5.23
Patients experiencing transient ischaemic attacks (TIAs) should be referred to consultant-
led, same-day, rapid-access TIA/stroke prevention clinics with appropriate diagnostic 
and management facilities, including secondary prevention advice, pharmacological 
management and access to vascular surgery, where needed, within 2 weeks.
Clear pathways of referral and use of risk stratification are needed to identify high-risk patients 
and aid ‘immediate admission’ decisions to be made in primary care and in emergency 
departments.
Lead organisation: HSE
Carotid stenosis and carotid endarterectomy
An estimated 20% of ischaemic stroke is due to emboli from high-grade carotid stenosis, with a 
smaller contribution from carotid occlusion. Carotid disease may be asymptomatic, symptomatic 
or remotely symptomatic, reflecting the dynamic nature of atherosclerotic plaque formation, 
inflammation, rupture, thrombus formation and healing by fibrosis and calcification.
The degree of carotid stenosis is most commonly calculated by Doppler ultrasound estimation of 
velocities in the common carotid and internal carotid arteries. Research evidence strongly supports 
the benefits of surgery over medical management alone in symptomatic moderate-to-severe (70%-
99%) carotid stenosis to reduce the incidence of recurrent neurovascular events (TIA and stroke) (see 
Recommendation 5.24). The absolute risk reduction in stroke varies from 15%-21% over 2 years. This 
benefit is greatest when carotid endarterectomy is performed within 2 weeks of symptoms, with no 
significant benefit for carotid endarterectomy if patients wait 3 months. A smaller benefit of carotid 
endarterectomy over best medical treatment is also demonstrable in moderate stenosis (50%-69%), 
but not in mild stenosis (<50%).
Asymptomatic carotid artery disease is a risk factor for stroke, with an estimated annual risk of 
stroke of 4%. Carotid endarterectomy in asymptomatic patients has been shown to halve this risk in 
randomised controlled trials, but this was before strategies for intensive medical treatment were fully 
developed. Selection of high-risk patients (predominantly older men with a low intraoperative risk and/
or demonstrable microemboli on trans-cranial Doppler, unstable plaque morphology) ensures most 
benefit from surgical intervention. Carotid stenting or angioplasty may have a role in reducing risk of 
stroke where carotid endarterectomy is technically difficult or where operative risk is prohibitively high. 
Its application as a wider strategy for stroke prevention in carotid disease is still being evaluated.
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RECOMMENDATION 5.24
Clinical management of carotid disease should involve the following:
• All patients with recent TIA or non-disabling stroke should have urgent ipsilateral carotid 
assessment by Doppler ultrasound or CTA/MRA. Carotid endarterectomy should be offered 
to all patients with symptomatic moderate-to-severe (70%-99%) carotid stenosis and 
performed within 2 weeks of symptoms.
• Patients with asymptomatic moderate-to-severe carotid stenosis should be considered for 
carotid endarterectomy on a case-by-case basis and have a full risk assessment, including 
TCD monitoring/intima medial thickness measurement.
Organisational management at stroke network level should involve the following:
• Defined care pathways with vascular surgery units experienced in performing carotid 
endarterectomy.
• Access to expertise in carotid imaging and vascular surgery.
• Decision-making forum about surgical intervention to incorporate multidisciplinary 
neurovascular meetings involving geriatricians/stroke physicians, neurologists, vascular 
technicians, neuroradiology and vascular surgeons.
• Regular audit of carotid interventions to ensure high standards; this could contribute to a 
national register of carotid surgery.
Lead organisation: HSE, in collaboration with Irish Association of Vascular Surgeons and other 
relevant professional organisations
ORGANIsATION OF HOsPITAL sERvICEs FOR sTROkE
Similar to cardiac networks outlined above (see ‘Organisation of specialist cardiac services’, see p. 90), 
it is proposed that hospital stroke services be configured into stroke networks, with a number of 
hospitals working together to provide the comprehensive range of services needed for optimal 
stroke care, working closely with community services (see Recommendation 5.25). The stroke 
network would consist of a series of general stroke centres, with associated comprehensive stroke 
centres (see Appendix 4 for an overview of relationships within stroke networks). One or more hospitals 
(comprehensive centres) within the partnership will provide acute services for the network, i.e. 
services that are not expected to be available at all hospitals. It is proposed that each network would 
have at least one comprehensive stroke centre, with general stroke centres in other acute general 
hospitals. Certain services would be provided in one location on a network level, in some cases 
providing national specialty care.
RECOMMENDATION 5.25
specialist stroke services should be organised into population-based stroke networks, with 
network hospitals designated as (i) General stroke Centres or (ii) Comprehensive stroke 
Centres.
A broad plan for service reconfiguration needs to be developed. This will identify general 
and comprehensive stroke centres and allow service planning – involving workforce and 
emergency service development in particular – to evolve within the new network structure.
Lead organisations: HSE and Department of Health and Children
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Stroke networks will be configured on an approximate ratio of one network per 500,000 population, 
depending on geography and population density, and in line with current regional health service 
reconfiguration plans.
specialist stroke services provided on a network basis
Services provided on a network basis will include a stroke prevention service and a same-day TIA 
service, emergency thrombolysis for eligible patients, advanced diagnostics, vascular surgery and 
comprehensive rehabilitation. Given the complexity of stroke and vast array of complications, networks 
may involve rotation of clinics, tele-medicine support for hospitals serving remote areas and off-site 
rehabilitation. Certain services will be provided on a national or network comprehensive centre level, 
such as vascular neurosurgery, interventional radiology, neuropathology and the services of the 
National Rehabilitation Hospital. Box 3 outlines the services provided at a general and comprehensive 
stroke centre level within each network.
box 3:   stroke networks: Roles of hospitals designated as general and 
comprehensive stroke centres
GENERAL sTROkE CENTREs
Role: To provide sub-acute and chronic care services.
services provided:
•      Care for patients ineligible for thrombolysis as well as providing limited thrombolysis for 
suitable patients and multidisciplinary rehabilitation and general prevention.
•      Work with pre-hospital emergency services to determine emergency stroke thrombolysis 
appropriate to individual patient circumstances.
•     Triage and transfer of eligible acute stroke patients for emergency thrombolysis.
•     Provide diagnosis and treatment of other sub-acute and chronic cardiovascular conditions.
•     Provide secondary prevention advice, rehabilitation and palliative care.
Facilities needed:
•      A mixed acute/rehabilitation stroke unit or separate acute and rehabilitation stroke 
units. These must also be adequately resourced with appropriate medical, nursing and 
rehabilitation staff (including physiotherapy, occupational and speech/language therapy) 
and sufficiently large to allow capacity for direct admission from the emergency department 
and allow treatment of all stroke/TIA patients.
•      Core diagnostic infrastructure: CT brain imaging, carotid imaging (may be performed by CT 
carotid angiography, carotid ultrasound or MRI angiography), trans-thoracic echocardiography 
and 24-hour ECG recording, videofluoroscopy imaging for swallow assessment.
•      Emergency stroke thrombolysis may be provided by some general stroke centres within 
working hours or at nights/weekends as arranged within the stroke network.
•      Tele-medicine facilities may be required by some general stroke centres, particularly those at 
some distance from the comprehensive hospital or serving geographically remote areas.
•      Close liaison and integration with community services, including community rehabilitation, 
by medical social work, stroke liaison nurse and rehabilitation staff.
•      Stroke/TIA clinics. Some general stroke centres may provide same-day rapid access TIA clinics.
continued
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COMPREHENsIvE sTROkE CENTREs
Role: To provide acute care services.
services provided:
•      24-hour 7-day thrombolysis; MRI; vascular surgery; multidisciplinary rehabilitation; assess, 
treat and return protocol; rapid access TIA clinic; cardiac assessment; carotid artery stenting; 
tele-medicine support.
Facilities needed (in addition to those available in general stroke centres):
•      Acute and rehabilitation stroke units must be adequately resourced with appropriate 
medical, nursing and rehabilitation staff. There must be sufficient capacity for direct 
admission of all patients with suspected stroke from the emergency department and for 
patients transferred from other hospitals in the network when required.
•      Facility for same-day rapid specialist assessment of suspected minor stroke and TIA,  
as in-patient or out-patient, including protected access to diagnostic investigations and  
beds for selected patients requiring admission for observation and monitoring.
•      Emergency stroke thrombolysis to the population served by the comprehensive hospital 
and a stroke thrombolysis service to the population served by general stroke centres within 
the network as required (24-hour 7-day or nights/weekends/leave coverage, depending on 
specific arrangements in individual hospital networks).
•      Expertise frequently required by stroke patients, including neurology, rehabilitation 
medicine, neuropsychology, neuroradiology (including diagnostic neuroradiology and some 
interventional neuroradiology procedures, e.g. intra-arterial thrombolysis, carotid stenting), 
vascular surgery, neuro-intensive care beds, related care needs (e.g. dialysis), interventional 
cardiology (e.g. patent foramen ovale closure, coronary stenting), dietetic services.
•      Access to relevant diagnostic investigations: CT and MRI imaging, carotid duplex ultrasound, 
trans-thoracic and trans-oesaphageal echocardiography, prolonged cardiac rhythm 
monitoring, advanced diagnostic imaging (neurovascular MRI, invasive cerebral angiography, 
trans-cranial Doppler ultrasound).
•      Tele-medicine/video-conference facilities will be required by many network hospitals to 
provide links to general stroke centres in the stroke network and to comprehensive and 
national specialty services.
•     Community liaison staff, including medical social workers and stroke liaison nurses.
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box 3: stroke networks (continued)
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EMERGENCY REsPONsE FOR ACuTE CARDIOvAsCuLAR EvENTs
Emergency response services
Recommendations for best practice in the emergency treatment of acute cardiac and cerebrovascular 
events, as outlined above, highlight the importance of rapid onset of treatment (in particular 
thrombolysis and primary PCI). Detailed recommendations for the development of the emergency 
services and in cultivating an integrated emergency medical service community response were 
outlined in the 2006 report of the Task Force on Sudden Cardiac Death (Department of Health and 
Children, 2006) (see Recommendations 5.26 and 5.27). Much progress has been made since then on 
the configuration of services and on education and training in emergency medical response and 
intervention for both priority healthcare staff and in the auxiliary, voluntary and community sectors.
A single National Ambulance Service has been established within the HSE. Over 170 advanced 
paramedics have been introduced. Dublin Fire Brigade has deployed advanced paramedics in a rapid 
response vehicle in Dublin. The HSE has implemented the strategic deployment of, and thrombolysis 
by, advanced paramedics in the North East Region. However, their strategic deployment nationally is 
still awaited, as is the implementation of pre-hospital thrombolysis nationally.
Public awareness and response
One of the most important impediments to good outcomes in AMI is the time taken to initiate help-
seeking by the patient or member of the public. This is still unacceptably long in Ireland (Doyle et al, 
2005). Reducing delay is equally important for improving outcomes in people who develop ventricular 
fibrillation or stroke. At community level, first-responder programmes, basic life support training and 
training in the use of automated external defibrillators have been rolled out in certain community, 
voluntary and school settings. However, implementing national roll-out of training in the community 
is required, involving strategic and national involvement of the Gardaí, the retained fire services and 
auxiliary and voluntary services, and providing comprehensive basic life support training in all schools.
More generally, the lack of public awareness about the warning signs of cardiovascular conditions 
must be addressed as an important contribution to reducing mortality and morbidity. For example, 
recent Irish research suggests poor recognition of symptoms of stroke (Hickey et al, 2009). Public 
education is challenging and lessons from international experience are needed to inform any effective 
education campaign.
sudden cardiac death
An estimated 5,000 people die every year in Ireland as a result of sudden cardiac death (SCD) 
(Department of Health and Children, 2006). Survival rates following cardiac arrest are directly related 
to time to resuscitation and, in particular, defibrillation. The ESC Task Force on SCD recommended a 
target time of 5 minutes for out-of-hospital cardiac arrest, i.e. from call to defibrillation (Priori et al, 
2001). It is therefore important that procedures are in place to enable rapid response and intervention 
in the community setting.
Regional evaluation of an out-of-hospital cardiac arrest register (OHCAR) has been implemented in 
the HSE North West Region and national roll-out is being planned. A national electronic patient-care 
record (ePCR) has also been implemented in the HSE North East Region, with plans ultimately for 
107
national roll-out; the ePCR includes live data links between ambulance control stations, vehicles and 
hospital emergency departments. Spatial analysis research has been undertaken to inform ambulance 
service and community response developments. However, national collection, collation and analysis 
of pre-hospital data needs to be implemented as a matter of urgency. This should include analysis of 
regional variation and of equitable access to emergency services.
Since the publication of the report by the ESC Task Force on SCD (Priori et al, 2001), evidence-based 
educational standards have been developed by the Pre-Hospital Emergency Care Council. These 
include the Cardiac First Response standard, the first statutory standard for Basic Life Support and 
Automated Advisory Defibrillator Use in Ireland. In addition, clinical practice guidelines have been 
developed to support delivery of cardiac interventions by emergency medical technicians, paramedics 
and advanced paramedics.
RECOMMENDATION 5.26
This policy endorses the recommendations of the Task Force on sudden Cardiac Death (2006) 
for the development of emergency medical service capacity to respond and deliver timely 
acute cardiovascular care.
The following initiatives are seen as having the highest priority within the new network 
structures:
• Strategic deployment of advanced paramedics and implementation of pre-hospital triage 
and cardiac thrombolysis nationally.
• Prioritised national roll-out of the electronic patient-care record in order to guide 
emergency medical services in the collection, collation and analysis of pre-hospital data.
• National roll-out of information systems, including the out-of-hospital cardiac arrest 
register, the register of sudden cardiac deaths in young people, and the general patient 
electronic patient-care record.
• Integration of emergency medical service activities through coordinated approach to the 
participation of auxiliary and voluntary services, Gardaí and retained fire services.
• Improved first response and therefore survival from cardiac arrest through development, 
coordination and integration of the emergency medical service with co-responder 
networks (auxiliary and voluntary services, Gardaí and retained fire services) and 
community first-responder programmes across the country.
Lead organisation: HSE, in association with Irish Heart Foundation
RECOMMENDATION 5.27
Increase the proportion of the public who are aware of the major signs and symptoms 
of acute cardiovascular events (e.g. ACs, TIA and stroke), who know the importance of 
immediately contacting ambulance services and who are skilled in basic life support.
A public education campaign should be undertaken to raise awareness of the symptoms of 
acute cardiovascular events and of the need to take urgent and appropriate action. In parallel, 
basic life support training in schools could help develop an upcoming generation with greater 
awareness and skills in this area.
Lead organisation: HSE, in association with Irish Heart Foundation
 Hospital and Emergency Care Services
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6.    CARDIAC AND sTROkE REHAbILITATION  
AND CONTINuING CARE
Rehabilitation is the phase following acute medical intervention, during which structured approaches 
to halt or slow progression of the underlying health condition are undertaken and where the patient 
is enabled to return to an optimal level of physical, psychological and social well-being. Rehabilitation 
goals focus on recovering lost function and reconditioning, reducing the risk of a recurrent event 
(secondary prevention) and optimising quality of life. To be effective, rehabilitation must start as soon 
as the patient is stabilised in the acute medical setting. Rehabilitative care should be integrated across 
acute, out-patient and community services, to include access to both intensive acute rehabilitation and 
long-term follow-up. The ambitions for seamless and comprehensive rehabilitation and continuing care 
services for cardiovascular patients as outlined in this policy are consistent with the current objective of 
transferring care as appropriate from acute hospitals to community services, including via rehabilitation 
in-patient/out-patient services when disability is severe. The rehabilitation perspective considered in 
this policy will complement a specific National Policy and Strategy for the Provision of Neuro-Rehabilitation 
Services in Ireland 2010-2015, to be published by the Department of Health and Children/HSE during 2010.
A review of secondary prevention profiles of almost 14,000 community-dwelling coronary (AMI and 
revascularisation) patients in 22 European countries in 2005/06 (EuroASPIRE III) showed that most did 
not meet professional targets for cardiovascular prevention in clinical practice (Kotsova et al, 2009). 
Furthermore, the general profile has disimproved since previous surveys, with increasing obesity and 
diabetes, along with high rates of hypertension, signalling the ongoing need for structured delivery 
of rehabilitation and prevention to achieve recommended lifestyle, risk factor and therapeutic targets. 
The challenges are similar for preventive targets for stroke patients. For example, a major UK study of 
male stroke survivors found that only one-third were on the appropriate evidence-based profile of 
medication (Ramsay et al, 2007).
For patients with coronary heart disease, rehabilitation is offered in the form of structured ‘cardiac 
rehabilitation’ programmes, delivered by a multidisciplinary team. The aim is to improve physical 
and psychological function, with a focus on secondary prevention and lifestyle modification. Cardiac 
rehabilitation is characterised by a continuum of rehabilitation services that spans in-patient (Phase I), 
early out-patient (Phase II), medium-term out-patient (Phase III) and ongoing community rehabilitation 
(Phase IV). Phase III (typically a structured 8-10 week out-patient rehabilitation programme) is the 
main component of out-patient cardiac rehabilitation as delivered in Ireland. Out-patient cardiac 
rehabilitation includes assessment, review and follow-up; low or moderate intensity physical activity 
and exercise training; and education, discussion and counselling in relation to lifestyle and risk factor 
modification. Attendance at structured out-patient cardiac rehabilitation programmes should start 
soon after discharge from hospital, ideally within the first month (Saner et al, 2003).
Stroke patients need support similar to cardiac patients for lifestyle and risk factor modification. 
However, stroke can also incur serious motor, sensory, cognitive or communication deficits, and 
many stroke survivors are left with severe long-term disabilities. Stroke rehabilitation is essential for 
minimising the overall burden of stroke for the stroke survivor and the family/caregiver, and also for 
the healthcare system. A specialist multidisciplinary stroke team is required to deliver comprehensive 
rehabilitation, whether in hospital or in the community. The care pathway for people with stroke must 
include access to both intensive acute rehabilitation and long-term follow-up. Hospitals admitting 
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stroke patients should have in-patient rehabilitation in a stroke unit, with associated day service and 
out-patient units to facilitate patients to progress through an integrated service. Initial rehabilitation 
assessment should occur within the first 24 hours of admission or as soon as feasible according to 
the patient’s condition. Secondary prevention should be incorporated in a structured manner within 
stroke rehabilitation.
Until now, rehabilitation services for cardiac, stroke and other vascular conditions have mostly been 
considered as separate entities, in Ireland as elsewhere. This is despite their common philosophies 
of integrated delivery of care to address individual patient needs, their shared aims of improving 
physical function and reducing risk of a further vascular event, and their overlapping expertise. In 
line with the philosophy of this report, development of the rehabilitation potential of the Irish health 
system needs to be considered as a single task. Figure 7 illustrates the hierarchy of rehabilitation 
activities, ranging from (top) those activities that should be available to all cardiovascular patients 
who have achieved ambulatory status, to (bottom) more specialist rehabilitation services needed 
by the minority with serious and very individualised needs. Conceptualising a common pathway 
does not negate the importance of disease-specific training and expertise. Disease-specific 
rehabilitation programmes deliver rehabilitation expertise via multidisciplinary teams. Those who 
work in rehabilitation programmes require disease-specific training. In Ireland, cardiac rehabilitation 
is directed by cardiologists and stroke rehabilitation by a combination of specialists in geriatric and 
general medicine, rehabilitation medicine and neurology. Service delivery needs to be fully integrated 
throughout the system. The cardiac rehabilitation system is currently more developed, but the 
increasingly rapid pace of throughput of patients in the in-patient system challenges the delivery of 
early rehabilitation. As acute stroke intervention develops, an integrated comprehensive stroke service 
will be able to deliver the rehabilitation phase.
Figure 7: Hierarchy of rehabilitation phases – from services for all ambulatory cardiovascular 
patients to services for severely compromised patients
Cardiac and Stroke Rehabilitation and Continuing Care
Structured support for adopting healthy lifestyle
(smoking, nutrition, physical activity, stress
Vocational counselling, medication adherence
Education and counselling 
about cardiovascular disease
Restoring lost 
physical function
Communication/
Cognitve function
All ambulatory cardiovascular 
patients with priority functional 
needs addressed
All cardiovascular patients 
once priority functional needs 
are addressed
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severe stroke/Class III heart 
failure
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To make recommendations for service development, it is first necessary to outline the present status 
of rehabilitation services for both cardiac and stroke populations since there have been very different 
developments to date in each.
CARDIAC REHAbILITATION
Cardiac rehabilitation programmes have been thoroughly evaluated, with robust clinical trials 
evidence showing that they reduce mortality and morbidity, increase quality of life and are cost-
effective (Taylor et al, 2004). Cardiac rehabilitation programmes are, in effect, the quintessential 
chronic disease management programme for hospitalised patients. Thus, apart from provision of 
services to cardiovascular patients, consideration should be given to the potential wider contribution 
of the cardiac rehabilitation context as a mechanism for delivering on the Department of Health and 
Children’s (2008a) recently developed policy framework for the management of chronic disease.
Cardiac rehabilitation was addressed in the first national cardiovascular health strategy, Building 
Healthier Hearts (1999), with 10 recommendations ranging from service provision to national training 
and audit systems. When Building Healthier Hearts was launched, the necessary environmental 
enablers were in place to deliver on its recommendations. Pioneering activities outside of formal 
service delivery commitments, such as initiatives to train specialist coordinators in the 1990s, meant 
that a group of trained coordinators could be deployed to establish services in accordance with 
international guidelines. While services had been in development in Ireland since the mid-1970s, 
cardiac rehabilitation programmes were available in only 29% of relevant hospitals in 1998. This 
increased to 95% by 2005, with a three-fold increase in staff and six-fold increase in patients receiving 
a service (Delaney et al, 2006). All centres now have programmes. Cardiac rehabilitation was thus a 
notable success of the first cardiovascular health strategy. 
Current status of cardiac rehabilitation services in Ireland
In recent years, there has been a loss of momentum in relation to programme development in cardiac 
rehabilitation. What was a significant national service achievement for the early part of this decade 
is now a very overstretched service, at risk of under-coverage of the increased population who need 
the service. Instead of being weakened, cardiac rehabilitation urgently needs to move from a phase 
of establishing programmes to one of ensuring all who can benefit will be able to do so, in keeping 
with the 2008 chronic disease management national framework (Department of Health and Children, 
2008a). It has been estimated that approximately half of those who could benefit are currently 
enrolled, compared to 8% coverage in 1996 (Delaney et al, 2006; Jennings and Carey, 2003). In terms 
of setting targets, the UK National Service Framework has set a target of 85% of relevant groups being 
offered cardiac rehabilitation services (NSF, 2000).
The evidence shows that most patients invited to attend a cardiac rehabilitation programme do so and 
most continue with the programme once initiated. Thus the block to service delivery is invitation and 
enrolment. Many centres (11 of 35 surveyed in 2005) are staffed by only one individual, with only 24 of 
35 having dedicated facilities. Evidence suggests that other growing patient groups with challenging 
needs, such as heart failure or peripheral arterial disease, may benefit from participation in tailored 
multidisciplinary rehabilitation programmes (Corra et al, 2003; Ashworth et al, 2005; Jeger et al, 2008). 
However, cardiac rehabilitation services have generally not been able to accommodate these patient 
groups because of staff and resource constraints (Saner et al, 2003; Delaney et al, 2006). 
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In sum, although there has been an expansion of cardiac rehabilitation services, many services are 
staffed by one individual, without dedicated facilities and without administrative support. These 
centres need to be supported and developed (see Recommendation 6.1). On the positive side, the 
current set of cardiac rehabilitation programmes across all relevant hospitals does provide core 
expertise and an important basis for a harmonised cardiovascular rehabilitation system in many 
hospitals.
Prevention programmes in community settings for cardiovascular patients
Community settings are the appropriate source of preventive activities, such as education and lifestyle 
support, for individuals identified as having high cardiovascular risk and those who have attended 
hospital-based rehabilitation programmes following acute events or interventions. Until now, the 
needs of these two groups have been addressed separately, if at all (see Recommendation 6.2). 
For post-coronary event or intervention patients, community-based Phase IV cardiac rehabilitation 
programmes aim to facilitate long-term maintenance of lifestyle changes and monitoring of risk 
factors and secondary prevention, following participation in a structured (Phase III) hospital out-
patient programme. Such programmes provide an ongoing opportunity for patients to maintain 
supported physical activity and other advised lifestyle changes in the community. Many Phase IV 
programmes have physical activity as a central component and provide exercise programmes in 
supervised community environments. In the UK, many Phase IV exercise classes operate in leisure 
centres or similar settings. This facilitates discharge from the hospital setting following completion of 
a Phase III cardiac rehabilitation programme. In these settings, supervision is provided by members of 
the Register of Exercise Professionals, who must have completed a dedicated Phase IV training course 
of the British Association of Cardiac Rehabilitation. In Ireland, community-based Phase IV cardiac 
rehabilitation has not been formally established. However, a training programme for gym instructors 
has been developed in conjunction with the Irish Association of Cardiac Rehabilitation: 20 gym 
instructors have been trained to professional standards, legal and insurance issues have been clarified, 
and Phase IV classes have commenced in 5 centres across the country.
Essential and complementary to Phase IV cardiac rehabilitation is the secondary prevention 
programme in GP/primary care, where the emphasis is on improvement in risk factors and the 
attendant pharmacological treatments. On the recommendation of the first cardiovascular health 
strategy, a programme called HeartWatch, involving 20% of GPs and a specified cohort of established 
coronary heart disease patients, was set up to achieve these secondary prevention goals. At this point, 
a model addressing all patients who can benefit, including high-risk patients (as specified in the  
ESC Clinical Practice Guidelines – Graham et al, 2007), is needed to provide proactive and cost-effective 
cardiovascular care to maximise life expectancy and quality of life.
Also in the primary care setting, a GP exercise referral scheme for high cardiovascular risk patients 
has been underway as a demonstration project in the HSE South Region. A wide range of preventive 
activities is provided in these settings to comprehensively address the range of cardiovascular 
risks. Health promotion staff cover smoking cessation, physical activity and dietetics, and provide 
individualised services as well as supporting other community-based staff. The community pharmacist 
also plays a role in promoting adherence to medication in this group of patients.
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Until now, little attention has been given to coordinating these activities within the community 
sector. Furthermore, focusing attention on the individuals identified as having high cardiovascular 
risk, alongside those who have been provided with early hospital-based rehabilitation following acute 
events or interventions, is now important. Consequently, it is desirable that all community-based 
efforts to support individuals in developing and maintaining lifestyles consistent with preventive 
cardiovascular guidelines be united – whether they focus on individuals with high cardiovascular risk 
or established cardiovascular disease.
One model combining high-risk patients and those with established coronary heart disease is the 
EuroAction model developed to support patients to achieve the lifestyle, risk factor and therapeutic 
targets defined in the ESC Prevention Guidelines (Wood et al, 2008), This multidisciplinary, family-
based ambulatory programme demonstrated that participation resulted in greater lifestyle changes 
and improvements in risk factors for patients and their partners than those in usual care. The model 
addresses family lifestyle (including diet, physical activity and smoking), medication adherence and 
psychological and motivational factors, and is designed to be delivered in primary care settings by a 
multidisciplinary team, including a physician, nurse, physiotherapist and dietician. 
Building on these initiatives, it is proposed that ‘Prevention Services’ be established in the community 
setting, to provide coverage across a number of primary care teams and to be staffed by these 
teams with hospital linkages (see Recommendations 6.3-6.6). Staff would include members of the 
multidisciplinary team needed to run cardiovascular prevention activities, including links with 
referring physicians for pharmacological management. Participants could be high-risk individuals 
identified in risk assessment consultations, alongside those referred following completion of Phase III 
cardiac rehabilitation programmes and ambulatory patients from stroke and other vascular services. 
In time, such services could grow as models of prevention across the chronic disease spectrum, to 
include patients with diabetes and pulmonary diseases. The philosophy of such services would be 
to promote and maintain ‘wellness’, rather than to move clinical care activities out into a community 
setting. Supervised physical activity sessions would combine with programmes on topics such as 
healthy eating, stress management and smoking cessation. Staff time and expertise could be more 
efficiently used by providing such prevention support in group sessions rather than in individual 
sessions. Flexible timing of activities could also accommodate participants with scheduling challenges, 
such as employment or childcare. 
Demonstration services in at least two different geographic areas would provide valuable evidence 
on the delivery and effectiveness of these proposed ‘Prevention Services’ before considering more 
widespread establishment. Areas where Phase IV cardiac rehabilitation programmes or GP exercise 
referral programmes have been established should provide ‘early start’ models for such services.
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RECOMMENDATION 6.1
Ensure adequate and equitable coverage of cardiac rehabilitation for all eligible patients 
through investment in staffing and facilities in all relevant hospitals.
Eligible patients (i.e. ACS or coronary intervention patients and patients with heart failure 
and peripheral arterial disease) should be offered cardiovascular rehabilitation services. All 
programmes should have adequate facilities and be delivered by a multidisciplinary team, in 
accordance with agreed national standards.
Lead organisation: HSE
RECOMMENDATION 6.2
Cardiac rehabilitation should be an integral part of the spectrum of cardiac services in public 
and private healthcare settings.
Cardiovascular rehabilitation services are not routinely provided in private hospitals or 
reimbursed for private patients in public hospitals. This has significant implications for 
capacity and for access of patients in private hospitals to evidence-based care. A requirement 
for rehabilitation service provision, as a core component of evidence-based care, should be 
included in the HIQA-managed licensing requirements for acute hospitals.
Lead organisation: HIQA
RECOMMENDATION 6.3
Cardiac patients should have timely access to cardiac rehabilitation services.
Active early rehabilitation should commence in line with international professional guidelines. 
The early rehabilitation challenge is to deliver appropriate and adequate rehabilitation advice 
and support in the ever-shortening phase before hospital discharge of cardiac patients. 
The next main challenge is to commence Phase III cardiac rehabilitation as soon as possible 
– approximately one month post-discharge to optimise benefits. All cardiac patients should 
leave hospital with a formal plan for subsequent rehabilitation activities.
Lead organisation: HSE
RECOMMENDATION 6.4
Equity of access to services and models of care: A menu-driven system of delivering 
rehabilitation should be established to support equitable access for groups vulnerable to 
exclusion from traditional programmes.
Age, gender, education, income, distance from specialist services and transport availability,  
all mitigate against equitable access to cardiac rehabilitation programmes. Rehabilitation 
services must ensure that the particular physical, psychological, vocational and social needs  
of differing groups of patients are addressed.
Lead organisation: HSE
continued
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RECOMMENDATION 6.5
Models of care and patient preferences: Criteria should be established for the endorsement 
of different models of programme delivery, based on delivery of agreed cardiovascular 
targets.
A number of models of programme delivery exist, with variations on programme duration 
and emphasis. This is an area of ongoing debate and innovation. From a service perspective, 
all models of programme delivery should audit their output against agreed short-term targets 
(programme end) and long-term targets (one year).
Lead organisations: HSE and Irish Association of Cardiac Rehabilitation
RECOMMENDATION 6.6
Ensure that cardiac rehabilitation services are effective and efficient through regular 
evaluation, with robust ICT systems and appropriate governance.
Eligible patients (i.e. ACS or coronary intervention patients and patients with heart failure 
and peripheral arterial disease) should be offered cardiovascular rehabilitation services. All 
programmes should have adequate facilities and be delivered by a multidisciplinary team, in 
accordance with agreed national standards.
Lead organisation: HSE, in association with Irish Association of Cardiac Rehabilitation
sTROkE REHAbILITATION
underlying principles
•    All patients with stroke will need multidisciplinary rehabilitation.
•     Rehabilitation needs to be tailored to patient need and may involve improving cardiovascular 
fitness; restoring physical, mental, communication and cognitive function and well-being; 
adaptation to loss of function and impairment of participation; treatment of associated co-
morbidity affecting function and prevention of further impairment; promoting a return to 
independent living and full participation in society; continuing assessment of patient and 
carer needs to sustain as full a quality of life as possible; and return to independent living.
•    The principles of good stroke rehabilitation apply to all ages. Most stroke patients are over  
65 years of age and many have multiple age-related co-morbidities. However, approximately 
30% are younger and many also have vascular risk factors and co-morbidities. Thus absolute 
age cut-offs for rehabilitation services in stroke are not acceptable – services must be 
responsive to patient need, regardless of age. 
•    Rehabilitation in stroke is multidisciplinary, involving medicine, nursing, physiotherapy, 
occupational therapy, speech and language therapy, psychology, dietetics and medical social 
work. 
•    Rehabilitation input in stroke is interdisciplinary and for stroke patients usually involves 
geriatric and general medicine, rehabilitation medicine, neurology and psychiatry as the main 
medical disciplines with clinical input.
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stroke rehabilitation services in Ireland
The first Irish National Audit of Stroke Care (INASC), carried out in 2006-07, found stroke rehabilitation 
services to be seriously inadequate, leaving many patients with potentially avoidable or unduly 
prolonged disability (Horgan et al, 2008):
•   Acute rehabilitation was only available to 1 in 4 patients or was delayed beyond the point at 
which it could be most effective. 
•   Less than half of stroke patients were seen by a physiotherapist within 72 hours of admission 
and only 1 in 4 had been assessed by an occupational therapist within 7 days of admission. 
•   There was little evidence of systematic management of secondary prevention targets before 
hospital discharge. 
•   Continuing care, long-term recovery programmes and community stroke services were 
haphazardly organised or did not exist. 
Most rehabilitation for stroke patients is provided through geriatric and rehabilitation medicine. Some 
stroke services are restricted on the basis of age, with limited access to intensive rehabilitation facilities 
for most people and a lack of age-appropriate physical and vocational rehabilitation services for 
younger patients and those with less severe strokes. Vocational services are also inadequate for older 
patients, many of whom were in employment or actively contributing to society in other ways prior to 
their stroke. 
Some patients with serious disability or complex needs post-stroke require specialist rehabilitation 
services. There is a current shortage of such services, involving rehabilitation medicine consultants, 
multidisciplinary rehabilitation teams, in-patient rehabilitation beds and out-patient treatment 
services. This leads to unacceptable delays in accessing specialist rehabilitation services.
Models for delivery of stroke rehabilitation services
The configuration of services is influenced by local demographic and geographic characteristics and 
the nature of existing healthcare facilities.
Acute care and early stroke rehabilitation: Patients in the early acute phase of stroke need a 
comprehensive multidisciplinary assessment of functional loss and therapeutic input to prevent 
complications (e.g. aspiration pneumonia, pressure sores, early spasticity and contractures). Most 
patients follow one or more of the following care pathways:
•   in-patient rehabilitation in the acute hospital setting or in a rehabilitation unit on-site;
•   return to own home, with hospital, community or home-based rehabilitation;
•   specialist in-patient rehabilitation on another site;
•   long-term residential care.
In-patient early stroke rehabilitation: Early acute stroke rehabilitation should occur within an acute 
or comprehensive stroke unit, delivered by a multidisciplinary team with input from geriatric and 
rehabilitation medicine and other specialist services as required (see Recommendation 6.7). Active 
rehabilitation should commence within the first 24 hours of admission post-stroke. There should be 
weekly multidisciplinary team meetings to review progress and update rehabilitation goals. 
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Stroke rehabilitation units should be properly resourced and staffed (see, for example, UK standards 
at: www.dh.gov.uk/en/Healthcare/Stroke/DH_081389). Similar standards of care should apply where 
patients are transferred to an on-site or off-site stroke or general rehabilitation unit. 
Transfer of patients to an off-site stroke or mixed rehabilitation ward facilitates access to the acute 
stroke unit for new patients and provides a less acute, more rehabilitation-focused environment for 
patients and their carers. Many stroke patients, however, will continue to experience ongoing neuro-
medical complications of stroke and non-acute rehabilitation units should have an appropriate 
specialty mix to address patient medical and rehabilitation needs, including liaison services from 
psychiatry, neuropsychology and neurology.
RECOMMENDATION 6.7
A multidisciplinary assessment of rehabilitation needs, using a formal procedure or protocol, 
should be completed within 5 working days of admission for stroke. An appropriate service 
plan should then be commenced.
Lead organisation: HSE
Out-patient and day hospital rehabilitation: Out-patient care may be in a day hospital setting or in 
specialised stroke rehabilitation units, such as in the National Rehabilitation Hospital, Dun Laoghaire, 
or Baggot Street Hospital, Dublin. A hospital-based out-patient setting with a transportation 
service is appropriate for those patients who are suitable for discharge, but still require substantial 
multidisciplinary team input. Complex cases may need a further period of regular medical follow-up 
or ongoing investigations, specialised rehabilitation facilities (e.g. orthoptic (visual) rehabilitation 
services, spasticity treatment, botulinum therapy, splinting or orthotics) and rapid access to 
diagnostics, specialist opinion and ongoing multidisciplinary input in a hospital environment.
specialist hospital-based rehabilitation units: For patients with very severe stroke, specialist 
rehabilitation units are needed to provide rehabilitation care as early as possible. Medically unstable 
patients continue to need the acute hospital to access facilities such as gastroenterological PEG 
insertion, ENT tracheostomy interventions and radiologically-guided video fluoroscopy. Shared  
24-hour 7-day clinical team cover is needed in order to facilitate transfer to in-patient rehabilitation 
managed care.
Acute hospital stroke rehabilitation units allow acute stroke units to improve throughput and admit 
new stroke patients. The presence of an on-site acute stroke rehabilitation unit facilitates the timely 
transfer from acute care to rehabilitation, with subsequent home discharge or onward transfer to 
rehabilitation in a non-acute hospital facility after a short in-patient phase. 
Experience elsewhere has demonstrated that 25-bed general rehabilitation units work well within 
a larger acute hospital setting. The number, size and location of specialist rehabilitative care of such 
units should be determined by a national policy that takes into account the needs for this level of care 
for patients with other conditions such as acquired brain injury. One such model is the development 
by the National Rehabilitation Hospital of a service at Beaumont Hospital, Dublin. It will cater for a 
range of neurological patients, including those with severe stroke referred for rehabilitation during 
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their in-patient stay in the acute hospital. A similar unit is being developed in Cork University Hospital. 
These units will be accessible by patients of all ages with complex rehabilitation needs. They will not 
be used for the type of in-patient rehabilitation required by most stroke patients prior to discharge 
from the acute hospital setting. The forthcoming National Policy and Strategy for the Provision of  
Neuro-Rehabilitation Services in Ireland 2010-2015, to be published in 2010 by the Department of Health 
and Children/HSE, will provide guidance on the development of further units and on the size of such 
units to meet the needs for intensive in-patient rehabilitation.
Early supported discharge
As recommended in Chapter 5 on acute hospital services for stroke (see Recommendation 5.22), each 
patient should have a full needs assessment, aiming to support discharge home or to their place of 
residence prior to admission to hospital. Placement in long-term care should only be considered on 
the basis of medical or social need, rather than as a result of inadequate community services and 
facilities. People with mild-to-moderate levels of disability achieve at least equivalent outcomes 
if, instead of receiving rehabilitation in the acute hospital setting, they are discharged to specialist 
and fully resourced rehabilitation teams. Advantages include a patient-centred discharge focus and 
reduced hospital stay. However, early discharge should only be considered where there are adequate 
community services for rehabilitation and carer support (Australian National Stroke Foundation, 2005). 
Care delivered in the community by multidisciplinary teams with rehabilitation and geriatric medicine 
inputs is recommended as best practice (see Recommendation 6.8). Hospital discharge for stroke will 
be informed by the wider Code of Practice for Integrated Discharge Planning, recently launched by the 
HSE (2008b).
RECOMMENDATION 6.8
For patients with stroke who are suitable for early supported discharge, resources and 
systems should be in place to facilitate early rehabilitation in a community setting, delivered 
by a multidisciplinary team with input from rehabilitation and geriatric medicine. This should 
begin with a full needs assessment.
Lead organisation: HSE
Community rehabilitation
Integration between hospital-based and community-based stroke services is essential to ensure 
quality of care, including the early detection of neuro-medical problems or functional decline needing 
more intensive input to prevent re-admission or discharge failures. Quality of life issues for people 
living with stroke, including return to work, management of long-term communication difficulties 
and spasticity, and the supports required for families and carers, can usually be addressed within the 
community setting. 
Comprehensive community rehabilitation should be developed to facilitate early supported discharge 
and to deliver maintenance rehabilitation programmes to people with stroke, at home or in a nursing 
home or other residential care location. This should be supported by a liaison rehabilitation medicine 
consultant service for specific catchment populations, as in other countries. Those organising 
delivery of community rehabilitation services should strive to find solutions that combine the patient 
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and family preferences with high-quality care. In addition, a comprehensive transport system for 
people with mobility problems following stroke is essential to facilitate access to community-based 
rehabilitation services from home or from long-term care locations (see Recommendation 6.9).
Ongoing/longer term rehabilitation
When a person with stroke has gained as much benefit as possible from the initial phase with the 
rehabilitation team, he or she should be transferred into the care of the GP and primary care team. 
A system of review (e.g. 6 months from hand-over) would serve to systematically identify residual 
problems and provide both the person with the stroke or other cardiovascular condition and their 
family with a link back to specialist services where indicated.
Those who require admission to residential care or ‘slow to recover’ units should have access 
to appropriate levels of rehabilitation, delivered by a multidisciplinary team with input from 
rehabilitation and geriatric medicine. The role of the community stroke team in extended care 
facilities includes setting up treatment programmes to manage the complications of chronic stroke 
and to educate relevant staff in the care plan. Therapy assistants can provide treatments in extended 
care facilities under the supervision of more experienced staff. For those in such facilities, a system 
of periodic review and active treatment phases from the community stroke team will maximise 
independence in mobility, communication and lifestyle. In addition, stroke patients should have 
access to secondary prevention and cardiovascular reconditioning programmes where applicable.
Some patients will transfer to, or return as prior residents to, a nursing home following stroke. The 
Irish National Audit of Stroke Care (INASC) showed that stroke patients were considered as effectively 
‘discharged from active care’ when transferred to nursing home care (Royston et al, 2007). Good quality 
stroke care in the community should also extend to those residents whose home is in a nursing home 
setting. The HIQA should include structured care for patients with stroke in their standards for nursing 
homes and long-stay care facilities, including a review of each patient’s needs (e.g. for physiotherapy, 
speech and language therapy, occupational therapy and neuropsychology) at least every 6 months.
Reintegration of people with stroke into the community
There is very little information on the profile of stroke patients in the community in Ireland (Horgan  
et al, 2008; Hickey et al, 2009). A pilot stroke rehabilitation programme found that participants did not 
maintain acquired levels of physical activity after one year (Lennon et al, 2007). Nonetheless, the social 
potential of structured physical activity sessions for patients following stroke living in the community 
was highlighted in the study. Expansion of the current Volunteer Stroke Service (VSS) would facilitate 
community reintegration for people with stroke; to become involved, participants may require 
enabling supports, such as transport (see Recommendation 6.9).
RECOMMENDATION 6.9
A partnership framework should be developed between the HsE and the voluntary sector to 
enable expansion of stroke rehabilitation support services and the provision of services, such 
as transport, where needed.
Lead organisations: HSE and Local Authorities
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Equity of access to rehabilitation and models of service
All stroke patients should have access to appropriate levels of rehabilitation regardless of age or 
location (see Recommendation 6.10). Rehabilitation services must ensure that the particular physical, 
psychological, vocational and social needs of differing groups of patients are addressed. This applies 
to younger patients (those under 65 years of age), who represent nearly one-third of those who have 
a stroke each year, as well as to the oldest patients, who benefit as least as much from focused stroke 
care and rehabilitation. For those in rural areas, efforts should be made to avoid fragmentation of 
services.
RECOMMENDATION 6.10
All stroke patients should have access to appropriate levels of rehabilitation, regardless of 
age or residential location.
Lead organisation: HSE
Integrated, patient-centred services to provide a continuum of care
Within each stroke network, acute hospitals should have stroke rehabilitation units with associated 
out-patient and day-service units to facilitate patient throughput, and good liaison with community 
health services. Care should be under the direction of both geriatricians and rehabilitation medicine 
specialists so as to manage and provide the continuum of care needed – from acute care to 
rehabilitation units and the community.  The forthcoming National Policy and Strategy for the Provision 
of Neuro-Rehabilitation Services in Ireland 2010-2015, to be published in 2010 by the Department of Health 
and Children/HSE, will address the complex neuro-rehabilitation needs of patients who require this 
and provide guidance on how these services should be integrated.
Given the particularly wide spectrum of rehabilitation needs following stroke, a key worker should 
be assigned to each person with stroke to develop an individualised discharge plan with the patient 
and carers, and to liaise between hospital and community services on behalf of the patient (see 
Recommendation 6.11). A discharge document on each patient should capture key information to 
facilitate seamless transfer of care from acute to community teams. There needs to be an effective 
interface between acute team and community teams. A single manager should be appointed for 
therapists between the hospital and community settings; this is consistent with plans to amalgamate 
the acute hospital and community services management structures of the HSE.
RECOMMENDATION 6.11
stroke rehabilitation services should be patient-centred, to include individual assessment 
of need and ongoing review, and coordinated by a key worker to ensure that rehabilitation 
is available as required on an ongoing basis. There needs to be a continuum of care from 
hospital to community. stroke rehabilitation services should be consistent with the broader 
neuro-rehabilitation service requirements as identified in the forthcoming National Policy and 
Strategy for the Provision of Neuro-Rehabilitation Services in Ireland 2010-2015.
Lead organisation: HSE
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AN INTEGRATED APPROACH TO CARDIOvAsCuLAR REHAbILITATION
At this juncture, there is much to be learned from experience with cardiac rehabilitation about 
building a comprehensive rehabilitation system for all cardiovascular patients. Components of a 
successful approach are most likely to include staff training and development; systematisation of 
programme delivery; resources for staff deployment; a forum for continuing professional development 
and exchange; mechanisms to share expertise; and audit. The phases of rehabilitation, starting with 
a hospitalised patient, are outlined in parallel for cardiac and stroke patients. While there may be 
different emphases, with stroke patients typically needing more individually tailored rehabilitation 
inputs, the principles of a rehabilitation programme tailored for the individual patient, with group or 
individual therapeutic inputs as appropriate, is a common one. A common system seeks to share staff 
and facilities efficiently and to allow for both individual specialisation and general skills development 
of staff towards a common goal of tackling residual disability and promoting a single cardiovascular 
prevention message. There will be a need to specify the types of patients who can be amalgamated 
in specific levels of cardiovascular prevention programmes. For example, a programme aimed at 
reasonably mobile, but de-conditioned or anxious patients might also include mild-to-moderately 
impaired coronary heart disease patients (acute coronary syndromes and revascularisation); those 
with mild-to-moderate heart failure (e.g. Class II and III); those following TIA or mild strokes with minor 
cognitive or motor deficit; and peripheral arterial disease patients with mild-to-moderate impairment.
service development
A complementary rehabilitation system is envisaged for patients traditionally seen as ‘cardiac’ or 
‘stroke’ (see Recommendation 6.12). This would accommodate differences in patient needs that are in 
part dictated by the nature of the cardiovascular condition, but also by the severity of the condition 
and patient characteristics such as age and co-existing morbidity. Individualised assessment of patient 
needs, rather than set programmes to determine the level of rehabilitation inputs, is required.
A review of current rehabilitation capacity (both cardiac and stroke) and an outline of resources and 
facilities needed for cardiovascular prevention is needed as a first step in developing integrated 
services. These services can then be re-engineered to deliver the range of rehabilitation services 
needed in an efficient manner. For more specialised services, a regional or network approach should 
provide economies of scale alongside specialist access. For more general rehabilitation support 
services – for example, regarding understanding and establishment of secondary prevention targets, 
such as physical activity and stress management – a common approach across hospitals should ensure 
that patients have the opportunity to attend programmes at a location that maximises their capacity 
to enrol and adhere to programme attendance. Thus, for example, for the most ambulatory patients, a 
combined out-patient programme (modelled on the Phase III cardiac rehabilitation programme) could 
be provided with exercise sessions as the timetabling anchor and with all but the condition-specific 
educational sessions equally suited for all patients (e.g. acute coronary syndrome, post-PCI, TIA, mild 
stroke and peripheral arterial disease). This could maximise staff resources, provide more timely access 
to rehabilitation to a wider group of patients and enable flexibility to be built into the system  
(e.g. through out-of-hours sessions for those working regular office hours).
Mechanisms for the auditing of rehabilitation services and quality assurance are discussed in Chapter 7.
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Cardiac and Stroke Rehabilitation and Continuing Care
RECOMMENDATION 6.12
There is a need to establish or redirect services to address effectively the common 
rehabilitation goals of all cardiovascular patients.
Lead organisation: HSE
staff training and leadership needs
Training programmes should build on the achievements of cardiac rehabilitation training 
programmes, aiming to advance the skills of a range of staff in cardiovascular rehabilitation (see 
Recommendation 6.13). This will require investment to support skills development among the relevant 
multidisciplinary professionals through a range of formats for continuing professional development, 
including workshops, short multidisciplinary courses and personal distance learning. There should 
be greater emphasis on population health, prevention and management of chronic disease in 
undergraduate medical, nursing and related health professional training programmes in order to 
facilitate understanding of concepts of integrated care.
Appropriate recognition of the pivotal role of the Rehabilitation Coordinator is needed, through 
senior staff level grading, if the position is to attract the calibre of professional necessary to fast-track a 
comprehensive rehabilitation network across hospitals. 
Consultant leadership is also pivotal in service development, evaluation and innovation. As advised 
in Building Healthier Hearts (1999) concerning cardiac rehabilitation, each hospital with cardiovascular 
patients should have an identified Lead Consultant for rehabilitation services. This has implications 
for consultant recruitment to ensure that specialties such as preventive cardiology and rehabilitation 
medicine are identified as recruitment priorities.
RECOMMENDATION 6.13
There is a need to deliver a structured training and leadership system for professionals 
involved in cardiovascular rehabilitation.
Lead organisations: Irish Heart Foundation (IHF), Irish Association of Cardiac Rehabilitation and 
IHF Stroke Council, in association with professional and educational bodies
Role of primary care in community rehabilitation
The new service model for primary care, as described in the Primary Care Strategy (Department 
of Health and Children, 2001), is designed to deliver locally accessible services to communities, 
particularly to those with long-term conditions such as cardiovascular diseases. The primary care team 
can develop a coordinated team response to the spectrum of cardiovascular needs after discharge, in 
conjunction with hospital liaison services (see Recommendation 6.14). The primary care team can also 
manage the referral process for review by the cardiovascular rehabilitation team, as part of integrated 
long-term care. Ideally, members of the community team, in partnership with hospital services, will 
develop lead roles in community cardiovascular disease management, similar to GP roles in diabetes, 
asthma and methadone programmes. 
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GPs must be involved in the care of cardiovascular patients as early as possible following diagnosis 
to ensure ongoing and appropriate clinical care and support. They have a pivotal role in preventing 
subsequent cardiovascular events by monitoring and treating known risk factors. They should also 
be supported to participate in the development of self-management programmes for people who 
have been discharged from hospital following cardiovascular episodes or procedures. GPs are also 
well positioned to refer patients to, and collaborate with, specialist providers of rehabilitation care to 
improve functional outcomes.
RECOMMENDATION 6.14
Primary care teams and cardiac and stroke rehabilitation services need to be developed to 
deliver integrated, shared care between hospitals and the community.
Lead organisation: HSE
Information and education for patients and carers
Education is a vital support for optimum recovery from cardiovascular illnesses. Provision of 
information alone is not effective. Inclusion of the person with the illness, family members and formal 
and informal caregivers enables all involved to have a better understanding of the needs of the patient 
and enhances recovery and coping. 
Information and education should be provided for all patients, and their families and caregivers, at all 
stages of care across the continuum – from prevention, acute care and rehabilitation, to community 
reintegration (see Recommendation 6.15). Information and educational materials should be interactive, 
timely, up-to-date and provided in relevant languages and formats (written, oral, counselling 
approach), as well as being specific to the needs and impairments of the patient, family and caregiver. 
Information and education can be provided in the hospital and GP setting, but also usefully in more 
publicly accessible settings, such as community pharmacies.
There should be national integration of the development of educational materials and mechanisms 
for ongoing delivery and updating, to replace duplication of effort and expertise across many sites and 
individuals.
RECOMMENDATION 6.15
Information and education should be provided for patients, their families and caregivers. 
Information should be timely, up to date, accessible and responsive to the needs of the 
particular patient and family.
Lead organisation: HSE, in partnership with Irish Heart Foundation and other voluntary agencies
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Psychosocial support and community reintegration
In terms of emotional well-being, patients with cardiovascular conditions experience relatively high 
levels of psychological distress, particularly depression. Depression is an independent predictor 
of cardiovascular mortality (Carney et al, 2002; Pelle et al, 2008). Cardiovascular patients should 
be screened and where appropriate managed for depression at appropriate times, including time 
of diagnosis, discharge from hospital and at key stages of the rehabilitation process. Individual 
psychosocial and support needs should be reviewed on a regular basis as part of the longer term 
management of cardiovascular conditions (see Recommendation 6.16).
RECOMMENDATION 6.16
Access should be provided to comprehensive psychosocial support, including management 
of depression, for cardiovascular patients and their families.
Lead organisation: HSE
Needs of carers
The needs of family members and carers should also be addressed as part of the rehabilitation 
process (see Recommendation 6.17). Caregivers are at risk of high levels of stress, depression and other 
psychological problems, particularly, but not exclusively, in the short- and longer-term after stroke. 
There is evidence that provision of information, together with necessary training of carers following 
stroke, can reduce stress and improve knowledge and satisfaction (Kalra et al, 2004). Carers should be 
supported and trained as needed, particularly in relation to manual handling skills, and personal and 
domestic activities of daily living. Informal family caring should be supplemented with home care 
provided by the HSE, as well as by voluntary organisations.
Those who have experienced serious limitations from their cardiovascular condition (e.g. heart failure 
or stroke survivors) and their carers must have access to aids and appliances to assist with daily living. 
An enhancement of the ‘Aids and Appliances’ grant is needed to ensure timely access to required 
adaptations in the home and work environment. In the UK, legislation has been developed to provide 
for a ‘Carer Needs Assessment’, providing adult carers with an assessment of their needs by social 
services in order to consider the carer’s own needs and to provide information on practical support, 
benefits, grants, carer groups and voluntary services. Similar legislation should be considered in 
Ireland.
RECOMMENDATION 6.17
Families and carers should be provided with the appropriate information, support, training, 
appliances and facilities, including respite care, to enable them to contribute to their 
relative’s care in a way that optimises quality of life and supports independent living for 
relative and family.
Lead organisation: HSE
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End of life issues/Palliative care
In-hospital mortality rates for cardiovascular conditions are considerable. For example, the CCU 2003 
census reported 9% in-hospital mortality for those admitted for acute coronary syndromes (Doyle 
et al, 2005), while 19% of those admitted with stroke died in hospital (Horgan et al, 2008). A large 
proportion of cardiovascular care is in the context of the threat of sudden death and the likelihood of a 
long terminal phase for many patients. Palliative care is the continuing active total care of patients and 
their families at a time when the expected medical outcome is no longer cure. It responds to physical, 
psychological, social and spiritual needs, and extends to support in bereavement.
There is substantial evidence of considerable unmet palliative care needs for patients with 
cardiovascular disease and their informal carers, for example, in relation to heart failure. Issues of 
sudden death and living with uncertainty are pertinent to all patients with heart failure. The palliative 
needs of patients and carers should be identified, assessed and managed at the earliest opportunity 
(see Recommendation 6.18). Patients with heart failure and their carers should have access to 
professionals with palliative care skills within the heart failure team. 
In tandem, greater skills in relation to end-of-life care need to be available in the general 
cardiovascular setting. An initiative called the Hospice Friendly Hospitals Programme, launched by 
the Irish Hospice Foundation in May 2007, is being undertaken in two phases over a 5-year period, 
in partnership with the HSE, HIQA and a range of public service and academic organisations. It aims 
to put hospice principles into general hospital practice by addressing all aspects of dying, death 
and bereavement in an integrated way. This programme is striving to transform the culture around 
dying and death to ensure that good end-of-life care is consistently available in Irish hospitals. Its 
implications for cardiovascular settings need to be formally considered to enable maximum benefit 
for patients in a reasonable timeframe. Heart failure is one of the specific conditions considered in the 
2008 report published for consultation by the HSE and Irish Hospice Foundation, entitled Palliative 
Care for All: Integrating Palliative Care into Disease Management Frameworks.
The principles of end-of life care are, of course, also relevant to patients with severe stroke and their 
families.
RECOMMENDATION 6.18
Each cardiac and stroke network should have access to a comprehensive specialist palliative 
care service and should actively seek to incorporate hospice and end-of-life care principles 
into its routine practice.
A proportion of cardiovascular patients will need palliative care services. Palliative care should 
be incorporated into care pathways and protocols for all patients with end-stage cardiovascular 
disease. Many patients with heart failure, for example, will have a palliative care phase, with 
disimproving health and risk of death, during which patients and carers will need to be 
supported. Care structures, processes and services need to be put in place, or be adapted, to 
meet these needs.
Lead organisation: HSE
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7.   WORkFORCE PLANNING FOR THE NATIONAL 
CARDIOvAsCuLAR HEALTH POLICY
The workforce is the ultimate enabler of policy and service development. This national cardiovascular 
health policy envisages new or adapted roles within existing services as the basis for its delivery (see 
Recommendation 7.1). Additional staff, recruited within the framework of the policy, will be a crucial 
component of the developments envisaged and necessitated in terms of delivering on duty of care 
commitments to best practice. Two further key enablers are resourced and tailored programmes of 
continuing professional development across disciplines and grades and universal access to integrated 
ICT systems.
Shortages of personnel – as identified in recent audits of cardiovascular service provision, such as 
Ireland: Take Heart (HSE, 2007) and the Irish National Audit of Stroke Care (Horgan et al, 2008) – already 
limit current capacity and impair service quality. The proposed restructuring and re-organisation of 
the current system of care into stroke and cardiac networks will require some redefinition of existing 
posts and development of additional cardiovascular leadership roles. Acute and non-acute service 
reconfiguration will also require new or redefined nursing, general practitioner and allied health 
professional and auxiliary service roles in hospital, community and administrative settings.
RECOMMENDATION 7.1
Workforce planning for cardiovascular services needs to be integrated effectively with service 
planning, liaising closely with education and training bodies.
Training and development must be considered a continual process, encompassing continuing 
professional education, personal development planning and management development. 
An annual audit of cardiovascular services should include information on workforce needs, 
in line with the current national cardiovascular health policy, and on training and continuing 
professional development needs in order to deliver an integrated cardiovascular service.
Lead organisations: Department of Health and Children and HSE
An annual audit of cardiovascular services should include information on workforce needs in line with 
the national cardiovascular health policy and on training and continuing professional development 
needs in order to deliver an integrated cardiovascular service. 
Workforce planning will require:
• An accurate registry of cardiovascular health personnel, including discipline, professional 
association and training completed.
• Adequate stakeholder participation and communication in the development and 
maintenance of the cardiovascular workforce plan.
• An annual report describing the cardiovascular workforce and an inventory of staffing needs 
by discipline and location within each network.
• Identification of key standards, assessment and accreditation processes to support training 
and continuing professional development in cardiovascular health professionals. 
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• Close liaison with education and training bodies responsible for training members of the 
cardiovascular workforce.
• Demonstrated and ongoing commitment to continuous learning and facilitating employees 
to undertake education and development programmes, which contribute to their career 
development and enhance the quality of patient care.
• Facilities to support the information and communications technology (ICT) needs of services 
and to support research, consistent with a continual service quality improvement model of 
service delivery.
• Ongoing research to investigate professional development needs, recruitment and retention 
issues, and role development and evolution for cardiovascular service enhancement.
Detailed recommendations on all aspects of the cardiovascular health workforce are beyond the scope 
of this document. Specific recommendations are outlined below regarding consultant numbers and 
key areas of attention for other disciplines are highlighted. Workforce issues should form a key part 
of the annual audit process proposed in Chapter 8. Effective planning and investment in education, 
training and continuing professional development will be required, in line with the new structures of 
cardiovascular health service delivery.
Development of existing cardiovascular services will require attention to workforce in a number of 
areas:
• Adequate hospital consultant numbers to deliver a consultant-led service, as committed to in 
the new consultant contract.
• Adequate provision of non-consultant hospital doctors (NCHDs) dedicated to cardiovascular 
services to ensure that the next generation of senior medical staff in cardiovascular services 
are fostered.
• Development of nursing roles to enable further specialisation in cardiovascular services, 
including more integration of skills across previously separate roles in cardiac and stroke care.
• Development of the multidisciplinary team to include adequate access to health and social 
care professionals.
• Adequate provision of technical support staff for cardiovascular diagnostics and procedures.
• Establishment of primary care teams with skills to address group and health-promoting tasks, 
as well as individual disease-managing tasks, for defined populations. General practitioners 
working within a risk assessment and chronic disease management framework are key to the 
delivery of this cardiovascular health policy. Projections about inadequate supply of GPs in the 
coming years need to be addressed in this regard.
• Adequate administrative support, including expertise in database and patient register 
development and management.
• Fostering of community and voluntary involvement.
• Support for private sector contributions to the overall thrust of the policy.
Priority areas for attention are outlined in the following sections.
Workforce Planning for the National Cardiovascular Health Policy
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MEDICAL CONsuLTANT LEADERsHIP ROLEs
Adequate consultant leadership is essential for the delivery of this national cardiovascular health 
policy.
Consultant cardiology within cardiac networks
Cardiology – Hospital consultants
The final report of the Joint Working Group to review consultant cardiology requirements in 2004 
recommended a consultant cardiology ratio of 1 per 48,000 population, giving a total complement of 
81 posts at that time. In 2008, there were 56 established consultant posts, not including those working 
in the private system. The Joint Working Group further recommended a ratio of one per 500,000 
population paediatric cardiologists, including adequate numbers to provide a specialist service in 
grown-up congenital heart (GUCH) disease, making a figure of at least 8 paediatric cardiologists 
needed. There are currently 5 paediatric cardiologists in place. Services for GUCH disease currently rely 
on one specialist team nationally, a situation that needs to be addressed with a concerted national 
plan for service delivery.
Regarding cardiac surgery, staffing has increased from 7 surgeons in 1998 to 16 nationally in 2008. 
Numbers now in post or approved are deemed adequate to meet current cardiac surgical demand.
Cardiac network establishment should include, alongside adequate numbers of interventional 
specialists to deliver emergency care, a consultant with a major interest in preventive cardiology and 
rehabilitation. This role might also include responsibility for the organisation of cardiac services at 
primary care level, in conjunction with general practitioners. The second key appointment within each 
cardiac network will be a consultant specialising in heart failure. All networks should ensure that there 
is available expertise in chronic disease management, as well as peripheral arterial disease, GUCH 
and hypertension (see Recommendation 7.2). There are increasing demands on vascular surgery more 
generally which have implications for comprehensive management of peripheral arterial disease.
Paediatric cardiology services are effectively configured as a single specialty of national networks 
delivered from Dublin and this is considered appropriate. Other networks will seek to ensure that 
staffing to provide the 24/7 cover and operator volumes necessary for delivery of quality services are 
in place.
RECOMMENDATION 7.2
The Joint Working Group on consultant cardiology requirements (2004) should be used as a 
guide to consultant cardiology workforce planning in future national service plans.
Decisions on the appropriate level of consultant cardiology staff to deliver the expanded 
emergency PCI and other cardiac services as set out in Chapter 5 of this policy should involve 
a gap analysis at each cardiac network level with reference to the above guidelines and taking 
into consideration any effective developments in medical technology and good practice in this 
and related areas since 2004.
Lead organisation: HSE
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sTROkE CONsuLTANT PHYsICIANs
stroke – Hospital consultants
The majority of stroke patients have substantial medical co-morbidities. Co-morbidities and 
complications of stroke require consultant/specialist input throughout the care pathway. There is a 
requirement to provide acute stroke care as well as ongoing care in the community. Stroke physicians 
with specific expertise in cerebrovascular disease come from a variety of backgrounds, including 
consultant geriatricians, neurologists, pharmacologists and rehabilitation medicine specialists.
Total stroke consultant requirements
Up to recently in Ireland, patients with acute stroke were admitted into a variety of medical specialties. 
To provide specialist stroke services, the British Association of Stroke Physicians estimate that a typical 
hospital serving a population of 350,000 and admitting approximately 600 acute stroke patients per 
year would require 3.3 consultants with a sub-specialty stroke interest. This equates to 5 consultants 
in a stroke network serving a population of 500,000. These estimates are based on stroke physicians 
providing the required emergency acute treatment.
The British Association of Stroke Physicians also highlights the acute consultant requirements for  
out-patient care and community rehabilitation. It is estimated that the additional service requirements 
identified in this policy, such as rapid access TIA clinics, atrial fibrillation management and other aspects 
of stroke care, would include an additional 2 or 3 consultants per network and additional rehabilitation 
physician expertise to meet the ongoing stroke care needs identified in Chapters 5 and 6 of this policy.
Specific numbers in each network will require a gap analysis at the network level with adequate and 
appropriate staffing levels specified in the national service plan (see Recommendation 7.3). There are 
several existing consultant appointments where stroke expertise and partial stroke service delivery exist. 
These may be reconfigured to create full-time stroke specialist posts, with non-stroke duties of these 
existing consultants being assigned to additional incoming consultant staff. This will establish an early 
cadre of identifiable stroke specialist physicians. The number and distribution of consultants between 
comprehensive and general centres in each network will depend on the number of stroke centres, the 
population of the network and the density of the population and distance between centres. Some posts 
should be reserved to boost the number of consultants in centres providing a tele-medicine support service.
RECOMMENDATION 7.3
The staffing ratios and roles outlined in this policy should be used as a guide to consultant 
appointments and workforce planning in formulating future national service plans.
This will require an appropriate level of consultant neurologists, geriatricians and 
rehabilitation medicine specialist stroke staff to meet the need for stroke units, emergency 
thrombolysis, rapid access TIA clinics and other elements of stroke care as set out in Chapters 
5 and 6 of this policy. This should involve a gap analysis at the stroke network level so that 
staffing levels are compatible with the comprehensive range of stroke services outlined 
previously. Consultant workforce for stroke services should be reviewed midway through 
implementation of this policy.
Lead organisation: HSE
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Comprehensive stroke centres: Stroke physicians with expertise in emergency stroke thrombolysis 
will be required to provide a consultant-delivered 24-hour 7-day emergency stroke service in the 
comprehensive stroke centres of each stroke network. This includes provision of same-day rapid 
access specialist assessment of TIA/minor stroke and a tele-medicine stroke service to patients 
attending hospitals with primary stroke centres in the network. 
It is expected that these stroke consultants will engage in dual/sub-roles as network clinical  
co-directors and as a director for each of the following areas – the stroke unit in the comprehensive 
centre, community liaison/integration, tele-medicine, preventive medicine including management  
of atrial fibrillation and TIA, and education within the network.
To ensure an appropriate mix of skills within each stroke network, appointments should be balanced 
between geriatric medicine and neurology with a special interest in stroke. The consultant neurologist 
appointments are additional to those recommended previously by Comhairle and others since stroke 
services were specifically excluded from the terms of reference of these reports. 
General stroke centres: Depending on the configuration of the stroke network and patient volumes, 
one or two consultant stroke physicians (geriatrician, neurologist or rehabilitation medicine physician) 
will be required at each hospital providing general stroke care. These consultants are responsible 
for the acute care and rehabilitation of patients with suspected stroke who are not eligible for 
thrombolysis and are admitted directly to the general stroke centre. Stroke physicians based in general 
stroke centres also have a role in relation to patients eligible for thrombolysis. This should be agreed 
in the context of planning services at stroke network level, to provide thrombolysis using a common 
protocol by day and participate in the network out-of-hours rota for thrombolysis; consultants may 
also participate in any tele-medicine service in the network. One consultant will take a leadership role 
on all aspects of care of TIA and acute stroke in the hospital, including clinical audit. The other will lead 
on coordination of care between the hospital and community settings, including quality assurance for 
community-based stroke services. 
Rehabilitation: An additional one or two consultants in rehabilitation medicine will be required per 
stroke network, depending on the population served. 
Consultant neuroradiology: All stroke networks should have network-level access to expertise 
provided by one or more consultant neuroradiologists, who have completed at least one additional 
year in neuroradiological training. Although some expertise may be provided by tele-radiology 
linkage, it is essential that a consultant neuroradiologist is available on-site at each comprehensive 
stroke centre for regular interdisciplinary discussion of neuro-imaging.
NON-CONsuLTANT HOsPITAL DOCTORs
An adequate supply of dedicated non-consultant hospital doctors (NCHDs) is essential to deliver 
consultant-provided services in an expanding scheme of consultant appointments. It is also essential 
to build capacity for the next generation’s consultant workforce in cardiovascular disease. A ratio of  
3 NCHDs per 2 consultant stroke specialists is preferable, with at least one of these posts at registrar or 
specialist registrar level. While acknowledging the value of these ratios, particularly in the context of 
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the need to expand the consultant stroke physician workforce for the future, it is acknowledged that a 
one-to-one staffing ratio of consultant-to-NCHD is more realistic in the short to medium-term, in line 
with staffing guidelines in the HSE in the present economic circumstances.
MuLTIDIsCIPLINARY TEAM INvOLvING HEALTH AND sOCIAL CARE 
PROFEssIONALs
The audit of the first national cardiovascular health strategy, Ireland: Take Heart (HSE, 2007), assessed 
workforce deficits in hospital cardiology services. There were also variations in levels of coronary care 
unit nursing, cardiac technician and multidisciplinary cardiac rehabilitation staff across locations. 
The Irish National Audit of Stroke Care (INASC) identified major shortages in specialist stroke nursing 
care and in the multidisciplinary health professionals necessary to provide comprehensive stroke 
rehabilitation (Horgan et al, 2008).
As emphasized throughout this report, input from the multidisciplinary team is a basic requirement 
to provide quality care. Management of cardiac and stroke patients requires specialist teams led by 
clinicians with differing relevant expertise. However, it is possible to have many multidisciplinary team 
members work across the cardiovascular services spectrum in a manner that shares resources and 
builds expertise, for example, in secondary prevention and rehabilitation activities.
The core cardiovascular multidisciplinary team should include:
• A consultant cardiovascular-related physician with relevant expertise, who is responsible for 
care provision by the team.
• Adequate non-consultant hospital doctor staffing to support current service delivery and 
development of future cohorts of cardiovascular specialists.
• A clinical nurse specialist with relevant expertise, supported by nursing teams.
• Technical support staff for diagnostics and ICT service requirements. A database manager will 
facilitate development of integrated information systems across each network.
• Access to speech and language therapist, physiotherapist and occupational therapist services, 
depending on individual patient needs.
• Access to dietician, psychologist/neuropsychologist, pharmacist and social worker services.
• Community liaison coordinator, which role can be allocated to a particular team member 
depending on workforce capacity.
It is difficult to be proscriptive about staffing ratios. For specialist multidisciplinary services available 
as needed, local arrangements within networks will vary and will thus reflect somewhat differing use 
of staffing resources. Over time, the annual review by the Cardiovascular Policy Monitoring Group will 
provide information to inform more specific workforce planning. One useful example of workforce 
estimates for stroke unit care is provided by the UK’s Department of Health 2009 Workforce Planning 
Resource (see www.dh.gov.uk/en/Healthcare/Stroke/DH_081389).
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DEvELOPMENT OF NuRsING ROLEs
The roles of clinical nurse specialists and advanced nurse practitioners have developed significantly 
since the Commission on Nursing (Government of Ireland, 1998). Implementing new directions 
in cardiovascular health service delivery will provide an important window of opportunity for 
cardiovascular nursing.
Clinical nurse specialists will have undertaken formal recognised post-registration education at 
higher diploma level. A clinical nurse specialist should form part of every specialist cardiac and 
stroke multidisciplinary team, with a view to expansion to advanced nurse practitioner level. Such 
posts are not yet widely available in Ireland. For example, the INASC study reported only 5 clinical 
nurse specialists in stroke across all (37) relevant hospitals audited (Horgan et al, 2008). All posts 
were accredited by the National Council for the Professional Development of Nursing and Midwifery 
(NCNM). Clinical nurse specialist positions should not be limited to hospital services, but should also 
be used to develop a seamless service into the community (see Recommendation 7.4). For example, 
clinical nurse specialists can facilitate atrial fibrillation, TIA, chest pain and heart failure services in 
conjunction with the multidisciplinary team.
Other nursing roles will also evolve in line with implementation of this policy, including practice 
nurses, community and public health nurses, and nursing roles across the cardiovascular rehabilitation 
spectrum. For example, with the widespread introduction of cardiac rehabilitation programmes 
following the first national cardiovascular health strategy, formal diploma and masters level training in 
programme coordination was established for nursing and other professionals.
RECOMMENDATION 7.4
Workforce planning is needed to ensure adequate development and provision of 
cardiovascular clinical nurse specialists and other specialist cardiovascular nursing roles to 
ensure adequate provision of personnel in line with best practice guidelines.
Development of a group of cardiovascular clinical nurse specialists will be an important 
resource in delivering on this policy. Training and recruitment should prioritise a community 
liaison role for some of this expanding group of specialists.
Lead organisation: HSE, in association with nursing training organisations
TECHNICAL suPPORT sTAFF FOR CARDIOvAsCuLAR DIAGNOsTICs AND 
PROCEDuREs
The capacity to deliver cardiovascular services depends on all of the team members being available in 
sufficient quantity. Technical support staff for existing and emerging diagnostic and procedural work 
must be factored into workforce planning if services are to be delivered to the maximum potential of 
other medical and nursing team members (see Recommendation 7.5). Workforce review can identify 
existing or emerging gaps in specialist personnel and plan for these identified training needs. For 
Building Healthier Hearts (1999), an early initiative to train additional ECG technical staff meant that 
an adequate supply of personnel was available when more consultant cardiologist posts became 
available from mid-way through the delivery period. 
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RECOMMENDATION 7.5
Workforce planning is needed to ensure adequate development and provision of 
cardiovascular nursing, health and social care professionals, and related clerical and technical 
support personnel in line with best practice guidelines.
Appropriate representation is needed within multidisciplinary teams, covering a range of 
nursing, health and social care professionals, and clerical and technical support staff. Assistant 
or support grades of health and social care professionals are also needed to help increase 
efficiency of service provision. An annual review of workforce issues will assist in planning.
Lead organisation: HSE, in association with Department of Health and Children
PRIMARY CARE AND COMMuNITY sERvICEs 
Primary care teams are currently being implemented in line with the Primary Care Strategy 
(Department of Health and Children, 2001) (see Chapter 4). The development of these teams is such 
that they can become a major driver of this cardiovascular health policy (see Recommendation 7.6). 
With a focus on cultivating a preventive and primary care-led system, the aspirations of the primary 
care teams and this policy are as one. Support for primary care team members will be required to 
enable effective management of patients with chronic cardiovascular disease and high cardiovascular 
risk. Structured care services, such as heart failure services, will require re-organisation in conjunction 
with hospital services and development of specialist nursing and multidisciplinary care roles. Current 
roles may need to be reconfigured to support cardiovascular prevention activities, including the 
development of centres of prevention in community settings. The Ireland: Take Heart audit identified 
specific shortages in the supply of dieticians and public health nurses in current community 
prevention and treatment activities (HSE, 2007).
RECOMMENDATION 7.6
Planning and coordination is needed to ensure that the community healthcare workforce 
addresses the cardiovascular prevention and rehabilitation recommendations of this policy.
Lead organisation: HSE
Workforce Planning for the National Cardiovascular Health Policy
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CLERICAL AND ADMINIsTRATIvE suPPORT, INCLuDING sTAFF WITH 
ExPERTIsE IN DATAbAsE AND PATIENT REGIsTER DEvELOPMENT AND 
MANAGEMENT
Implementing the integrated information systems proposed in Chapter 8 will require adequate clerical 
and technical support. The change-over from paper-based to electronic systems will require training 
and skills that should be factored into continuing professional development opportunities available to 
clerical staff. A database manager may be required across each network to coordinate this process.
COMMuNITY AND vOLuNTARY INvOLvEMENT
Voluntary sector involvement must be considered within the overall context of cardiovascular care 
delivery. Formal voluntary sector organisations, such as the Irish Heart Foundation, play a pivotal role 
in patient support, advocacy and empowerment. It is important also to note that such organisations 
represent a very small component of the care provided to individual families and communities on an 
ongoing basis.
Voluntary organisations should be acknowledged by service providers and involved at every 
opportunity in filling in some of the gaps in care that are difficult to provide on a formal basis, such  
as peer support and community initiatives of benefit to cardiovascular health and psychosocial  
well-being. The importance of the role of carers and their needs is addressed in Chapter 6.
The private sector, including business and philanthropic agencies, also have a valuable contribution 
to make in promoting cardiovascular health. Many examples of good citizenship exist and private 
sector contributions deserve acknowledgement for supporting innovation, start-up or demonstration 
projects, and local initiatives in the interests of cardiovascular health.
CHAPTER 8     A NATIONAL FRAMEWORK FOR 
QUALITY IN CARDIOVASCULAR 
HEALTH
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8.   A NATIONAL FRAMEWORk FOR QuALITY  
IN CARDIOvAsCuLAR HEALTH
This chapter presents a national framework for the delivery of high-quality care in cardiovascular 
services. This includes identifying key requirements to enable quality service delivery. These 
requirements include information and communications technology (ICT) and, as discussed in 
Chapter 7, workforce planning and investment alongside a programme of continuing professional 
development. Staff will need support to integrate rapidly changing evidence-based practices and 
methods of team-working into a responsive quality-focused system.
Cardiovascular health policy is developed and agreed by the Department of Health and Children, in 
this instance through the appointment by the Minister of a Cardiovascular Health Policy Group in 
2007. That policy is then delivered through a range of agencies, primarily the Health Service Executive 
(HSE) and the Health Information and Quality Authority (HIQA). Mechanisms include the annual 
National Service Plan between the Department of Health and Children and the HSE. Evaluation of 
policy implementation is an integral component of this new cardiovascular health policy covering the 
period 2010-2019. A Cardiovascular Policy Monitoring Group will advise the Department of Health and 
Children on the achievement of policy objectives. 
Some of the key structures and relationships in this framework are outlined in Figure 8. As discussed in 
Chapter 5, the HSE will reconfigure hospital services into networks for cardiovascular care. Reports on 
progress with the policy will come from these networks, as well as from primary care teams and other 
community-based services. The Cardiovascular Policy Monitoring Group will include Department of 
Health and Children officials and a small group of external experts. The group will meet twice annually 
and will provide a brief annual report highlighting progress and identifying potential barriers in order 
to guide service planning. It will also coordinate a major mid-term review of progress on the policy, 
reporting in Year 5 (2014).
Key components of delivering high-quality healthcare are effectiveness, patient-centeredness, 
timeliness, safety, efficiency and equitable access. To ensure a ‘whole systems’ approach in delivering 
these components, committed governance and clinical leadership are necessary. In order to monitor 
and improve outcome of care for the population, a number of developments will be important to 
institute: 
• workforce planning (see Chapter 7);
• standards setting (see below, next section);
• education, training and ongoing professional development (see Chapter 7);
• information and communications technology (ICT) (see below);
• research and health technology assessment (see below).
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Figure 8: Cardiovascular Policy and National Treatment Programmes
NATIONAL sTANDARDs OF CARDIOvAsCuLAR HEALTH sERvICEs
Cardiovascular health services in Ireland should be based on international best practice and deliver 
the best possible health return on investment. Previous chapters in this report have presented plans 
for systematic development of cardiovascular health services. These plans need to be developed and 
delivered in a quality framework with guidance and accountability. The development of national 
cardiovascular management guidelines involves many stakeholders and includes the development of 
national service plans/corporate business plans. It is recommended that the governance structure for 
the development of national treatment programmes reflects the development of national standards 
for quality and safety, and develops performance indicators as well as treatment guidelines in support 
of better quality in cardiovascular health services (see Recommendation 8.1). 
A National Framework for Quality in Cardiovascular Health
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This will involve representation from the Department of Health and Children, the HSE, HIQA and other 
stakeholders as appropriate. The work will involve:
• the development of evidence-based guidance;
• performance indicators relating to guidance and national standards for quality and safety;
• information and data requirements.
A number of standards are in use internationally. These are based on guidelines from professional 
societies, including the European Society of Cardiology (ESC) and the European Stroke Organisation 
(ESO), as well as on agreed local priorities and structures. Adoption of uniform standards across 
professional groups and components of the health system is needed if targets are to be set and 
achieved. Guidelines for shared care between hospital and community settings (e.g. in heart failure 
and atrial fibrillation) need to be developed. The HSE, through the National Directorate of Quality and 
Clinical Care, is responsible for oversight of the disease programmes, for developing clinical guidelines 
and for providing clinical leadership in this area. It is important that these functions are supported and 
evaluated as part of the mid-term 5-year review of this policy.
RECOMMENDATION 8.1
Evidence-based guidelines and standards should be agreed, with appropriate performance 
indicators identified and reporting structures established.
Lead organisations: Department of Health and Children, HIQA and HSE
CARDIOvAsCuLAR HEALTH suRvEILLANCE
Surveillance consists of the ongoing collection, analysis and dissemination of data of public health 
importance to allow for the planning and implementation of health policy. The objectives of a 
cardiovascular health surveillance system are:
• to access and analyse routine mortality and morbidity data to estimate trends in the burden of 
cardiovascular disease at population level;
• to monitor the state of the health of the population with regard to lifestyles and risk factors for 
cardiovascular disease;
• to support clinical audit of care of patients with cardiovascular disease and evaluation of 
health promotion programmes;
• to estimate the use of health services resources and to support health services planning.
The Irish National Audit of Stroke Care (INASC), carried out in 2006-07, identified many gaps in hospital 
and community services for patients with stroke and their carers (Horgan et al, 2008). These findings 
are in the absence of a Government strategy for stroke. There have, on the other hand, been notable 
developments in cardiology services as a result of the Government strategy Building Healthier Hearts 
(1999), as outlined in Ireland: Take Heart (HSE, 2007). For example, the identification of minimum 
datasets for cardiac care (i.e. the Cardiology Audit and Registration Data Standards system) has been 
internationally credited and is now used at European level. Much consensus was also achieved by 
groups such as the National Cardiovascular Information Systems Group. However, substantial national 
changes at Government and health service levels in recent years have meant little consolidation of 
much effort in this regard. Thus, cardiovascular health information in Ireland is still collected and 
processed by various agencies in a fragmented, non-standard and inconsistent way. 
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A systematic approach needs to be implemented as a matter of urgency to facilitate the collection and 
use of patient-based data for surveillance, audit and research (see Recommendation 8.2). This would 
require:
• systematic validation of data and annual reporting as part of a quality and standards 
monitoring system. High-quality routine mortality and morbidity data collection requires 
development in a number of areas, including training in death certification and training and 
access to national information services, particularly HIPE. 
• Development and implementation of common data standards nationally to ensure that 
the various systems can interact. 
• Progress on finalising the unique patient identifier is essential and will benefit the whole 
system.
• A heart and stroke registry should be initiated and informed by current datasets (e.g. 
the Coronary Heart Attack Ireland Register (CHAIR), HeartWatch, the Cardiac Rehabilitation 
Information System (CRIS), HeartBeat, SCD Register, INASC, North Dublin Population Stroke 
Study). Priority databases should be established, including for acute stroke care and stroke 
thrombolysis. 
These initiatives would benefit cardiovascular services and also wider health system surveillance. A 
comprehensive system should also be capable of delivering information on equity regarding access to 
service and disease prevalence across socio-economic groups.
RECOMMENDATION 8.2
A comprehensive cardiovascular health services information system should be developed as 
a priority to enable the implementation of this policy.
This will entail agreement on systematic data collection methods and analytic standards across 
healthcare pathways nationally to ensure coordinated collation, analysis and evaluation of data.
Lead organisation: HSE
Registers and information systems
Comprehensive and interpretable service provision data and information on patient care pathways 
cannot be achieved without the development of nationally comprehensive and compatible 
cardiovascular information systems, including patient registers. Registration of cardiovascular disease 
events is particularly important given the changing epidemiology of the disease. At present, a number 
of independent systems are used to collect and present data on patient care, including the Central 
Statistics Office (CSO), Hospital In-Patient Enquiry Scheme (HIPE), Public Health Information System 
(PHIS), Patient Information Management System (PIMS), the Primary Care Reimbursement Scheme, 
the Disability Database and the National Cancer Registry. There is a need to develop a comprehensive 
Cardiovascular Disease Registry containing data on people with, or at risk of, cardiovascular disease 
(see Recommendation 8.3). The National Cancer Registry can provide valuable expertise from which to 
start in the Irish setting.
A National Framework for Quality in Cardiovascular Health
Changing Cardiovascular Health:  National Cardiovascular Health Policy 2010 – 2019
142
RECOMMENDATION 8.3
Minimum cardiovascular-specific datasets should be agreed and mechanisms established 
for collection of this information as part of routine care and in a manner that enables ready 
collation of national profiles.
Lead organisations: Department of Health and Children, HIQA (standards) and HSE (audit system)
Development of current patient registers
A number of independent cardiovascular registers are in development in Ireland as outlined below 
in ‘Data Standards’. While the priority for cardiovascular registers across care settings in Ireland is to 
support patient care and to enable service evaluation, such registers should also take population-
based measurements into account when agreeing data standards. Common data standards are 
needed across health and social services to allow for inter-operability of information systems. Clinically 
based registers will facilitate the provision of quality care by promoting improved processes of care. To 
facilitate integrated care for the benefit of the patient, information using a standard format should be 
shared between primary care and secondary care. 
Data standards
During Ireland’s EU Presidency from January to June 2004, the Department of Health and Children 
worked with the European Society of Cardiology (ESC) on the Cardiology Audit and Registration Data 
Standards (CARDS) project. Data standards (variables, definitions and coding systems) were agreed for 
three topics within cardiology: acute coronary syndromes, percutaneous coronary interventions and 
electrophysiology. Cardiac rehabilitation standards were subsequently developed and agreed. The 
CARDS dataset has now been agreed for use in coronary heart disease throughout the European Union. 
Experience with existing registers in Ireland can inform the establishment of a national cardiovascular 
disease registry. These include:
• the Coronary Heart Attack Ireland Register (CHAIR) system for acute coronary syndrome, 
which has registered patients with a diagnosed acute coronary syndrome admitted to acute 
hospitals in Co. Cork and Co. Kerry since 2002;
• the Cardiac Rehabilitation Information System (CRIS), established in 2002;
• the UK-developed Sentinel audit system for stroke, as used in the Irish National Audit of Stroke 
Care (INASC) in 2006-07;
• data managed by the Independent National Data Centre (INDC), which was established to 
collect and analyse data from HeartWatch, a pilot secondary prevention programme.
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HEALTH suRvEYs
Population health data can be achieved through regular national health surveys. There have been 
repeated surveys of health-related behaviours among adults (SLÁN) and school-aged children 
(HBSC) in Ireland in 1998, 2002 and 2006/07. The main aims of these surveys are to produce reliable, 
representative cross-sectional population data to inform Government policy and programme 
planning. Over the lifetime of this national cardiovascular health policy, high-quality population-based 
data will be essential in measuring its challenges and achievements (see Recommendation 8.4). As the 
key national nutrition and health behaviour profiles assessed in these surveys are also those central to 
cardiovascular health, these surveys provide invaluable cardiovascular population health profiles.
RECOMMENDATION 8.4
Regular population-based surveys should be conducted to establish health profiles in adults 
and children.
Challenges in delivering such surveys need to be addressed promptly to enable ongoing 
delivery of high-quality and robust data for service planning. At least two national adult and 
child surveys are needed during the 10-year lifetime of this policy.
Lead organisations: Department of Health and Children and HSE
AuDIT
Clinical audit involves structured review against agreed standards in order to promote improvements 
in healthcare and public health. There have been two national audits on cardiovascular care 
(mainly cardiology services) since Building Healthier Hearts (1999) and a Irish National Audit of Stroke 
Care (INASC) was completed in 2007. However, there is no routine national system of clinical and 
organisational audit of cardiovascular disease services at hospital or community level. 
A routine national audit system for all aspects of cardiovascular care is needed, based on agreed 
standards and minimum datasets as discussed above. While a comprehensive system will take some 
time to establish, it is important that a system of review be established from the start of this policy. 
Until compatible data standards are fully implemented and data routinely collected, each sphere 
of cardiovascular healthcare should be encouraged to conduct a brief annual audit, highlighting 
developments and barriers in relation to service delivery, for submission to the Department of Health 
and Children (see Recommendation 8.5). Data should be extracted from existing databases and 
registers, and from those that will require establishment to implement service recommendations in 
this report, e.g. primary care registers to support cardiovascular risk screening and heart failure, and 
stroke registers to support chronic disease management in the community.
A national audit review process will enable rapid identification of common barriers and transfer 
of information on innovative solutions across cardiovascular networks in a quality enhancement 
framework. This review process will have the capacity to deliver a feedback report on progress and to 
identify barriers to implementation and provide specific recommendations to address these barriers. 
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The key areas for audit would be:
• patient throughput and key performance indicators in relation to recommendations and 
adherence to best practice guidelines;
• workforce issues;
• facilities and equipment issues, including ICT development.
RECOMMENDATION 8.5
An annual audit of cardiovascular networks should be conducted to assess volume and 
quality of service delivery and to aid in service planning.
Lead organisations: Department of Health and Children and HSE
ROLE OF INFORMATION AND COMMuNICATIONs TECHNOLOGY
Information and communications technology (ICT) systems should support the management and 
delivery of patient care services, as well as their quality assurance, through audit, accreditation and 
other processes (see Recommendation 8.6). Electronic health records and a unique patient identifier, 
as outlined in the Health Information Strategy (Department of Health and Children, 2004), have not 
yet been developed and implemented. The lack of a unique patient identifier is a formidable barrier 
to integrated patient care and to service monitoring and development. In particular, it is needed 
to enable integrated care pathways between hospital and primary care, decision support systems, 
costing of interventions and processes of care, audit and accreditation.
RECOMMENDATION 8.6
Information and communications technology (ICT) infrastructure, capacity and training 
should be developed. This should include the implementation of patient identifier and 
electronic health records as a matter of urgency.
Enhanced electronic communication methods are needed to support new models of health 
service delivery. Information systems and technology need to be developed within and across 
secondary and primary care settings.
Lead organisations: HIQA (enabling mechanisms) and HSE (systems)
REsEARCH AND EvALuATION, INCLuDING HEALTH TECHNOLOGY 
AssEssMENT
A research climate in the health services is fundamental to improving quality by contributing to 
policy development and planning efforts. Recent commitments by the Department of Health and 
Children (2009b) to a plan for a successful health research economy (Action Plan for Health Research 
2009-2013) and by the Health Research Board (HRB, 2009) to a complementary plan for research to 
transform the Irish health services (Strategic Business Plan 2010-2014) set the scene for what is needed 
in cardiovascular research, for both economic and health gain. Programmes of research within 
both biomedical and health services research fields should continue to be supported in relation to 
cardiovascular care. 
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A key component of evidence-based practice is the use of health technology assessment (HTA). The 
HTA function is to ensure that health service resources are used effectively by assessing the clinical 
and cost-effectiveness of the medicines, devices, diagnostics and health promotions used across 
the health system. Topics that require further investigation to inform delivery of this policy include 
projects evaluating the effectiveness of risk factor assessment and intervention in primary care; 
population quantification and management of people with PAD and GUCH; and evaluation of the 
needs of community multidisciplinary teams for rehabilitation and continuing care services for stroke. 
A coordinated approach is vital to ensure the projects needed to inform this policy are prioritised and 
funds made available in order to deliver findings during the lifetime of the policy (see Recommendation 
8.7). The research supported will provide the treatments and insights to inform the next policy. In this 
way, the continuum of ‘research to policy to practice’ can be fostered and the Ireland of 2020 will be a 
healthier place for all its citizens.
RECOMMENDATION 8.7
A national group representative of stakeholders should be convened to determine priorities 
for research and health technology assessment in cardiovascular care.
Tasks include ensuring that enabling research support skills in areas such as biostatistics and 
health economics are developed and that the information needs of this policy are enabled 
through research.
Lead organisation: Health Research Board to coordinate and involve key stakeholders, i.e. policy, 
service, academic and public representatives
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APPENDIx 1: ICD CODEs
International Classification of Disease (ICD) Codes pertaining to Cardiovascular Disease 
Discharges in Hospital In-patient Enquiry (HIPE) analyses
ICD-9-CM Codes (1998) ICD-10 AM Codes (2006)
CHD 410-414 120-125
stroke 430-434, 436-438 160-169
TIA 435 G45
PvD/PAD 440, 441, 442, 443.1, 443.9, 444 170, 171, 172, 173.1, 173.9, 174
Heart Failure 402, 425.4, 435.5, 435.9, 428 111.0, 111.9, 142.0, 142.2, 
142.5, 142.6, 142.7, 142.8, 
142.9, 150
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APPENDIx 2: IMPACT CHD MORTALITY MODEL 2000-2006
Factors contributing to the total deaths prevented or postponed (DPPs)
Note: Negative values indicate that the factor has contributed to increases in CHD mortality; positive 
values to decreases in CHD mortality.
Risk factors* DPPs % of total DPPs
Smoking (self-report) 138 6.0%
Population Blood Pressure (physical exam) -25 -1.1%
Population Cholesterol (physical exam) 580 25.1%
Physical inactivity (self-report) 34 1.4%
Diabetes (self-report) -178 -7.7%
Obesity (physical exam) -172 -7.4%
Total Risk Factors 376 16.3%
Treatments DPPs % of total DPPs
AMI treatments 79 3.4%
Secondary prevention post-AMI 268 11.6%
Secondary prevention post-CABG/PTCA 88 3.8%
Chronic angina
 CABG/PTCA
 Community aspirin/statin
134
115
5.8%
5.0%
Unstable angina** 7 0.3%
Heart failure (hospital) 102 4.4%
Heart failure (community) 185 8.0%
Hypertension 16 0.7%
Statins primary prevention 113 4.9%
Total Treatments 1,107 47.8%
Total Risk Factors and Treatments 1,483 64.1%
* Data from SLÁN 2007
** Made assumption that there was a 10% increased uptake of treatments for unstable angina between 2000 
and 2006 since no data available.
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Comparison of findings of 1985-2000 and 2000-2006 IMPACT CHD Mortality Model
1.   1985-2000 changes were associated with 47% reduction in mortality  
(variance explained by model: 93%).
2.   2000-2006 changes were associated with a further 45% reduction in mortality  
(variance explained by model: 58% men and 77% women).
Proportions explained 1985-2000 2000-2006
Improved risk factor profile +60% +32%
Worsened risk factor profile -15% -16%
Treatments +55% +48%
Smoking +26% contribution to improvement in 1985-2000 evaluation
+6% contribution to improvement in 2000-2006 evaluation
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APPENDIx 3:  ALGORITHM FOR MANAGEMENT OF PREsENTATION TO 
HOsPITAL OF susPECTED ACuTE CORONARY sYNDROME
Model as developed by st. James’s Hospital, Dublin (reprinted with permission)
Guideline for management of patients presenting with ACS
ASSESSMENT
ECG, enzymes, physical examination, targeted history
Box 1
Box 2
TREATMENT
O2 100%, Aspirin 300mg, Cloipdogrel 300mg(600mg if undergoing PCI), Metoprolol PO / IV, Nitroglycerin SL /  Morphine IV for pain
LOW / INTERMEDIATE RISK HIGH RISK
• Chest pain of possible cardiac origin
• Non-specific ECG changes
• Negative enzymes
Non ST segment elevation      ST segment elevation
Box
• Suspected cardiac chest  pain / 
discomfort @ rest > 20 minutes
• ST / T wave changes
• Enzyme elevation OR
• Suspected cardiac chest  pain / 
discomfort @ rest > 20 minutes
• ST elevation                                            
(in 2 contiguous leads):  
Assess for exclusion criteria: admit CPAU
• ST segment monitoring x up to 12 hours
• CK MB mass X 2
Box 11
12
Box 13
• Recent AMI / re-vascularisation             
(< 6/52) OR
• Haemodynamic compromise
>1mm in limb leads or                                           
>2mm in chest leads  
OR
• New LBBB
• Enzyme elevation
• Troponin T @ adm, 6hrs and 12hrs
• Stress test prior to discharge (if above normal)
Evidence of ischaemia / infarction?
• Admit CCU
• Continuous cardiac monitoring
< 12 hours from onset of most severe 
cardiac pain?
No Yes
No Yes
Thrombolysis + anti ischaemic Rx 
as indicated
• LMWH 1iu/kg x 24-48 hrs
• Morphine / nitrates as indicated
Repeat ECGs / Enzymes
Fibrinolytic if not contraindicated / PCI 
(primary / rescue / non-urgent)
Discharge
Review @48 hrs in CPAU 
review Clinic
Negative Positive
EST +/- PCI Urgent PCI
Refer to Cardiology
Admit CCU
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APPENDIx 4: sTROkE NETWORks – DEsCRIPTION AND GOvERNANCE
Evidence and rationale
A stroke network model is recommended internationally as the favoured system to improve regional 
stroke care. This model has substantial international precedent, having been successfully introduced 
in Canada, the USA, UK, Austria, Germany and other European countries. The creation of a partnership 
model of stroke networks has also been supported by the Council on Stroke of the Irish Heart 
Foundation, which represents all major professional, patient and advocacy groups involved in stroke 
care in Ireland. 
The stroke network model proposed has important differences with the ‘hub and spoke’ model 
introduced elsewhere. A key feature of the proposed Irish model is that it aims to balance the 
elements of stroke care that can be delivered effectively at all ‘general’ hospitals with those that 
are most efficiently delivered at one ‘comprehensive’ hospital. It recognises the importance of the 
role of the general hospital for provision of many aspects of stroke care close to the patient’s home. 
These include medical management of many acute stroke patients not eligible for thrombolysis or 
other highly specialised interventions (e.g. carotid endarterectomy), provision of multidisciplinary 
rehabilitation and prevention services. 
The Irish stroke network model does not propose to centralise stroke care. Instead, it aims to 
strengthen the quality of care available to patients attending general hospitals, by improving access 
to services available at the comprehensive hospital (e.g. MRI, neurology, vascular surgery, out-of-hours 
thrombolysis) and having stroke specialists at general hospitals become part of multidisciplinary 
stroke groups integrated across all hospitals in the network. In many cases, it is anticipated that 
patients referred to the comprehensive hospital will be managed on a ‘treat-and-return’ basis, with 
ongoing care provided in their nearest general hospital.
It is expected that each stroke network will provide same-day out-patient or in-patient services for 
rapid access to stroke prevention services, emergency thrombolysis, advanced diagnostic facilities, 
vascular surgery services and comprehensive multidisciplinary rehabilitation and follow-up services. 
Models may involve rotation of clinics, tele-medicine support for hospitals serving remote areas, 
centralised services for stroke occurring out of regular working hours, regional or supraregional centres 
for surgery and advanced diagnostics, and off-site rehabilitation services as appropriate to local 
demographics and service needs. The overriding principle will be delivery of high-quality stroke care.
key features of proposed stroke networks
It is proposed that stroke networks will comprise a number of hospitals working together to provide 
a comprehensive range of services needed for optimal stroke care and integrating with community 
services. A single larger hospital within the partnership will provide specific comprehensive services 
that are not expected to be available at all general hospitals. In some regions (e.g. Dublin city), two or 
more large teaching hospitals may provide the services within the stroke network that are provided by 
one comprehensive hospital elsewhere.
Services must meet international criteria for stroke care. The definitions of the European Stroke 
Organisation (ESO) for primary and comprehensive stroke centres are as follows: 
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Primary stroke centres: Centres with the necessary staffing, infrastructure, expertise and 
programmes to provide appropriate diagnosis and treatment for most stroke patients. Some patients 
with rare disorders, complex stroke or multi-organ disease may need more specialised care and 
resources that are not available in primary stroke centres.
Comprehensive stroke centres: Centres that provide both appropriate diagnosis and treatment 
for most stroke patients, and also high technology medical and surgical care (new diagnostic and 
rehabilitation methods, specialised tests, automatic monitoring of multiple physiological parameters, 
interventional radiology, vascular surgery, neurosurgery).
Each stroke network will have at least one hospital meeting international criteria for a comprehensive 
stroke centre. In some instances, this may be through a formalised arrangement at a supra-regional 
level for services needed by a minority of patients. These may include:
1. vascular neurosurgery;
2. selected (but not all) interventional neuroradiological procedures (e.g. intracranial aneurysm 
coiling, vascular malformation ablation);
3. neuropathology;
4. some specialist services available at the National Rehabilitation Hospital.
Other hospitals treating stroke/TIA within the stroke network will meet criteria for an ESO-defined 
primary stroke centre. It is intended that each stroke network will have all services needed by most 
patients at a comprehensive level. The populations served by each stroke network will vary depending 
on geography and population density. The configuration of each stroke network should allow most (at 
least 80%) of the population to access a consultant-delivered 24-hour 7-day thrombolysis service by 
ground ambulance within 90 minutes of stroke onset. It is expected that stroke networks will provide 
services to geographic regions of approximately 500,000 population.
stroke specialist groups
The stroke specialists at general and comprehensive hospitals (geriatricians, neurologists, 
rehabilitation medicine physicians, vascular surgeons, neuroradiologists) will work together in an 
integrated manner in stroke groups. To ensure an adequate mix of specialist skills within each stroke 
network, there must be a balanced appointment of stroke specialists from all three main parent 
specialty areas (i.e. geriatric medicine, neurology, rehabilitation medicine) within the network.
Stroke groups will operate regular clinical care, academic and audit meetings integrated between 
specialties and between the individual hospitals in the stroke network to ensure good communication 
and maintain high standards of clinical care within the network. These meetings may be facilitated by 
video-conferencing to ensure participation by all members of the stroke group.
Where required, timely access to expertise (whether by on-site consultation, video-conferencing 
or transfer) in neurology, neuroradiology, rehabilitation and vascular surgery and to the advanced 
diagnostics located in the larger comprehensive hospital must be made available for patients treated 
in general hospitals within each stroke network.
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Governance of stroke networks
• It is proposed that clinical governance of each stroke network be provided by two stroke 
specialist consultants, acting as Lead Physician and Deputy Lead Physician, and serving terms 
of 3-5 years. They may be appointed by consensus or interview.
• To facilitate integration and foster close working relationships between medical specialties 
and hospitals within the stroke network, it is recommended that these positions are filled by 
two stroke consultants from different parent specialties and from different hospitals.
• Given the importance of developing emergency stroke thrombolysis at a comprehensive level, 
it is recommended that at least one of the two Lead Physician positions is filled by a stroke 
specialist who provides emergency stroke thrombolysis.
• The Stroke Network Lead and Deputy Lead Physicians should be supported by a business 
manager and secretary, and have responsibility for assignment of the stroke network budget, 
including personnel appointments within the stroke network.
• It is recommended that reporting relationships of staff within the stroke network should be 
via the departmental line manager to the Lead and Deputy Lead Physicians.
• A management group should be established within each stroke network. This should meet 
on at least a quarterly basis to review implementation of recommendations within the region. 
Recommended membership is:
• Stroke Network Lead Physician and Deputy Lead Physician;
 • HSE Area Network Manager;
• CEOs of all hospitals within the stroke network;
• Stroke Network Business Manager;
• Senior member of nursing staff from one hospital stroke unit;
• Senior member of allied health professions (physiotherapy, occupational therapy, 
speech/language therapy, social work, psychology);
• Senior General Practitioner within the stroke network.
summary of stroke network recommendations
1. Comprehensive stroke networks, consisting of groups of hospitals providing a comprehensive 
range of services for stroke and TIA, should be established nationally.
2. Core standards should be met by all hospitals providing acute care for stroke within the stroke 
network to fulfil recommended international standards for either a Primary Stroke Centre 
(general hospitals providing stroke care) or Comprehensive Stroke Centre (comprehensive 
hospitals).
3. Stroke specialist physicians (including neurologists, geriatricians and rehabilitation medicine 
physicians) in participating hospitals within each stroke network should form joint stroke 
groups providing high-quality comprehensive hospital care for patients with stroke and TIA, 
integrated within hospitals and across comprehensive and general hospitals, working in a 
shared partnership within the network.
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4. Physician members of stroke groups should establish multidisciplinary (i.e. between 
neurology, geriatric and rehabilitation medicine) structures and work processes to ensure 
regular communication, audit and education on clinical practice within the stroke network.
5. Clinical governance of each stroke network should be provided by a Lead Physician and a 
Deputy Lead Physician from different parent specialties (neurology, geriatric or rehabilitation 
medicine), ideally from different hospitals within the stroke network. At least one of these 
physicians should have expertise in emergency stroke care.
6. The Stroke Network Lead Physician and Deputy Lead Physician should be supported by a 
Stroke Network Management Group, comprising the HSE Area Network Manager, hospital 
CEOs and senior representatives from nursing, allied health professionals and general practice.
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